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Abstract
This thesis investigates the growth dynamics of Escherichia coli bacteria in the
presence of cell wall-targeting antibiotics, using experiments and mathematical
modelling in order to understand quantitatively how these antibiotics interact
with growing bacterial cells. In the experiments E. coli were grown in various
growth media (which result in different growth rates), with a range of antibiotic
concentrations. Measurements of optical density and viable colony counts
revealed complex growth medium-dependent inhibition dynamics for the different
antibiotics, contrary to the “standard” picture that cell wall-targeting antibiotics
are more effective against fast growing bacteria. Complementary microscopy
analysis suggested a strong correlation between the antibiotic mechanism of action
and changes in cell morphology, and consequently the population’s inhibition
dynamics.
To link the mechanism of antibiotic action to bacterial population dynamics, a
mathematical model is presented, guided by the experiments. The model is able
to reproduce the inhibition dynamics and morphological changes observed in the
presence of mecillinam and aztreonam. The model’s robustness and generality
is tested by applying it to other growth conditions, to other antibiotics such
as fosfomycin, and to combinations of antibiotics. The model performs very
well, capturing many of the inhibition dynamics and morphology changes as
observed experimentally, as well as testing different hypotheses for the mechanism
triggering division in E. coli.
In summary this thesis presents a unified experimental and theoretical approach




This thesis investigates how Escherichia coli bacteria grow in the presence of
antibiotics. The antibiotics studied here target the E. coli cell wall, which is a
support structure that completely surrounds the bacterial cell. When antibiotics
target the cell wall, the support structure becomes compromised leading to
changes in the shape of the bacteria, and eventually death of the bacteria. In
our experiments we measured the number of viable E. coli via colony counts, the
total biomass via optical density readings and quantified the changes in E. coli
cell shape using phase contrast microscopy. We performed these experiments
at different antibiotic concentrations and in different growth media (where the
nutrient quality was varied, resulting in the bacteria growing at different rates)
primarily for two antibiotics: mecillinam and aztreonam. The combination of
experiments suggested a strong correlation between the mechanism of antibiotic
action, changes in cell shape and the population dynamics.
In order to better understand the interplay between the mechanism of antibiotic
action, cell shape changes and the observed population dynamics we developed
a mathematical model, guided by our experimental observations. The model
was able to reproduce the population dynamics and shape changes observed
in the presence of mecillinam and aztreonam, by considering the surface area
and volume dynamics of the average E. coli cell and simplifying the biochemical
processes going on within the bacterium. The model’s robustness and generality
was tested by applying it to other growth conditions, to other antibiotics and to
combinations of antibiotics. The model performs very well, capturing many of
the population dynamics and shape changes as observed experimentally, as well
as testing different mechanisms for triggering division in E. coli.
In summary this thesis presents a unified experimental and theoretical approach
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1.1 The broad context of this work
1.1.1 The antibiotic crisis
The emergence and spread of antibiotic resistant bacteria is one of the most
serious clinical problems currently facing the world’s population. By 2050 it has
been projected that more people will die from infections caused by antibiotic
resistant bacteria than from cancer [13]. From a biological point of view,
antibiotic resistance is pervasive and difficult to counteract because it can arise
in a variety of different ways. These can include modification of the antibiotic’s
target, production of enzymes that degrade the antibiotic (beta-lactamases), over-
expression of efflux pumps to remove antibiotic from the bacteria and loss of
porins which are channels that antibiotics diffuse through to enter the bacterial
cell [129].
1.1.2 Ways to overcome the antibiotic crisis
When antibiotics were first discovered in the 1940s, resistance evolution was
already recognised as a problem [75, 157]. Since the 1940s, the problem has
generally been overcome by developing new antibiotics [24]. Over time, finding
new antibiotics has become increasingly challenging, but drug discovery is still
an important part of our strategy to counteract resistant bacteria [153].
Combinations of antibiotics are another promising approach to resolving the
resistance problem. Some combinations of antibiotics behave synergistically,
meaning that lower concentrations of each antibiotic can be used in combination
to yield a greater effect than either antibiotic on its own [92, 100]. In theory
this should reduce the selection pressure for resistance as less of each antibiotic
1
is being used. Antibiotics can also be combined with other drugs that inhibit
antibiotic-degrading enzymes, thus allowing the antibiotic to work unhindered.
This approach is used in clinical practice, although it has been found to lead to
even more complicated resistance mechanisms, when resistance occurs [121].
Another way to reduce the amount of antibiotic required (to treat an infection)
could be by the provision of tailored treatment plans, which are based on
a detailed understanding of the antibiotic-bacteria interaction throughout an
infection. For example, during an infection the growth rate of the infecting
bacteria may change; as some antibiotics are more effective against slowly
growing bacteria it would not be effective to prescribe these antibiotics if the
bacteria are growing quickly [48]. Biofilm infections are another example where
bacterial growth state can be important [103]. For this reason, it is important
to understand how bacteria respond to antibiotics under different environmental
and growth conditions. This is one area where a physical modelling approach can
help.
1.2 Key background biology of E. coli
This thesis focuses on the bacterium Escherichia coli (E. coli). E. coli is one of
the most studied, and best understood, micro-organisms. Strains of E. coli are
responsible for a significant number of clinical infections (especially of the urinary
tract) and have developed extended-spectrum resistance, i.e. resistance to a wide
range of antibiotics, in clinical settings [13].
1.2.1 The E. coli cell envelope
Bacteria can be generally sub-divided into two categories, based on the structure
of the cell envelope: Gram-negative and Gram-positive [106]. E. coli is a rod-
shaped Gram-negative bacterium.
The structure of the cell envelope in E. coli, and other Gram-negative bacteria,
consists of three layers: an inner (cytoplasmic) membrane which is composed of a
phospholipid bilayer and integrated membrane proteins; a thin cell wall composed
of peptidoglycan (PG); and an outer membrane which is an asymmetric bilayer
of phospholipids and lipopolysaccharides (Fig. 1.1). The PG cell wall is anchored
to the outer membrane via lipoproteins. The space between the inner and outer
membranes, within which the cell wall is found, is called the periplasm. The
periplasm contains a variety of proteins in a gel-like solution. The periplasmic
proteins include the penicillin binding proteins (PBPs) which are some of the
main targets of cell wall-targeting antibiotics. The outer membrane provides a
protective layer but to enable the entry of nutrients and other necessary small







Figure 1.1: Left: A simple schematic of the E. coli cell envelope depicting the
inner phospholipid membrane which surrounds the cytoplasm, which in turn is
surrounded by the periplasm containing the peptidoglycan (PG) cell wall. The
entire cell is then surrounded by the outer phospholipid membrane which is
decorated with lipopolysaccharides [23]. The PG cell wall is anchored to the
outer membrane with lipoproteins. Right: An electron micrograph of the E. coli
cell wall showing the outer membrane (om), periplasm (mp) and cell membrane
(cm). Bar, 0.1µm. From Burdett and Murray [10]
these porin channels that antibiotics enter the periplasmic space and disrupt the
cell wall synthesis machinery [96].
In E. coli, the cell wall, made of peptidoglycan (PG), is generally considered to
have a simple single-layered molecular architecture. Peptidoglycan consists of a
network of glycan strands composed of alternating MurNAc (NAM) and GlcNAc
(NAG) sugar residues, which are connected by peptide bonds [33], as shown in
Fig. 1.2. New cell wall material is required for cell elongation and also for cell
division.
The peptidoglycan network forms a strong, but dynamic, macromolecular mesh
that is able to withstand pressures greater that 20 atmospheres [30]. This is
crucial as bacterial cells are under osmotic turgor pressure of several atmospheres
[57]. The PG cell wall is thus the structure that ensures that E. coli are able
to maintain their shape and integrity in a variety of environments (Figure 1.3).
As mentioned, E. coli is rod-shaped and can be considered a spherocylinder i.e.
a cylindrical body with hemispheres on each end (Figure 1.3) forming the poles.
E. coli divides by building a septum at mid-cell. The septum is composed of new
cell wall and will form two new poles once division occurs (Figure 1.3).
NAG NAM NAG NAM
NAM NAG NAM NAG
Figure 1.2: Schematic representing the structure of peptidoglycan. NAG
represents the GlcNAc residue while NAM represents the MurNAc residue, and
the larger, lilac unlabeled rectangle represents the pentapeptide chain. Peptide







Figure 1.3: Schematic of a typical rod-shaped bacterium which can be considered
as a cylinder with two hemispheres capping the ends. A stereotypical E. coli
bacterium is approximately 2µm long and 0.5µm wide, although this depends
on the growth conditions and the phase of growth. Constriction occurs at the
mid-cell during division, forming two new poles.
1.2.1.1 The cell wall synthesis pathway
The synthesis pathway of peptidoglycan is depicted in Fig. 1.4. The precursor
UDP-GlcNAc (UDP stands for uridine diphosphate) arises from the conversion






























Transpeptidase (PBP2, PBP3, PBP1b)
Figure 1.4: Schematic of the biosynthesis pathway of peptidoglycan indicating the
regions of the cell where the reactions occur and differentiating between different
enzyme types with different colours. Blue indicates a ligase, green indicates
a transferase and red indicates other enzyme types. UDP stands for uridine
diphosphate and is a nucleoside. The diagram also shows where some of the
antibiotics used in this study act i.e. fosfomycin, cefotaxime and mecillinam.
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PBP class Activity Examples
A bifunctional GTase/TPase PBP1a, PBP1b, PBP1c
B monofunctional TPase PBP2, PBP3
C monofunctional GTase MtgA
Table 1.1: Summary of E. coli PBPs (penicillin binding proteins) and their
classifications [33]. GTase refers to a glycotransferase and TPase to a
transpeptidase. PBP2 is the target of mecillinam, PBP3 and PBP1b are the
targets of cefotaxime and PBP3 is the target of aztreonam.
GlcNAc is converted to UDP-MurNAc-pentapeptide by the sequential activity of
the MurA transferase, MurB reductase and MurC-MurF ligases in the cytoplasm.
At the membrane, MraY catalyses the reaction of UDP-MurNAc-pentapeptide
with undecaprenylpyrophosphate (a carrier lipid) to generate Lipid I, and this is
coupled to GlcNAc by the MurG transferase to yield Lipid II [64]. Figure 1.4
shows that there are various different geographic points within the cell where a
cell wall-targeting antibiotic could disrupt the pathway: within the cytoplasm,
at the cytoplasmic face of the inner membrane or at the periplasmic face of the
inner membrane. In this project we study one antibiotic with a cytoplasmic target
(fosfomycin) and various antibiotics which act at the periplasmic face of the inner
membrane (including aztreonam, cefotaxime and mecillinam) (Figure 1.4).
1.2.1.2 The Penicillin Binding Proteins
Some of the more important enzymes in the context of the action of cell wall-
targeting antibiotics are the penicillin binding proteins (PBPs). As the name
suggests these were discovered after the mechanism of action of penicillin was
elucidated [125]. PBPs are peptidoglycan synthases, of which there are three
classes as summarised in Table 1.1. In order for the cell wall to grow successfully,
both glycosidic and peptide bonds need to be synthesised, therefore peptidoglycan
synthesis requires both transpeptidase (TPase) and glycotransferase (GTase)
enzymes. PBPs can be monofunctional, or bifunctional TPase/GTase enzymes
[57]. PBPs play various roles in cell division and peptidoglycan synthesis.
Importantly, different sets of PBPs are involved in elongation and cell division.
A schematic illustration of how the PBPs and auxiliary enzymes are organised
into the two main cell wall synthesis machineries can be found in Figure 1.5, these
are often called the “elongasome” and the “divisome” [16]. PBP2 and PBP1a are
thought to provide the main peptidoglycan synthesis activities for elongation
[147], while PBP3 and PBP1b are thought to provide the main PG synthesis
activity for cell division [33]. PBP3 is essential for cell division while PBP1b has
a semi-redundant role in peptidoglycan synthesis [33].
Another important player in the synthesis and maintenance of the cell wall is the
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Figure 1.5: An excerpt of Figure 1 from Cho et al. [16] depicting the
elongation (‘Rod System’) and division (‘Divisome’) associated cell wall synthesis
machineries. PBP2 and PBP3 are transpeptidases while PBP1a and PBP1b are
bifunctional transpeptidase/glycotransferases. FtsW is a Lipid II flippase. RodA
is thought to be a glycotransferase [17].
actin-like protein - MreB. MreB is required for rod-shaped growth and interacts
with a host of other proteins (MreC, MreD, RodZ and lipid II synthesis enzymes
MraY and MurG). MreB is thought to play a structural role and is hypothesised
to guide the localisation of the cell wall elongation machinery around the cell wall
[102, 117]. A similar structural protein, FtsZ, guides the localisation of the cell
division machinery [116].
1.2.1.3 The PBPs and growth rate
Bacteria grow at different rates depending on their environmental conditions (e.g.
the richness of the nutrient media). In this thesis we explore the impact of growth
rate on the efficacy of cell wall-targeting antibiotics. It is therefore useful to know
how the abundances of the main targets (the PBPs) of the cell wall-targeting
antibiotics are impacted by growth rate. Dougherty et al. [28] calculated the
numbers of PBPs (1a, 1b, 2, 3, 4, 5, 6, 7 and 8) per cell of E. coli MC4100
in different growth media (M9 glucose and LB) by radiolabelling the PBPs,
separating the PBPs by gel electrophoresis and comparing PBP abundance to
cell number as determined by colony counts. They found that slower growing
cells contain significantly less of each PBP per cell, in terms of absolute number.
The growth rate of E. coli can also impact the cell wall synthesis machinery
by affecting the rate at which each PBP is synthesised. We have performed
a sub-analysis of absolute protein synthesis rate data that was produced by Li
et al. [82] using ribosome profiling on rich and poor media (MOPSgluRDM and
MOPSgluMIN respectively). This is shown in Figure 1.6, for cell wall related
proteins. Li et al. [82] determined the absolute synthesis rate on two growth
media (in units of molecules produced per generation) by normalising the average
ribosome density for each protein in the proteome by the total amount of proteins
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Figure 1.6: The ratio between the absolute synthesis rates (units of molecules
produced per generation) on the poor growth media MOPSgluMIN (SMIN) and on
the rich media MOPSgluRDM (SRDM) for cell wall associated proteins using data
from Li et al. [82]. The proteins have been grouped according to their primary
function: synthesis of PG precursors, maintaining stability (e.g. associated with
lipoproteins and anchoring of the cell wall to the outer membrane), elongation,
division and other. A value less than 1 indicates a decrease in synthesis rate for
that protein at slower growth rate. The inset shows the ratio between poor and
rich synthesis rates as a function of doubling time.
synthesised during the cell doubling time. In our analysis we determined which
genes were associated with the cell wall using the Ecocyc database [67], and
grouped them by their primary function. To visualise the impact of growth rate
on the synthesis rates we took the ratio of the synthesis rate on poor medium to
the rate on rich medium (Figure 1.6). Figure 1.6 shows that the rate at which
the majority of cell wall associated proteins are synthesised decreases when the
bacteria are growing at a slower rate (in a poor growth medium, compared to a
rich medium).
1.2.1.4 Role of hydrolases
Hydrolases are enzymes which cut the peptidoglycan network - an activity that is
necessary for the insertion of new material during growth, and in separating the
two daughter cells during division [57, 140]. In E. coli as much as 40-50% of the
total peptidoglycan material is removed in each generation [104]. The resulting
soluble fragments of PG are reused via the peptidoglycan-recycling pathway [64,
104]. E. coli has more than 20 hydrolases which include amidases (e.g. AmiA-
EnvC), lytic transglycosylases (e.g. Slt), carboxypeptidases (e.g. AmpH) and
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endopeptidases (e.g. PBP4 and PBP7) [105].
It has been observed that PG hydrolases can help or hinder the action of cell wall-
targeting antibiotics. For example, Heidrich et al. [53] investigated the role of the
three amidases that are linked with the divisome machinery in E. coli, finding a
balance between PBP3, the three amidases and the lytic transglycosylase (Slt70).
If PBP3 and Slt70 were inhibited, the amidases became uncontrolled resulting in
lysis, while if PBP3 and an amidase were inhibited then Slt70 was unregulated
triggering lysis. This indicates that to achieve fast cell death when inhibiting
PBP3 it is necessary to also inhibit one of the hydrolases. Conversely, Dörr
et al. [27] found that endopeptidases in the bacterium Vibro cholerae enabled the
organism to tolerate cell wall synthesis targeting antibiotics, by remodelling the
peptidoglycan network into an osmotically stable sphere.
These observations suggest a balance between the activities of PBPs and
hydrolases, with two possible outcomes when PBPs are inhibited. Firstly, the
hydrolases may slowly remodel the PG when PBPs are inhibited resulting in
spherical bacteria which are relatively stable [27]. Alternatively, active hydrolases
may quickly out-balance PBP activity, leading to lysis [53].
1.2.2 Typical E. coli growth dynamics
A typical growth curve for E. coli in the absence of antibiotics can be seen in
Fig. 1.7 highlighting the different growth phases. Here, the optical density at 600
nm (OD600) is used as a measure of the number of cells present in the culture.
Optical density is a measure of how much light at a given wavelength is scattered
by the cells in a suspension [50]. If a culture is well dispersed, and assuming
cell shape does not change, optical density is proportional to bacterial density
throughout most of the initial growth phase. Thus, optical density measurements
provide a way of estimating the number of bacteria per milliliter of suspension [93].
Figure 1.7: An illustrative bacterial population growth curve from Hall et al.
[50] with the different growth phases labelled.
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Bacterial growth curves are normally characterised by three stages [96]. First
there is a ‘lag phase’, in which little growth is seen as the bacteria become
accustomed to the growth medium. Next there is a period of exponential growth,
followed by a ‘stationary phase’ where bacteria either do not grow or the rates of
growth and death balance.
During the exponential growth phase, cells proliferate at a rate proportional to




where N is the concentration of cells, t the time and λ a constant of propor-
tionality, which is called the specific growth rate. If this expression is integrated
between the limits of 0 and t and N1 and N2 the result is:
ln (N2/N1) = λ (t2 − t1) (1.2)
Therefore, if the natural logarithm of the number of cells present in a culture
(or of the optical density of the culture) is plotted against time, a straight line
should result during the exponential phase, where the gradient is the specific
growth rate.
Another common measure of the growth rate of a bacterial culture is the doubling
time, Td. This is the time required for the number of cells to increase by a factor
of 2 and can be determined by:
Td = ln 2/λ ≈ 0.693/λ. (1.3)
Under optimum conditions E. coli can achieve a doubling time of 20 minutes [96].
By altering the environmental conditions e.g. nutrient quality, one can alter the
growth rate in a controlled manner. We will use this approach in Chapters 3, 4
and 5 of this thesis.
1.2.3 Mechanisms of division initiation
As some cell wall-targeting antibiotics interfere with cell division, it is important
to discuss how E. coli initiates and controls its division process. The initiation of
division is still a topic of debate, with the added complication that bacteria may
employ different division triggering mechanisms under different growth conditions
[1, 12, 68, 128].
The general mechanism underlying E. coli cell division is as follows. An initial
group of divisome proteins assemble at the mid-cell, orchestrated by the MinCDE
system [116], before a constriction is visible [33]. This group includes FtsZ,
which is a structural, cytoskeleton-like protein that forms what is called the “Z-
ring” around the circumference of the cell, guiding the localisation of the other
division enzymes. Then, immediately before constriction, the divisome “matures”
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by incorporating the remaining divisome proteins, including the transpeptidase
PBP3 [33].
Much of the debate around the initiation of cell division centres on the “signal”
used by the cell to trigger division.
1.2.3.1 Timer hypothesis
The “timer paradigm” suggests that a bacterial cell attempts to grow for a fixed
amount of time between birth and division [128] - the rationale being that it is
necessary for the genome to be fully duplicated and separated before division
can occur. This paradigm is inspired by the work of Cooper and Helmstetter
[20] who suggested that the time between the end of a round of DNA replication
and cell division is constant and independent of the growth rate, assuming that
the rate of DNA synthesis per replication origin is a constant independent of the
overall cellular growth rate [20] (although the number of replication origins that
are active within the cell increases with growth rate [1, 20]).
Regarding the mechanism of E. coli division control, the timer hypothesis simply
states that division is initiated a fixed time after birth, and this fixed “division
time” is growth-rate dependent. No specific molecular mechanism is proposed.
1.2.3.2 Sizer hypothesis
The “sizer paradigm” suggests, instead, that a bacterial cell monitors its size and
triggers division once a critical size is reached [128]. The sizer model is generally
dismissed, as single cell data shows that the cell size at division is not fixed but
is instead positively correlated with the size at birth [6].
1.2.3.3 Adder hypothesis
The “adder paradigm” proposed by Campos et al. [12], suggests that bacterial
cells add a fixed volume between birth and division, irrespective of their newborn
size. Experiments using a microfluidic ‘mother machine’ in which many individual
E. coli and Bacillus subtilis cells can be observed growing under a range of growth
conditions, suggest that the adder model explains experimental data at both the
population and single-cell levels [128]. Taheri-Araghi et al. [128] also argue against
the sizer and timer division models. Firstly, they observed that the newborn cell
size was negatively correlated with the doubling time, which disagrees with the
timer model. Secondly, a positive correlation between the dividing size and the
newborn cell size was measured, counteracting the sizer model.
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Figure 1.8: An excerpt from Figure 3 of Taheri-Araghi et al. [128] demonstrating
the principle of the adder division model. Division occurs after a constant volume
∆ is added, and this results in convergence to a steady state cell size, sb.
1.2.3.4 Mixed models
Further work in the field has attempted to elucidate the mechanism underlying
the adder model by mapping the chromosome replication cycle at the single cell
level [148]. Applying the Cooper-Helmstetter model on a single cell level, Wallden
et al. [148] suggest that the underlying mechanism is actually a combination of the
timer and sizer pictures. They suggest that replication is initiated when the cell
has grown to a fixed volume per origin of replication (sizer-like). Then, the cell
divides at a growth-rate dependent fixed time after replication initiation (timer-
like). When E. coli cells are growing quickly replication is initiated in a previous
generation [1]. Therefore the volume at division becomes uncorrelated with the
birth volume. Thus this combined mechanism reproduces “adder-like” dynamics
for fast growing cells. In contrast, when cells are growing slowly, replication
initiation occurs in the same generation as the corresponding division initiation.
In this scenario, the division volume will be proportional to the initiation volume
and independent of growth rate. In this case the cells are expected to behave as
“sizers”. The data of Wallden et al. [148] indeed supports this view.
An improvement on the work of Wallden et al. [148] is found in Micali et al. [89].
In this improved model the assumption of growth-rate dependent division after
replication initiation is removed. Instead the model consists of two size-dependent
processes which occur concurrently, with division being determined by the slowest
of the two processes [89]. With this model formulation the correlation between
C+D period duration and growth rate, as well as the correlation between cell




The “precursor threshold model” is an alternative idea that has been suggested
by Harris and Theriot [51]. Based on careful examination of the surface
area and volume of growing E. coli, C. crescentus and B. subtilis cells, they
hypothesise that the surface area to volume ratio (SA/V) is the key variable in
bacterial growth. With this hypothesis they develop a simple model for SA/V
determination which attempts to explain how cells reach a steady state SA/V
over time.
Harris and Theriot [51] suggest that the rate of synthesis of new surface area
material per unit volume may be relatively constant over a cell cycle, such
that during cell elongation there will be an accumulation of excess surface area
“precursors”. Once a threshold “precursor level” is reached, Harris and Theriot
[51] suggest that division is initiated and the excess material used up in the
production of the new cell end-caps (poles). This mechanism is predicted to lead
to adder-like behaviour [51]. While there are no direct measurements of precursor
levels to back this hypothesis, it does provide a potential molecular mechanism
for division triggering. A similar concept has been discussed in Chien et al. [15]
using FtsZ as the molecule of interest.
1.2.4 Proteome-partitioning
As discussed, the growth rate of the bacteria can impact the synthesis rate of
proteins. However, there is a limit to how fast proteins can be synthesised based
on the need of the bacteria to also synthesise ribosomes, in order to synthesise
those proteins. This idea has led to the concept of “proteome-partitioning”, in
which the proteome is considered to consist of a number of distinct segments:
ribosome-affiliated proteins whose fractional abundance increases with growth
rate, a fixed “core” whose fractional abundance is independent of growth rate and
the remaining proteins whose fractional abundance decreases with growth rate
[9, 118]. These patterns of abundances can by explained by growth rate-dependent
partitioning of the cell’s translational resources between the production of new
ribosomes and the production of other proteins [118].
Scott et al. [118] showed that this partitioning can be described by a set of
empirically determined constraint functions [118]. Firstly, the RNA/protein ratio
r is linearly correlated with the specific growth rate λ:




This is expected if the ribosomes are growth-limiting and are engaged in
translation at a constant rate (κt) [118]. Here r0 is the minimal RNA to protein
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ratio. There is also another linear relation linked to the nutritional capacity κn:




Here, rmax is the (extrapolated) maximal RNA/protein ratio. These linear
relations can be combined to give the prediction that the maximal growth rate
is proportional to rmaxκt [118]. These relations have previously been employed
to aid our understanding of antibiotic mechanism of action. Greulich et al. [48]
showed that these relations, combined with a simple model for antibiotic action,
could explain several non-trivial features of the growth-medium dependent action
of ribosome-targeting antibiotics.
1.3 Cell wall-targeting antibiotics
1.3.1 Prevalence of cell wall-targeting antibiotics
Cell wall-targeting antibiotics are the most widely used class of antibiotics in
a clinical setting [11]. Of the antibiotics studied in this thesis, for example,
fosfomycin and mecillinam are used for uncomplicated urinary tract infections [38,
132]. Cell wall-targeting antibiotics are clinically successful because cell walls are
structures unique to bacteria leading to high target specificity [11] and reduced
toxicity to the patient [86]. Furthermore, cell wall-targeting antibiotics are often
bactericidal (i.e. they kill bacteria, rather than just preventing growth), leading
to complete bacterial clearance [11].
However, the effectiveness of antibiotic treatment has become diminished due to
ever increasing levels of resistance [11]. For example, the widespread use of the
cell wall-targeting antibiotic cefotaxime is thought to be the major cause of the
spread of extended-spectrum beta-lactamases [69]. Beta-lactamases are enzymes
produced by many strains of multi-drug resistant bacteria that degrade the beta-
lactam class of cell wall-targeting antibiotics.
Cell wall-targeting antibiotics include intracellular antibiotics, beta-lactams and
glycopeptides (Figure 1.9). Beta-lactams, which form the main topic of this
thesis, are a large family of antibiotics including cephalosporins, carbapenems,
penicillins and monobactams (see Figure 1.9 and later discussions). Glycopep-
tides predominantly target Gram-positive bacteria, and as such they will not be
discussed any further.
1.3.2 Targets in the cell wall synthesis pathway
As we have seen, the cellular pathway which synthesises peptidoglycan is


















Figure 1.9: Cell wall-targeting antibiotic “family tree” - lilac boxes differentiate
different antibiotics by general mode of action; blue boxes refer to the further sub-
categories in the beta-lactam class; italicised text shows named examples that are
not studied here; green boxes highlight the key antibiotics studied in this thesis.
This is not a fully comprehensive picture of the large class of cell wall-targeting
antibiotics but helps with visualising where the antibiotics of interest fit in.
antibiotics. However, there is some redundancy in the cell wall synthesis pathway
(as might be expected as it is a life-critical system of the cell) [33, 75]. Therefore,
many cell wall-targeting antibiotics have affinity to multiple targets [72, 133]. To
keep our study as simple as possible, in this thesis we focus mainly on antibiotics
which have a single major molecular target. In the following we briefly discuss
the chosen antibiotics in more detail.
1.3.2.1 Antibiotics that act within the cytoplasm
Fosfomycin (Fos.) (Fig. 1.10) is a hydrophobic molecule that is imported into
the cytoplasm via membrane bound transporters [99]. Fos. irreversibly inhibits
MurA, an enzyme found in the cytoplasm at the start of the biosynthesis pathway
of peptidoglycan (Fig. 1.4) [38]. As Fos. acts at a critical early stage of the
peptidoglycan pathway, which is found in all bacteria, it has a broad spectrum
of activity [90].
The chemical structure of fosfomycin can be seen in Figure 1.10. Fosfomycin has








Figure 1.10: The chemical structure of fosfomycin.
1.3.2.2 Antibiotics that act at the periplasmic face of the cytoplasmic
membrane
The beta-lactams are a large class of antibiotics which work by inhibiting
PBPs (penicillin binding proteins) [99]. Beta-lactams function by structurally
mimicking the D-Ala-D-Ala component of the peptidoglycan stem peptide, to
form an irreversible intermediate within the active site of the PBPs. Beta-
lactams have a long history: the original beta-lactam, penicillin, paved the
way for the discovery of many more chemically related beta-lactam antibiotics
[24]. For example, cephalosporins were discovered when beta-lactamase enzymes
started to make penicillins ineffective [45]. The core structures of the penicillin,
cephalosporin and monobactam classes of beta-lactams are shown in Figure 1.11.
Three beta-lactams are studied in this thesis: mecillinam, aztreonam and
cefotaxime.
Mecillinam (Mec.) (Figure 1.12) is classified as a penicillin but it deviates
from the core penicillin chemical structure (Fig 1.11), as it has a side chain
joined to the beta-lactam ring by an amidine bond rather than a β-acylamino
group (see Figure 1.12) [5]. Mecillinam is also known as amdinocillin [132] and
FL 1060 [136]. Mec. specifically targets the transpeptidase (TPase) active site of



























Figure 1.11: The core structures of the cephalosporin, penicillin and monobactam
classes of beta-lactam antibiotics. Monobactams have no secondary ring attached
to the beta-lactam ring [4], while penicillins have a five-membered thiazolidine
ring fused to the beta-lactam ring and cephalosporins have a six-membered










Figure 1.12: Mecillinam chemical structure.
The population dynamics of E. coli growing in the presence of mecillinam have
been previously described [14, 46, 137]. These studies report that a cell culture
continues to increase in optical density for some time after Mec. is added. Later,
the OD decreases (creating a ‘bump’) and, ultimately, apparent recovery of the
population (‘regrowth’) happens (Figure 1.13). The hypothesis has been put
forward that the bump is due to the formation of large spherical cells that divide
more slowly and eventually lyse [46]. The “regrowth” has been attributed to cells
that happened to have lower osmotic pressure, were therefore more osmotically
stable as spheres and thus tolerated mecillinam [46]. Others have suggested that
the regrowth may be due to decay of mecillinam [14].
Aztreonam (Azt.) (Fig. 1.14) is a monobactam that binds PBP3 irreversibly,
thus preventing cell division [107]. The mechanism behind the prevention of
division has been partly elucidated as it has been found that antibiotics which
Figure 1.13: Figure 1 from Greenwood [46] demonstrating the population

















Figure 1.14: The chemical structure of aztreonam.
target PBP3 reduce the localisation of PBP3 approximately two-fold at septation
sites [150], therefore these antibiotics prevent the complete maturation of the
divisome.
Exposure to sub-MIC levels of aztreonam results in the production of long
filaments, for levels of aztreonam corresponding to inhibition of 60% of the total
PBP3 [107]. These filaments eventually become unstable and lyse.
Cefotaxime (Ctx.) (Figure 1.15) is a third generation cephalosporin beta-lactam
(Figure 1.11) that targets several different PBPs. In particular, cefotaxime shows
a high affinity for PBP3 and PBP1b [72]. Therefore, like aztreonam, cefotaxime
directly inhibits cell division. Consistent with this, several studies have shown
that E. coli cells exposed to cefotaxime form filaments [45, 69] - for an example
see Fig. 1.16.
Another interesting morphological change in the presence of cephalosporins is
bulge formation (Figure 1.16). Yao, Kahn and Kishony (2012) argue that beta-
lactam killing of E. coli has four stages: cell elongation, bulge formation, bulge















Figure 1.15: The chemical structure of cefotaxime.
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Figure 1.16: Left: Images taken from Kjeldsen et al. [69] Fig. 1
showing filamentation of two sensitive strains cells at sub-MIC cefotaxime
concentrations [69]. Right: An example of bulge formation under the action
of cephalexin (another cephalosporin) taken from [154].
the observed dynamics. They argue that the outer membrane plays an important
role in stabilising bulges, thus delaying lysis due to the antibiotic activity. Bulges
are found to form abruptly at potential dividing sites and it has been suggested
that they might allow for recovery of normal growth once the antibiotic pressure
is removed [154]. It is however not clear why formation of a bulge should protect
a cell from killing by an antibiotic.
1.3.3 Beta-lactams and growth rate
An important focus of this thesis is on the growth-rate dependence of antibiotic
action. There are several reasons to expect that the activity of beta-lactams
should be different for fast-growing versus slow-growing bacteria. Firstly,
mecillinam, aztreonam and cefotaxime all target PBPs, whose abundance varies
with growth rate as discussed in Section 1.2.1.3. For example, Dougherty [28]
measured the numbers of PBP{1a, 1b, 2, 3, 4, 5, 6, 7, 8}s per cell of E. coli in
different growth media, finding that slower growing cells contain a significantly
lower number of each PBP per cell.
Direct evidence also exists for growth-rate dependent beta-lactam action. Cozens
et al [22] investigated how growth rate affects the killing activity of beta-
lactam antibiotics. By growing cells in a range of growth limiting conditions,
mimicking the conditions in a real, in vivo infection, they concluded that only
a few antibiotics remained effective at killing slow growing cells. Additionally,
slow growing bacteria were killed proportionately more slowly. In similar
work, Tuomanen et al. [134] found that the beta-lactam killing rates were
proportional to the bacterial generation time and that slow growing bacteria
become progressively more phenotypically tolerant to beta-lactam activity [134].
Therefore, in general, faster growing bacteria are more easily killed by cell wall-
targeting antibiotics. This contrasts with the naive expectation that slow-growing
cells have fewer PBPs and should thus be easier to kill.
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1.3.4 Resistance mechanisms to cell wall-targeting
antibiotics
Because beta-lactams often bind to multiple PBPs these antibiotics typically cir-
cumvent single-mutation resistance mechanisms. However, bacteria can become
resistant via reduced membrane permeability or efflux increase, expression of
PBPs with reduced affinity for the antibiotic, bypassing of cross-linking the stem
peptide with transpeptidases, or degradation of the antibiotic by β-lactamase
enzymes [129]
For intracellular antibiotics, transport provides a potential target for mutation.
As an example, the requirement for transport of fosfomycin into the cytoplasm
is a potential weakness in the efficacy of the antibiotic; decreasing the expression
of transporters can reduce the cell’s antibiotic susceptibility [99].
1.4 Modelling antibiotic-bacteria interactions
In Chapters 6, 7 and 8 of this thesis, we will develop a mathematical model
for the action of cell wall-targeting antibiotics. While mathematical modelling of
antibiotic action is far from new, our model is unusual in that it combines cell-level
physiology and cell morphology, with population dynamics. To set our work in
context, we briefly review the types of models that have previously been developed
for antibiotic action, with an emphasis on cell wall-targeting antibiotics.
A number of models have been developed with the aim of optimising antibiotic
treatments. These are population-based, with no description of the internal
workings of the target bacteria. For example, Levin and Udekwu [80] developed
a model that combined the known pharmacodynamics (the in vitro relationship
between antibiotic concentration and the growth or death rate of the target
bacteria) of antibiotics with the population dynamics of bacteria in order to
evaluate the efficacy of antibiotics and improve data on the minimum inhibitory
concentration (MIC) [80]. Their model consists of differential equations describing
different sub-populations of bacteria experiencing an environment with varying
antibiotic concentrations, as depicted in Figure 1.17. This model allows the
generation of testable hypotheses for how the density of viable bacteria changes
in a range of situations e.g. bacteriostatic versus bacteriocidal antibiotics, batch
versus continuous culture, low versus high initial bacterial density.
On the level of individual bacteria, various models have been developed that
look closely at the structure of the E. coli cell wall. Typically these model
the peptidoglycan mesh as a network of springs (see Figure 1.17) and predict
morphological changes when the peptidoglycan is perturbed (i.e. in the presence
of an antibiotic) [58]. One can also include the action of cell wall synthesis
enzymes and determine which enzymes need to coordinate for a cell to grow in a
stable fashion [98]. The growth dynamics of the cell wall have also been studied
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with more theoretical models: for example one can try to calculate the changes
in free energy when adding new peptidoglycan sub-units and how this determines
the interplay between cell wall growth and the structural MreB filaments [62].
Less modelling effort has been focused on the interaction of antibiotics with the
entire “cell system”. However, some work has been done for other antibiotic
classes. For example, Greulich et al [48] developed a model which simplifies
the bacterial cell as a box into which ribosome-targeting antibiotics diffuse in
and out. In the model, ribosomes produce proteins at a certain rate (including
more ribosomes), and the cell grows at a rate determined by the rate of protein
production. This results in a series of coupled differential equations which
link the mechanism of action of the antibiotic with the observable population
dynamics. The outcome of the model is a non-trivial prediction of the growth
medium-dependence of ribosome-targeting antibiotics that is in agreement with
experimental data. To our knowledge this kind of model does not yet exist for
cell wall-targeting antibiotics.
To summarise the field, mathematical models, tend to be constrained to one of
the zones depicted in Figure 1.17: population dynamics, cell structure or cell
physiology. The aim of this thesis is to develop a thorough understanding of the
action of cell wall-targeting antibiotics and hence build a mathematical model
which combines these zones. i.e. which uses the intracellular dynamics of the
antibiotic, with the target, to predict a change in cell structure, and thus a





e.g. Levin & Udekwu 2010
Cell structure
e.g. Huang et al 2008
Cell physiology
e.g. Greulich et al 2015
EXTRACELLULAR
INTRACELLULAR
Figure 1.17: Various examples of mathematical models looking at antibiotic
interactions with bacteria on different scales. Firstly, Figure 2 from Levin
and Udekwu’s 2010 paper [80] depicting a representation of their mathematical
model investigating the dynamics of bacterial sub-populations in the presence of
changing antibiotic concentrations. Secondly, Figure 1 from Huang et al’s 2008
paper [58] depicting a representation of their elastic model for the peptidoglycan
network and the predictions for a cracked cell. Glycan strands are shown in green
and peptide crosslinks in red. Thirdly, Figure 2 from Greulich et al’s 2015 paper




2.1 Culturing E. coli
2.1.1 E. coli strains
Two strains of the bacterium Escherichia coli (E. coli) were used for the majority
of the work in this project. These were E. coli MG1655 wild type, chosen
because it is a widely studied E. coli strain and therefore easy to compare and
contrast with the literature, as well as E. coli RJA002, which is an MG1655
strain carrying a chromosomal yellow fluorescent protein (YFP)/chloramphenicol
resistance reporter. The reporter is under the control of the constitutive λPR
promoter, and was made by P1 transduction from strain MRR of Elowitz et al.
[34][83].
2.1.2 Growth media
The E. coli strains used here can grow in a variety of growth media. Growth
media can be grouped into two broad categories: undefined and defined. These
terms refer to how well categorised the growth media composition is: for example,
growth media derived from yeast products or from blood are undefined, whereas
defined growth media are put together from a list of known chemical constituents.
One of the standard undefined growth media used worldwide is Lysogeny Broth
(LB), which is a nutrient rich yeast-derived growth medium, typically with pH
7.0. This was made in-house. In this project LB was used in both liquid and
agar forms. We used liquid cultures to measure bacterial population dynamics
or prepare bacteria for microscopy. LB agar plates were used to either isolate
individual colonies or to count the number of colony forming units present in a
sample.
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To investigate the population dynamics of E. coli in liquid culture, in the presence
of antibiotics, it was deemed best to use a defined growth medium. Using a defined
growth medium removed any potential batch differences in LB and gave us more
control over the nutrients present in the media. This was achieved by using MOPS
(potassium morpholinopropane sulfonate)-based media (originally developed by
Neidhardt et al. [95]), which has a defined chemical composition and in which
the nutrient quality can be varied. In earlier experiments the components of
MOPS media (the MOPS buffer, EZ amino acids and ACGU nucleotides) were
purchased from Teknova. However, there were problems with maintaining the
stability of these components in transport, so later in the project the production of
these components moved in-house (Sharareh Tavaddod, Angela Dawson, Tracey
Squires: University of Edinburgh). These components were made according to
the recipe in Neidhardt et al. [95]. The MOPS base medium is made up of:
MOPS, which acts as a pH buffer; tricine (source of iron); KOH (to buffer to
pH 7.4); FeSO4; NH4Cl; K2SO4; CaCl2:2H2O; MgCl2; NaCl; micronutrient stock
(ammonium molybdate, boric acid, cobalt chloride, cupric sulfate, manganese
chloride, zinc sulfate); sterile H2O and K2HPO4. Together, these components
provide many of the requirements for robust bacterial growth. The MOPS
medium needs to be supplemented with a carbon source: here we used glucose or
glycerol (2% w/v glucose or glycerol). Adding a carbon source to the MOPS
base gives a minimal growth medium (MOPSglu/glyMIN). To achieve faster
growth the minimal media is supplemented with amino acids and nucleotides (in
predefined mixtures known as ACGU nucleotides and EZ amino acids) to give a
rich-defined medium (MOPSglu/glyRDM). An intermediate medium (nutrient-
wise) can also be made by supplementing the minimal medium with casamino
acids (CAA) to a final concentration of 0.2% (w/v) from a 10% casamino acid
solution (MOPSglu/glyCAA).
This standard MOPS medium has pH 7.4. For some of our experiments the
medium was adjusted to pH 6.5 by gradually adding 1M HCl whilst measuring
the pH using a Mettler Toledo pH meter with LE409 probe calibrated with a
phthalate type buffer (pH 4.01) and a phosphate type buffer (pH 7) (both from
Hach). In the end there was 2-3% 1M HCl in the total volume.
2.1.3 Preparing bacterial cultures for experimental use:
steady state versus non-steady state
A bacterial population is typically genetically diverse, due to rapid mutation
rates [84]; the impact of this can be reduced by starting experimental cultures
with an (as close as possible) isogenic population. This is achieved by inoculating
a “starter culture” with a colony that has grown from a single bacterial cell [91].
The general protocol for all experiments in this thesis is as follows. A sample is
taken from a frozen aliquot of the desired strain and streaked out onto an LB agar
plate (Figure 2.1). This plate is incubated at 37°C overnight for approximately
18 hours, or until single colonies are clearly visible. It can be assumed that
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Figure 2.1: The streak plate protocol to mechanically disperse the bacteria.
Streaking the sample across the LB agar gradually reduces the number of cells
present in each streak.
each colony arises from a single starter cell and is therefore isogenic [91]. In my
experiments, single colonies were used to inoculate 5ml LB “seed cultures” which
were grown for 2 hours at 37°C and 200 rpm. 10µl of the “seed culture” was then
used to inoculate 5 ml liquid cultures in the chosen growth medium, which were
allowed to grow overnight in a shaker at 37°C and 200 rpm to reach a high cell
density.
From this point my experiments followed one of two pathways: “steady state” and
“non-steady state” growth (Figure 2.2). For non-steady state growth the overnight
culture is diluted 1/1000 into fresh media pre-warmed to 37°C and allowed to
grow until mid-exponential phase (this roughly corresponds to an optical density
of 0.2 at 600 nm, which corresponds to a bacterial density of approximately
2×107 cfu/ml (cfu stands for colony forming units i.e. viable cells)). This OD∼0.2
culture is then used as the inoculate for the experiment. This preparation is
called “non-steady state” as the bacteria have only undergone 3 or 4 generations
of exponential growth after the overnight culture and, while it is likely that most
cells will be growing exponentially, some may still be in the stationary phase and
not growing yet, while some may be in the early stages of growth. This leads to
a heterogeneous bacterial cell population.
For some experiments this heterogeneous population can cloud the results, so in
most of my work a “steady state” culture was used. To generate a steady state
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Figure 2.2: A diagram highlighting the protocols for non-steady state and steady-
state bacterial culture preparation.
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Figure 2.3: The standard deviation of the optical density for 8 wells across
two independent plate reader assays (4 wells in each) with no antibiotic (top),
and with 1.5µg/ml mecillinam (bottom) in MOPSgluMIN. Using a steady state
(SS) culture, versus a non steady state (NonSS) culture, greatly increases the
reproducibility of growth curves across experiments.
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generations by diluting periodically in pre-warmed growth medium (Figure 2.2).
The maximum optical density of a cell culture before each dilution was 0.4 at
450 nm. This method is used to achieve a “homogeneous bacterial culture” [49].
Figure 2.3 demonstrates the impact of having a steady state culture versus non-
steady state, by plotting the standard deviation in the optical density over time.
It is very clear that having a steady state culture greatly decreases the noise
in the optical density measurement, and reduces the standard deviation, both
with and without antibiotic (Figure 2.3). Working with steady state cells was
important for comparison to the mathematical model, where steady state growth
is assumed.
2.2 Protocols for measuring population
dynamics
2.2.1 Optical density
In my work, a key observable of interest is the number of bacteria present at any
given time. Since direct measurement of bacterial numbers is difficult, various
proxy measures have been developed e.g. measuring dry weight or estimating
the metabolic activity [93]. “Optical density” is a very common proxy measure
for the number of bacteria in a liquid culture, due to its ease of measurement.
Optical density (OD) is a measure of light scattered (log I0/I) by a sample, the
simple idea being that in a well mixed, dilute, sample of bacteria, the number
of bacteria present should correlate with the amount of light scattered [93].
There are several caveats to using optical density as a measure of cell number:
optical density and cell number are generally only well correlated up to a certain
bacterial density (due to the increasing occurrence of multiple scattering events
[74]); various wavelengths of light are used in the literature (e.g. 450 nm [152],
420 nm[134] , 550 nm[108] and 600 nm[16, 48, 81, 145]) which can make it more
difficult to compare results between studies; if cell size or shape changes during
an experiment this will also affect optical density (indeed optical density can be
argued to be a measure of total biomass) [87]. Nevertheless, OD is a convenient
measure for measuring trends in population size, and can be highly informative
if these caveats are properly taken into consideration.
2.2.1.1 Spectrophotometer
There are various methods for measuring optical density, two of which were
used in this thesis. The first method used in this work was a benchtop
spectrophotometer. A spectrophotometer sends a beam of light through a sample
and measures the decrease in light intensity due to scattering, at a photodetector
on the other side of the sample [74]. A benchtop spectrophotometer is commonly
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used when working with larger volumes of liquid culture, and in this case was
used primarily to measure the optical density of the inoculate when preparing for
experiments, and during experiments where samples were periodically removed
from a shake flask culture - for microscopy or for counting colony forming units.
A Cary UV spectrophotometer and polystyrene cuvettes (FisherBrand, FB55146)
with 1 ml of sample were used to measure the optical density at 600 nm.
2.2.1.2 Plate reader
In other experiments, high throughput growth curve measurements were carried
out in plastic microplates (flat-bottomed microplates from Greiner) like that
shown in Figure 2.4, using a Fluostar Optima plate reader. The microplate
is made of polystyrene and consists of 96 (8x12) flat-bottomed wells, of volume
392µl, indexed by the letters A-H and the numbers 1-12 (Fig. 2.4). The plate
reader incubates the plate at the desired temperature and shakes it in between
automated optical density measurements. This method enabled us to carry out
multiple experiments simultaneously - using different rows and/or columns. The
Fluostar Optima plate reader was generally set to incubate at 37°C (or 34°C/30°C
as needed) with double orbital shaking at 600 rpm. Optical density measurements
at 600 nm were taken approximately every five minutes, with continuous shaking
in between measurements. Each well contained 200 µl of sample or growth media.
Maintaining the same volume in each well was important as the path length
correction of the plate reader was calibrated for this volume and deviations from
this would have lead to erroneous optical density measurements. Lids were used
on the plates to reduce evaporation over the course of the experiments (various
tests were carried out to ensure that evaporation was not impacting results).
Lids were taped onto the microplate at four points to reduce the production of
plastic dust when the microplate was shaken, but also to ensure that air could
still circulate around the microplate.
A bacterial culture at an optical density of 0.2 was diluted 1:20 into the plate,
resulting in a starting cell concentration corresponding to an optical density of
Figure 2.4: An 8x8 snapshot of a 96-well microplate.
27
Figure 2.5: Wells grouped by location: TopEdge=Row A, RightEdge = Column
12, BottomEdge = Row H, NonEdge = all other wells. The bar charts indicate
the average growth rate (h−1) for E. coli MG1655 growing in LB medium at 37°C
in wells at these different locations.
0.01. This relatively high initial cell density was chosen because of the plate
reader’s relatively poor detection limit [61]. The same starting cell density was
also used in all other experimental set-ups for consistency.
In my experiments, all microplates contained a reference column filled with growth
medium only (no bacteria). The other wells contained varying concentrations of
different antibiotics, plus bacteria. The column containing only growth medium
acted as a contamination control - if any growth was observed in these wells
contamination had occurred and the rest of the plate had to be discarded (this
occurred in approximately 17% of experiments). Samples were pipetted into the
wells using an electronic multichannel pipette if > 6 wells required the same
input. Considerable time was spent on pilot experiments to find the optimum
set-up for recording reproducible growth curves. For example, trials were carried
out comparing growth in wells at the edges of the plate to growth in the centre
of the plate (Figure 2.5). From this it was observed that if the right edge of
the plate was ignored, there was no clear correlation between well position and
measured growth rate. As a result of this columns 11 and 12 were not used in
subsequent experiments. Different shaking regimes were also tested e.g. 600 rpm
and 200 rpm, for which no significant difference in the average growth rate was
observed (at 200 rpm the calculated growth rate was 0.034± 0.002h−1, while at
600 rpm it was 0.035 ± 0.002h−1). 600 rpm was used to minimise the impact of
sedimentation under experimental regimes where lysis occurred.
2.2.1.3 Growth rate calculations
One of the key features of the population dynamics of a bacteria culture is how
quickly the bacteria grow in the exponential phase. As described in Chapter 1









where λ is the growth rate, and N the number of cells. As optical density (OD)
is a proxy measure for the number of bacteria in a culture, N in this equation
can be replaced by OD. By taking the natural log of the measured optical density
(subtracting the background OD first), and measuring the gradient of the linear
portion, the growth rate is extracted.
In this thesis different methods were used for extracting the growth rate from
the benchtop spectrophotometer and plate reader optical density measurements.
Benchtop spectrophotometer measurements were taken at hourly intervals and
input into Microsoft Excel where the natural log of the OD was taken. The
LnOD data was plotted to determine the linear portion of the data, and then the
LINEST function applied to the linear portion. The LINEST function uses the
least squares method to return a best fit straight line to the data. The gradient,
and the standard error on the gradient, were used to describe the growth rate.
The plate reader optical density measurements were analysed using custom
Python code. As before, the natural log of the background-subtracted OD was
taken. The first optical density measurement for each well was taken as the
background for that well. The first step in measuring the growth rate was to
set the length of the “window” over which to measure the gradient. This was
generally ten datapoints for fast growing bacteria, and twenty datapoints for
slow growing bacteria. The next step was to determine at which datapoint the
analysis could start - the earliest datapoints were generally very close to the plate
reader’s background OD, resulting in noisy LnOD data (see Figure 2.6). Once the
initial datapoint had been determined, the gradient over the window was found
using the numpy.polyfit function (also returning the residual of the least squares
fit). The window was then moved along, one datapoint at a time, over the whole
dataset. This generates a list of gradients, and the accompanying residuals.
To find the best-fit maximal growth rate the next step in the analysis was to
find the highest gradient with the lowest residual - this was constrained to the
first 300 minutes of the growth curve to remove the influence of “regrowth” (see
Chapter 3). An example fit can be seen in Figure 2.6. This gradient and residual
were used to describe the growth rate.
2.2.2 Colony forming units
Colony forming units (CFUs) are used to estimate the number of viable bacteria
in a sample. The sample is diluted, and either spread, or pipetted in drops, onto
an LB agar Petri dish. The aim is to reach a bacterial concentration that results in
isolated, countable colonies after overnight incubation (Figure 2.7). Each colony
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The gradient and residual for the population growing in well H2
The linear fits for the populaitons growing in wells H2 and H3
Figure 2.6: Top: A demonstration of how the gradient, and residual, can vary
across a plate reader measured growth curve in the absence of antibiotic in




















Number of 1 in 10 dilutions
Figure 2.7: Left: A typical plate set-up with eight segments each containing six
10µl droplets. Each segment is for a different culture dilution with the number
referring to the number of 1 in 10 dilutions in PBS. For example segment 7
contains droplets of the sample culture diluted 1 in 10000000. The shade of blue
in the droplets is a visual guide to demonstrate the increasing diluted nature of
the sample across the segments. Right: Example CFU plate from an experiment
with the segments aligned with those in the diagram.
is initiated from a single, viable cell, or CFU, and thus by counting the colonies,
an estimate for the number of viable bacteria is reached. CFUs are used in this
thesis to elucidate the viable E. coli population dynamics, which may be obscured
in optical density measurements due to changes in bacterial morphology.
To make a CFU measurement, the E. coli culture of interest was vortexed for 6
seconds before an initial 1 ml sample was extracted and serially diluted ten fold
up to 10−8 in PBS (8x1.5 ml eppendorfs had been prepared containing 900µl PBS
to which 100µl sample was added). These eight dilutions were pipetted in 6-8
10µl drops onto LB agar plates using the layout in Figure 2.7. This protocol is
similar to that in Herigstad et al. [55]. It took an average of 15 minutes to serially
dilute and pipette out drops for three concurrent samples. Further measurements
were taken at hourly or two hourly intervals for up to six hours.
Once droplets had dried on the LB agar plates they were inverted and incubated
at 30°C overnight. This temperature was used to prevent overgrowth of the
colonies, which may lead to overlaps and introduce error into the colony count.
Viable colony forming units were counted the following morning from whichever
dilution that had 3-30 colonies per 10µl drop [55]. This number of colonies was
then scaled by the corresponding dilution and drop volume to give a measure of




The antibiotics used were mecillinam (Sigma-Aldrich, product no. 33447),
cefotaxime (Fisher Bioreagents, product no. BP2951-1), fosfomycin (Abcam,
product no. ab141215), aztreonam (Cambridge Bioscience, product no. 19784-
1 g-CAY), ampicillin (AppliChem, product no. A0839), and the antimicrobial
A22 (Calbiochem, product no. 475951). All antibiotic stock solutions that
were prepared with water were filter sterilised (using Merck Millipore MillexGP
0.22µm filters) before aliquoting (ampicillin (50 mg/ml), cefotaxime (10 mg/ml),
fosfomycin (25 mg/ml), mecillinam (3 mg/ml)). A22 stock solution was prepared
in DMSO (10 mg/ml) and aztreonam stock solution was prepared in ethanol
(25 mg/ml).
Antibiotics can degrade during storage [2], therefore care was taken with
antibiotic preparation. Stock solutions were prepared at the recommended
antibiotic concentration from the antibiotic powders and kept in 1 or 0.5 ml
aliquots at -20°C (wrapped in foil). These stock solutions were defrosted and
diluted to the required starting concentration for each experiment. Once a stock
solution had been defrosted it was discarded to avoid degradation of the antibiotic.
2.3.2 MIC measurement
A common measure used when discussing antibiotic efficacy is the minimum
inhibitory concentration (MIC). Theoretically, the MIC is the minimum antibiotic
concentration at which no bacterial growth is observed - thus the MIC is often
used to determine the antibiotic dose that should be given to treat a bacterial
infection [37]. The definition of the MIC is very generic: ‘the lowest concentration
of an antimicrobial agent that, under defined in vitro conditions, prevents the
appearance of visible growth of a microorganism within a defined period of
time’ [37], and it is debated whether the MIC should be used for determining
clinical doses [139]. Nevertheless, the MIC is a useful number for estimating the
antibiotic concentrations to be used in our experiments.
To determine MICs for our chosen antimicrobials, the plate reader and 96-well
microplates were used for higher throughput. The growth medium used was
Lysogeny Broth and the strain was E. coli MG1655. Antibiotics were added at
concentrations that decreased geometrically using a protocol known as the broth
microdilution technique [19]: antibiotics are added to the top row of the plate
at twice the desired volume, e.g. 2x µl, of the highest antibiotic concentration.
Then x µl of LB plus antibiotic are pipetted and diluted into the next row down,
into another x µl of LB. Thus at each row the antibiotic is diluted by a factor of
2 [61](Figure 2.8).
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Figure 2.8: Schematic of a 96-well plate set-up with three antibiotics. The
highest concentration of each antibiotic is in the top row, with subsequent one in
two dilutions down the columns up to the penultimate row. The last row is the
growth control with no antibiotic. Columns 1 and 8 contain only growth media
as contamination controls.
Initial antibiotic concentration ranges were chosen using the MIC values reported
on the EUCAST (the European Committee on Antimicrobial Susceptibility
Testing) website on 2/12/2015 and can be found in Table 2.1. The final volume
in every well was 200µl. To prepare the antibiotic dilutions, 190µl of growth
media was first added to every row, then an additional 150µl was added to the
top row giving a total of 340µl. 40µl of antibiotic was the added to the top row to
give a total volume of 380µl and a starting concentration of four times the MIC.
This was mixed using the electronic pipette by pipetting 190µl up and down,
five times. Once mixed 190µl of the top row was pipetted up and added to the
next row down, where mixing was again carried out (Figure 2.8). As described
previously, this resulted in antibiotic concentrations that decreased two-fold down
the columns. No antibiotic was added to the bottom row.
After the antibiotic had been distributed, each well contained 190µl, to which
10µl of E. coli MG1655 culture at optical density 0.2 was added, giving a starting
inoculation density of optical density 0.01. The 96-well plate was then incubated
at 37°C in the plate reader for 24 hours. The MIC was determined as the
concentration at which there was no visible growth after the 24 hour incubation.






A22 *2 [141] 0.25
Table 2.1: MIC values used as a starting estimate were found on the EUCAST
website, apart from that of the antimicrobial A22. The final MIC values which
were measured in this project are also listed here.
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12-bit image OME image
Figure 2.9: The two image formats used with the phase contrast microscopy:
12-bit and OME. The OME format results in a higher resolution image and was
used when available.
2.4 Microscopy
The focus of this thesis is on cell wall-targeting antibiotics, which are known
to cause changes in the E. coli morphology, and one of the aims of this work
is to link the antibiotic mechanism of action to changes in morphology. As
such, quantifying these morphological changes experimentally using microscopy
is crucial to this project. To be consistent with the population dynamics
experiments, the majority of the microscopy was carried out on cultures growing
in MOPS media variants. MOPS had the added advantage of having little auto-
fluorescence, improving the image contrast when fluorescence techniques were
used. Two microscopy protocols were used, which had very different cell number
throughput.
2.4.1 Phase contrast
The main microscopy protocol used here was phase contrast microscopy, which
was primarily performed by Sharareh Tavaddod (University of Edinburgh). In
these experiments, at every timepoint, a cell culture growing in a shake flask was
sampled and an imaging “chamber” prepared. For the imaging chamber 2−4µl of
cell culture was sandwiched between a cover slip and microscope slide, and sealed
with VALAP (1:1:1 vaseline, lanolin and beeswax). Imaging was done using an
inverted phase contrast microscope (Nikon Ti-U) with a 100×, 1.45 NA phase
oil objective in combination with a digital-camera (CoolSNAPHQ2). The images
(1392×1040 pixels, 12 bit images are 1450×1084 pixels (Figure 2.9)) were taken
from different parts of the chamber, and far from the edges. Some representative
images indicating the typical bacteria density per image in rich (MOPSgluRDM)
and poor (MOPSgluMIN) media can be seen in Figure 2.10.
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MOPSgluRDM MOPSgluMIN
Figure 2.10: Some representative images of E. coli RJA002 in MOPSgluRDM
and MOPSgluMIN at 100x magnification. Scale bar is 9µm.
Phase contrast microscopy images were processed using MicrobeJ [31] with a pixel
conversion of 15.625 pixels per micron. The thresholding used was ‘Local Default’
with an offset of -20 to 0, depending on the granularity of the images. For bacteria
growing in the absence of antibiotic the ‘medial axis’ mode of detection was used,
while for antibiotic-induced morphologies the ‘smoothed’ mode of detection was
employed. Example results of these detection modes can be seen in Figure 2.11.
Detected cells were then manually binned into three types: ‘septating’, ‘lysing’
and ‘normal’. Counts for the three types, and average lengths and widths (with
standard deviations) were found using the MicrobeJ results analysis component.
2.4.2 MACS
The MACS (microfluidic-assisted cytoplasmic screening) microscopy protocol
was also used in this thesis, in collaboration with Sebastían Jaramillo-Riveri
Figure 2.11: Representative images demonstrating the cell detection of MicrobeJ
on normal cells (left, using Medial Axis detection) growing for 2 hours in
MOPSgluRDM, and on large round cells (right, using Smoothed detection) after
growing for 3 hours in MOPSgluRDM with 3µg/ml mecillinam.
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Figure 2.12: Schematic representing the trapping process in the MACS
microfluidic device (adapted from Okumus et al. [101]). As pressure is applied,
and the flow turned off bacteria form a monolayer on the glass coverslip.
and Meriem El-Karoui (SynthSys, University of Edinburgh). This is a high
throughput, novel technique [101], which was employed in an attempt to achieve
good population statistics, as many cells can be imaged at each timepoint.
MACS works by trapping cells in a microfluidic channel (the “flow channel”).
This trapping occurs as follows: a small volume of sample is pumped into
the microfluidic device in the flow channel; pressure is applied in a channel
perpendicular to the flow channel (the “control channel”) deforming the device
and squashing the flow channel; bacteria are now trapped in the flow channel;
flow is maintained to flush out growth medium; flow ceases and imaging occurs
(Figure 2.12). Once images have been taken, the pressure is released and
more sample flows through the flow channel, flushing out the previous cells and
replacing them with new cells to be trapped [101].
In this way a large number of cells in a sample are rapidly imaged, with the
downside that the deformation of the channel to trap the cells may also be
deforming the cells themselves. MACS relies on having fluorescent bacteria and
a low-fluorescence growth medium in order to clearly visualise the bacteria.
The microfluidic device was used in conjunction with a Nikon Ti-E inverted
microscopy and 100x oil immersion objective, maintained at 37°C. The imaging
process was controlled by a custom Matlab GUI (Sebastían Jaramillo-Riveri)
which controlled the flow and pressure channel, and imaged bacteria trapped
Figure 2.13: A comparison of the length and width distributions measured using
the two image processing methods: Matlab GUI or MicrobeJ, for a MACS dataset
for E. coli RJA002 in MOPSgluRDM with no antibiotic.
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in two locations. MACS images were processed with a purpose-built Matlab
GUI (Sebastían Jaramillo-Riveri [130]), as the images were generated using
a Matlab protocol and saved as Matlab files. The Matlab GUI thresh-
olded the images and identified cell objects using a protocol based on a
Matlab routine (https://uk.mathworks.com/help/images/detecting-a-cell-using-
image-segmentation.html). The thresholded results from the GUI were then
converted to TIF and processed in ImageJ to find lengths and widths of the
cells using ‘Analyze Particles’. A sample of these images were also processed in
MicrobeJ and no significant difference in the average results was found (Fig. 2.13).
There is some difference in the tails of the distributions: the Matlab GUI reports
a higher frequency of longer, and thinner cells. The discrepancy in the length
distributions arises because the Matlab GUI does not perform well on bacteria
that are very close end-to-end. In contrast MicrobeJ provides the option for the
user to segment these as individual bacteria. Meanwhile, the discrepancy in the
width distributions is an artifact from the severe thresholding required when cells
were parallel to each other i.e. cells which were in close contact were eroded in
order to distinguish the individuals, decreasing the measured width.
For both microscopy protocols cells were alive during imaging. This avoided the
potential impact of any fixing procedures on the cell morphology, particularly for
delicate cells in the presence of antibiotic.
2.5 Raman Spectroscopy
In this thesis Raman spectroscopy is used to investigate the degradation of
antibiotics in growth media (Chapter 3). Raman spectroscopy is concerned with
vibrational transitions in laser-excited molecules which appear at frequencies of
104−102 cm−1. These vibrational transitions originate from vibrations of atomic
nuclei within the molecule. In Raman spectroscopy the sample is irradiated by an
intense laser beam, and scattered light is observed in the direction perpendicular
to the beam. The scattered light has two components: Rayleigh scattering,
which has the same frequency as the incident beam and is strong in intensity;
and Raman scattering, at the frequency of the incident beam plus/minus the
vibrational frequency of the molecule, which is weak [40]. Raman spectroscopy
was employed in collaboration with Hugh Vass (School of Physics and Astronomy,
University of Edinburgh) to detect changing concentrations of antibiotic in our
samples. As an antibiotic molecule has a unique Raman spectrum, changes in
antibiotic concentration due to degradation are observable in the Raman signal.
In particular, we were interested in the degradation dynamics of mecillinam in
MOPSgluRDM. The MOPSgluRDM growth medium is a complex medium with
a strong Raman spectrum. In order to see the mecillinam degradation dynamics
on top of this strong background it was necessary to start our experiments with
very high concentrations of mecillinam. Luckily mecillinam is usually prepared
in water, and therefore it was possible to directly add mecillinam powder to the
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Figure 2.14: The Raman spectroscopy set-up. Left: A representation of the
cuvette used to store the liquid sample, and the copper block used to regulate
the temperature and block stray light. Right: A diagram of the light path used
to obtain the Raman spectra of the sample within the copper block.
MOPSgluRDM at a starting concentration of 3 mg/ml (the typical stock solution
concentration). MOPSgluRDM was either used at the standard pH 7.4 or at pH
6.5.
Initially spectra were measured for MOPSgluRDM media at both pH 7.4 and
pH 6.5. The spectra for mecillinam in MOPSgluRDM were measured at various
timepoints over several days. Media-only spectra were obtained as averages of
three independent measurements, while one to two independent spectra were
obtained at each timepoint with mecillinam in the media. The Raman spectra
were obtained using a high contrast Coderg triple spectrometer set at a resolution
between five and six wavenumbers across the recorded spectral region. The
excitation source was an argon ion laser operating at 488 nm with plasma lines
removed by a prism spectrometer to produce approximately 1W pure laser light
though the cell. The sample cuvette was fitted into a copper block with 4 holes
at right angles to let the beam through and allow right-angle Raman collection;
Figure 2.14 shows a schematic of this set-up. The copper block was temperature
controlled to better than 0.1°C with a Eurotherm controller in P.I.D. mode, and
maintained at 37°C. To reduce the time taken per scan, allowing better time
resolution, spectra were recorded only in the range 0-1800cm−1.
Following data acquisition, difference spectra were obtained by subtracting
the (averaged) MOPSgluRDM spectra for a given timepoint from those of
the mecillinam-MOPSgluRDM samples at the same timepoint, using Origin.
The resulting difference spectra were then cross-referenced with the standard
mecillinam spectrum available in Biorad’s KnowItAll software. Using peak height
relative to the background, peaks were identified which showed clear decay over
time. These peaks were assigned using Biorad’s KnowItAll software, combined
with a literature survey [41, 52, 56, 59, 63, 111, 123, 127, 158]. Two main peaks
of interest were determined (see Figure 3.14): 1278 cm−1 (thought to be due
to twisting of C-N-C [63], or twisting of the CH2 group [127]) and 1450 cm−1
(linked to the CH2 ring [127]). The peak at 1278 cm−1 is thought to be of the
most interest as a database search of possible mecillinam degradation products
demonstrated that these degradation products generally did not have a peak at
1278 cm−1.
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2.6 Whole genome sequencing
In some of our experiments, we suspected that genetic mutants, resistant to the
antibiotic, might be emerging at long times (see Chapter 3). To investigate
this, we used whole genome sequencing which is a powerful tool to detect
mutations in the E. coli genome. Cell culture samples were taken from a 96-
well plate after incubation for 24 hours with and without antibiotic. Susana
Direito (School of Physics and Astronomy, University of Edinburgh) performed
genomic DNA extraction using the MasterPure DNA Purification kit and an
adapted protocol. Samples were sent to Edinburgh Genomics where the DNA
sequencing was performed. Edinburgh Genomics used the Nextera XT sequencing
library (a sequencing library is a collection of short DNA fragments with the
same short sequences on the 5’ and 3’ ends [120]) to process the DNA samples
into readable fragments (this is an enzymatic process). The DNA fragments
were then sequenced using an Illumina HiSeq 4000 75PE. The sequence results
were analysed by a bioinformatician (Dr. Alison Meynert, IGMM Bioinformatics
Analysis Core Manager, MRC Institute of Genetics and Molecular Medicine
kindly performed this analysis for us) and Dr. Bartlomiej Waclaw (School of
Physics and Astronomy, University of Edinburgh) carried out a post-processing
filtering step to determine the mutations with the highest incidence, and the
highest probability of being significant.
In this analysis, single nucleotide or insertion-deletion mutations were identified
by comparing the DNA sequence of interest with the DNA sequence of the control
strain: any differences between the control DNA sequence and the sample DNA
sequence may be mutations. The position of the mutation in the DNA sequence
is used to identify which gene has been mutated. As there will be DNA strands
from many cells in the sample, and not all cells will necessarily have the same
mutations, the frequency of each mutation in the sample is the returned result.
Genes with significantly frequent mutations were compared to known resistance
gene mutations in the literature for each antibiotic. However a limitation of this
gene sequencing method is its inability to identify certain deletions, due to the
enzymatic fragmentation (as DNA material may be lost or subjected to faulty
end-repair by the ligase [71]) and because the reads sample the genome in a
random and independent manner there is a certain percentage of the genome




Initial characterisation of E. coli
population dynamics in the
presence of cell wall-targeting
antibiotics
In this chapter we present a broad-scale investigation of the response of E. coli
populations to several cell wall-targeting antibiotics. The focus here is on
three antibiotics: fosfomycin, cefotaxime and mecillinam. We characterise the
population dynamics of E. coli during growth in these antibiotics, noting “bumps”
in optical density and cell population recovery at late times, which we term
“regrowth”. We also investigate how these phenomena depend on the growth
medium. In these experiments we use inocula prepared using a non-steady state
protocol (Chapter 2 Section 2.1.3). In subsequent chapters we will look at some
of these phenomena in more detail, and with inocula that are pre-grown to steady
state.
Three cell wall-targeting antibiotics were selected that target different stages
of the cell wall synthesis process: fosfomycin (Fos.), mecillinam (Mec.) and
cefotaxime (Ctx.). The hypothesis was that different growth dynamics might be
observed depending on which stage of the cell wall synthesis pathway is inhibited.
3.1 Literature observations of population
dynamics with cell wall-targeting antibiotics
Growth curves for E. coli in the presence of fosfomycin have been described in
the literature: an example from the work of Kurabayashi et al. [76] is shown
in Fig. 3.1. It is interesting to see that there is a “bump” in the optical density.
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Figure 3.1: Growth curves for E. coli MG1655 (shown with circle markers)
grown with and without fosfomycin (at a concentration of 0.78 µg/ml), found
in Kurabayashi et al (2014) [76].
Figure 3.2: Effect of the addition of different concentrations of fosfomycin to
cultures of E. coli 185 (circles) and E. coli 185(pOU900) (squares and triangles).
The arrow indicates the addition of fosfomycin [79].
Growth curves over longer times were reported in Leon et al. [79] (Fig. 3.2). These
curves also show bumps in the optical density although they do not look exactly
the same as those in Figure 3.1, likely due to the use of different E. coli strains
and different growth media. After 6 hours Leon et al. [79] observed “regrowth”;
they found that this was not due to inactivation of the antibiotic but rather some
phenotypic change in the bacteria. Along similar lines, Kurabayashi et al. [76]
argue that it is physiologically beneficial for the bacteria to reversibly regulate
fosfomycin resistance and that, specifically the CpxAR two-component system
reversibly controls fosfomycin resistance - thus transient fosfomycin resistance
can arise in the presence of fosfomycin [76] (as a side note, Leon et al. [79] also
report a growth-rate dependence of the emergence of fosfomycin resistance).
Bumps in the optical density have also been observed for E. coli populations
exposed to mecillinam (Figure 3.3). These bumps are believed to be due to
cell lysis [7]. Similarly, a bump and regrowth have been observed for E. coli
populations exposed to cefotaxime (Figure 3.4).
Based on this literature we might expect to see bumps, and potentially regrowth,
in our population dynamics experiments for E. coli exposed to cell wall-targeting
antibiotics.
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Figure 3.3: Figure 1 from Barbour et al. [7] showing absorbance at 450nm, cell
count and mean cell mass for various E. coli strains during exposure to 10 µg/ml
mecillinam in LB broth.
Figure 3.4: Panel C from Figure 3 from Molina-Quiroz et al. [92] showing optical
density at 600nm with time (in hours) for E. coli exposed to 0.5µg/ml cefotaxime
(black upwards triangles) in LB broth.
3.2 Initial growth curves in LB medium
Growth curves were initially measured in LB as this medium is widely used
and E. coli is known to grow well in it, with doubling times of 20-25 minutes
[119]. We used a 96-well plate and a plate reader (see methods Chapter 2) to
measure multiple replicate growth curves, using a non-steady state inoculum.
This inoculum is considered “non-steady state” as it was only diluted once after
growing over night and as such it is likely that the population is composed of
bacteria in different phases of growth.
Our plate reader growth curves for E. coli MG1655 growing in LB with various



























Growth of MG1655 in LB at varying concentrations of Cefotaxime - No=107
(b) Fosfomycin






















Growth of MG1655 in LB at varying concentrations of Fosfomycin - No=107
(c) Mecillinam






















Growth of MG1655 in LB at varying concentrations of Mecillinam - No=107
Figure 3.5: Plate reader growth curves (legends contain antibiotic concentrations
in µg/ml) for (a) cefotaxime, (b) fosfomycin and (c) mecillinam in LB medium
at 37°C. The starting inoculum size was ∼ 107 CFU/ml.
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mecillinam (Mec.) can be seen in Figure 3.5. In all three plots the red trace
is for growth with no antibiotic i.e. typical E. coli growth in the plate reader.
For the experiments with antibiotic, two distinctive features, the bump and the
regrowth, are found to be common to all three antibiotics (Fig. 3.5). However,
we also observe some differences among the three antibiotics.
For cefotaxime (Fig. 3.5a) at concentrations above a certain threshold, a clear
bump in the optical density can be seen at around 100 minutes, occurring
at the same time for all concentrations. At later times there appears to be
population recovery (“regrowth”) at sub-MIC concentrations, occurring later for
higher concentrations.
Our results for fosfomycin can be seen in Fig. 3.5b. As for cefotaxime, there is
a clear bump in the growth curve at a range of fosfomycin concentrations. The
growth dynamics are clearly different however, as the bumps occur at different
times for different fosfomycin concentrations. The bumps are also much more
pronounced than those seen for cefotaxime, with the peak height showing a
dependence on the antibiotic concentration. Compared to cefotaxime, there also
appears to be a lot more regrowth of the population even at very high fosfomycin
concentrations, with the majority of the regrowth appearing after 600 minutes.
Figure 3.5c shows our results for mecillinam. Mecillinam produces growth
curves that are different again. Similarly to cefotaxime, we observe a bump
above a certain mecillinam concentration which occurs at the same time for all
concentrations; however the bump is much less pronounced than those observed
for cefotaxime or fosfomycin. Making a comparison to the results of Barbour et al.
[7] (Fig. 3.3) it is also interesting to note that, even though a much higher Mec.
concentration was used in that work, the bump seems to occur in our experiments
at roughly the same time (120-150 minutes). Regrowth is also observed at all
concentrations, happening later the higher the antibiotic concentration.
These growth curves are quite different to those that have been reported for
antibiotics with other targets (for example, ribosome-targeting antibiotics show
a simple decrease in growth rate with increasing antibiotic concentration, with
no bumps [48]). Moreover “bumps” and “regrowth” have been relatively little
discussed in the literature, even though they are important for understanding the
efficacy of cell wall-targeting antibiotics in treating a bacterial infection. These
features could arise for several different reasons. The bump indicates an initial
increase in optical density (OD) followed by lysis (bursting of the cells). Lysis
results in debris which scatters the light less than intact cells, resulting in a
decrease in OD. For mecillinam the gradual decrease in OD might suggest that
growth is arrested i.e. cell division does not occur, but the non-dividing cells are
somewhat stable, only lysing sporadically. In contrast, for fosfomycin, we could
hypothesise that lysis is much more sudden, since the decrease in OD occurs
sharply and at a well-defined time. An interesting question concerns why for
Mec. and Ctx. the bump happens at the same time for all concentrations whereas
the bump shifts in time with concentration for fosfomycin. Another factor that
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needs to be considered is possible morphological changes of the cell induced by
the antibiotics [7, 132]. Changes in cell shape could result in light being scattered
differently, impacting on the observed optical density. This will be discussed in
detail in Chapters 4 and 5.
The common phenomena of the bump and regrowth will now be investigated in
more detail.
3.3 Understanding the bumps
3.3.1 Characterising the bumps: Inoculum effect
We wished to determine whether lysis (which causes the bump) is triggered at a
fixed time, or at a fixed population density. We hypothesised that this could be
determined by varying inoculum size, i.e. by exposing different initial bacterial
inoculum sizes to the same antibiotic concentrations.
(a) No antibiotic (b) Lysis at fixed population size
(c) Lysis at a fixed time after antibiotic exposure
Figure 3.6: a) Hypothesised impact of inoculum size on a standard antibiotic-
free growth curve. b) Impact that inoculum size is predicted to have on the
bump dynamics if lysis occurs at a fixed critical population size. c) Impact that
inoculum size is predicted to have on bump dynamics if lysis occurs at a fixed
time after antibiotic exposure.
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We had two simple hypotheses about how the dynamics of the bump would change
with inoculum size. First, let us consider what is expected if the initial inoculum
size was varied in the absence of antibiotics (Figure 3.6a, this has been verified
experimentally). As the inoculum is decreased in size, the bacterial density will
remain below the detection threshold of the plate reader for longer (if we assume
that the lag phase of the bacterial population is independent of the inoculum
size). This results in growth curves that appear shifted to later times but have
the same gradient. Now let us suppose a cell wall-targeting antibiotic is present.
Applying the same thought process to the bump dynamics leads to two potential
scenarios, depending on the criteria for lysis onset. If lysis starts to occur at a
fixed critical population size (which could depend on the antibiotic concentration)
then the bump will be shifted to later times with decreasing inoculum size as in
Fig. 3.6b. However if lysis occurs a fixed time after antibiotic exposure then the
bump will occur at the same time, but will decrease in height with decreasing
inoculum size as the bacterial density at the onset of lysis will decrease.
As can be seen in our experimental results (Fig. 3.7, where only some antibiotic
concentrations are shown for clarity), we find that decreasing the initial inoculum
size in fact has different effects depending on which antibiotic is present. In
the presence of cefotaxime the bump decreases in height and disappears with
decreasing inoculum size, Fig. 3.7a. This fits with the hypothesis that lysis starts
at a fixed time after antibiotic exposure. In contrast, in the presence of fosfomycin,
the bump is shifted to later times (Fig. 3.7b), fitting with the hypothesis that
lysis starts to occur once a fixed critical population density has been reached. The
situation with mecillinam is more subtle. Figure 3.7c shows that at mecillinam
concentrations where growth is barely inhibited, decreasing the inoculum size
increases the lag time until growth is detected by the plate reader, similar to
the hypothesised scenario in Figure 3.6 when there is no antibiotic. However at
higher mecillinam concentrations lowering the inoculum size to 105 cfu/ml leads
to the emergence of a bump and regrowth pattern where there was previously
uninhibited growth, and at the even lower inoculum size of 103 cfu/ml no growth is
observed (until the regrowth). This cannot be explained by either of the suggested
hypotheses. Instead we can conclude that mecillinam shows an “inoculum effect”
in combination with lysis onset a fixed time after antibiotic exposure. The term
inoculum effect is used to describe a scenario when an antibiotic has different
inhibition capacity at different inoculum sizes [139]. In this case mecillinam
becomes more inhibitive as the inoculum size decreases from 107 cfu/ml to 105
cfu/ml.
Broadly speaking our results show support for both lysis hypotheses. For
fosfomycin, where the antibiotic target is in the cytoplasm, lysis appears to occur
at a fixed population size. Meanwhile, for cefotaxime and mecillinam, where the
antibiotic targets are PBPs, lysis appears to occur at a fixed time after exposure to




















Growth of MG1655 in LB at 0.031 ug/ml Ctx. at varying inoculum sizes
(b) Fosfomycin
















Growth of MG1655 in LB at 1 ug/ml Fos. at varying inoculum sizes
(c) Mecillinam
















Growth of MG1655 in LB at 0.189 ug/ml Mec. at varying inoculum sizes
Figure 3.7: Growth curves at 1/8 MIC at different initial inoculum sizes of 107,
105 and 103 CFU/ml for cefotaxime (a), fosfomycin (b) and mecillinam (c). The
inset of (c) shows the growth curves at 1/4 MIC mecillinam.
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3.3.2 How the bump depends on growth medium
It is known that some antibiotics can be more or less effective depending on
whether bacteria are growing quickly or slowly [22, 48, 134]. The “bump” can be
regarded as an indicator of antibiotic efficacy (as it signals lysis). Therefore we
repeated our experiments on a range of well-defined growth media to determine
the impact of the growth medium on the bump dynamics.
Six different nutrient media were explored using MOPS (3-Morpholinopropane-1-
sulfonic acid [95]) as a base (in order of increasing growth rate): MOPSglycerol,
MOPSglucose, MOPSglycerol+casamino acids, MOPSglucose+casamino acids,
MOPSglycerol Rich Defined Media (RDM) and MOPSglucose RDM (see Methods
Ch. 2). These media give bacterial doubling times ranging from 25 to ∼170
minutes (Table 3.1). The growth curves for E. coli in the presence of
fosfomycin, cefotaxime and mecillinam, for the rich and poor MOPSglucose
variants (MOPSgluRDM and MOPSgluMIN respectively) can be found in
Figure 3.8 and for the intermediate MOPSglucoseCAA and all MOPSglycerol
variants in the Appendix (Figures B.5, B.6 and B.7).
To summarise broadly, the bumps that we saw in LB medium (Fig. 3.5) are
still observed for all three antibiotics in the rich defined medium MOPSgluRDM
(Figure 3.8), demonstrating that this ‘growth then lysis’ dynamic is associated
with a fast growth rate rather than the specific growth medium. Similarly, the
dynamics observed on the minimal MOPS defined media (Figure 3.8) correlate
well with separate observations on M9 minimal growth medium (Appendix B.2).
In Figure 3.8 we have rescaled time by the antibiotic-free doubling time; this
makes it easier to compare and contrast the growth dynamics across different
growth rates. For example, this rescaling allows us to see that, in the presence
of cefotaxime, the bump occurs at approximately five antibiotic-free doublings
in both MOPSgluRDM and MOPSgluMIN (Fig. 9.1a and 9.2a). This suggests
that we can use the optical density at a set number of antibiotic-free doublings
to compare the antibiotic effectiveness across different growth media.
To summarise the growth-medium dependence, the optical density after ten







Table 3.1: Doubling times for the different MOPS growth media as measured
using the plate reader optical density measurements.
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(a) Cefotaxime in MOPSgluRDM.























(b) Cefotaxime in MOPSgluMIN.




















(c) Mecillinam in MOPSgluRDM.























(d) Mecillinam in MOPSgluMIN.




















(e) Fosfomycin in MOPSgluRDM.






















(f) Fosfomycin in MOPSgluMIN.




















Figure 3.8: Rich and poor MOPSglucose variants with cefotaxime, fosfomycin
and mecillinam. Time has been rescaled by the antibiotic-free doubling time to
give the growth curves in terms of the number of antibiotic-free doublings. This
enables better comparison between the rich and poor growth media.
antibiotic-free doubling times has been taken as a measure of the antibiotic
effectiveness (Fig. 3.9). In Figure 3.9, poor growth media curves are shown in
the blue spectrum whereas rich growth media curves are shown in the orange
spectrum. The optical density at ten antibiotic-free doubling times turns out not
to be a very good measure for the effectiveness of fosfomycin as all concentrations
lead to a low optical density at this time, missing the bump behaviour that occurs
earlier. The optical density at five antibiotic-free doubling times is thus also
displayed for fosfomycin to clarify the growth-medium dependence. To further
clarify the growth-medium dependence this data has also been plotted in an IC50-
like manner (Figure 3.10). The IC50 is the half-maximal inhibitory concentration
of the antibiotic and is generally represented as the concentration which leads to
a 50% reduction in growth rate of the bacteria. In this case we normalised the
optical density at six antibiotic-free doubling times (we used six in this case for
increased consistency between the antibiotics) so that it was 1 in the absence
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of antibiotic, and then found the antibiotic concentration that would result in
a factor of 2 decrease, by linear interpolation, for each growth medium. This
“IC50” is then plotted against the drug-free doubling times to indicate how the
antibiotic effectiveness changes with growth rate (Figure 3.10).
Below we summarise the results for each antibiotic, combining observations from
Figures 3.8, 3.9 and 3.10.
Fosfomycin is more inhibitive on poor media
Fosfomycin exhibits greater inhibition in poorer media (all bumps disappear in
Figure 9.2e compared to Figure 9.1e). We also observe an interesting phenomenon
that appears in the rich media (Fig. 9.1e) of a “double bump”. The reason for
this is unclear. Also note that the IC50 decreases with antibiotic-free doubling
time in Fig. 3.10.
Mecillinam is more inhibitive on intermediate media
The general observation for mecillinam is that there is greater inhibition at faster
growth rates (compare Fig. 9.1c and Fig. 9.2c). This is marked by the separation
Figure 3.9: ‘Inhibition’ plots comparing the optical density at ten (or five)
antibiotic-free doubling times for various concentrations of mecillinam (top left),
cefotaxime (top right) and fosfomycin (bottom left: at ten antibiotic-free doubling
times, bottom right: at five antibiotic-free doubling times) across the six different
growth media (see legend).
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Mecillinam: more inhibitive at intermediate doubling times
Cefotaxime: more inhibitive at long doubling times
Fosfomycin: more inhibitive at long doubling times
Figure 3.10: Alternative representation of the data in Figure 3.9 using a similar
format to the IC50 but relative to OD at 6 drug-free doubling times rather than
growth rate. 51
in the ‘OD after ten drug-free doubling times’ between MOPSgluMIN/MOPSglyc
and the other media, particularly at the higher mecillinam concentrations
(Figure 3.9). More subtly, in Figure 3.9 it can be seen that on the intermediate
growth media (MOPSglycCAA, MOPSgluCAA and MOPSglycRDM) apparently
greater inhibition is observed than on the richest growth medium MOPSgluRDM.
This is presented more clearly in Figure 3.10, which suggests a possible non-
monotonic dependence on growth medium.
Cefotaxime is more inhibitive on poor media
For cefotaxime, there appears to be little medium-dependence at high concentra-
tions. However, at the lowest cefotaxime concentration of 0.016 µg/ml we observe
greater inhibition in the poorer media compared to MOPSgluRDM (Figure 9.1a,
Fig. 9.2a and Fig. 3.9). This increased inhibition at longer doubling times is
clarified in Figure 3.10 where the IC50 decrease with antibiotic-free doubling
time. Interestingly, this is the opposite scenario than observed for mecillinam.
These observed growth rate dependencies may be linked to the mechanism of
action of the antibiotics. Mecillinam primarily inhibits the elongation mechanism
of E. coli, whereas both cefotaxime and fosfomycin inhibit the division process in
some way. One might then hypothesise that cell wall-targeting antibiotics that
only inhibit the elongation machinery are more effective at faster growth rates,
whereas antibiotics that inhibit the division machinery are more effective at slower
growth rates. As will be discussed in later chapters, however, this situation turns
out to be more complex.
3.4 Understanding “regrowth”
A striking characteristic of our growth curves is the “regrowth” of the bacterial
population at long times (after 400 minutes). This could be important clinically
as it suggests that apparently eliminated infections may be able to regrow. One
explanation for the regrowth is that the antibiotic is simply degrading or being
used up over the course of the experiment. Another possibility is that bacteria
within these populations are becoming resistant to the antibiotic. This could be
transient resistance (e.g. due to gene regulatory changes), or it could be genetic
resistance (due to mutations) which will be maintained even when the antibiotic
is removed. To investigate this in more detail we determined the properties of the
bacterial population at the end of growth curve, by carrying out ‘re-inoculation’
experiments, combined with whole genome sequencing (Section 3.4.1.1). Later
we also tested directly for antibiotic degradation (Section 3.4.2).
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3.4.1 Re-inoculation experiments
We hypothesised that if regrowth was due to a decrease in the effective
antibiotic concentration then when the population that is present at the end
of an experiment, is re-inoculated into fresh media (with antibiotic), then the
population should be sensitive to the antibiotic and should reproduce its original
growth curve for that antibiotic concentration. Alternatively, if regrowth is due
to resistant mutants then the population at the end of the experiment will be
resistant and growth curves upon re-introduction to the antibiotic should be
more like wild-type growth curves with no antibiotic present. Furthermore, as
resistance can be permanent or transient, allowing the population to grow for
some time in the absence of antibiotic (LB only), prior to re-introduction to
the antibiotic, should show if resistance is transient. For permanent resistance,
growth curves upon re-introduction to the antibiotic should be similar regardless
of how long the population has grown in LB only. However, if resistance is
transient a reversion to antibiotic-sensitive growth is expected after longer periods
of growth in LB only.
To test these ideas, we designed the following protocol. 100µl samples were
extracted after 24 hours’ growth in the plate reader, at a range of concentrations
of mecillinam, fosfomycin and cefotaxime. These samples were diluted so that
the inoculum size for the next “round” would be comparable to the initial











































































































































Figure 3.11: Growth when cultures are re-inoculated into the same antibiotic
concentration as previously exposed to on Day 0, with breaks in LB of varying
lengths, shown in hours in the legend i.e. the pink curves show growth at
the indicated antibiotic concentration after a 72 hour break growing only in
LB. Fosfomycin curves indicate the emergence of resistance. Cefotaxime curves
indicate antibiotic degradation. Mecillinam curves seem to indicate a mixture of
resistance and antibiotic degradation.
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inoculum size. The samples were then either re-introduced to the same antibiotic
concentration that they had grown in (for another 24 hours), or were inoculated
in LB only. We defined a “break” as a period of 24 hours’ growth in LB only.
Multiple breaks were carried out, so some samples had up to 72 hours growing in
LB before being re-introduced to the antibiotic. After each break the sample was
diluted to achieve the desired inoculum size and re-inoculated. The purpose of
the breaks in LB was to determine whether any resistance observed was transient
or permanent.
This protocol resulted in a large number of growth curves. A select sample of these
can be seen in Figure 3.11. Here, the first row shows experiments in the presence
of fosfomycin, the second row cefotaxime and the third row mecillinam. The
first column shows growth curves at 1/16 MIC for the respective antibiotics, the
second column at 1/2 MIC and third column at 2xMIC. The grey growth curves
are from the initial exposure to the antibiotic, while the other colours correspond
to the different numbers of breaks: no break, one, two or three breaks.
The fosfomycin curves clearly indicate, at all three concentrations, that the
population at the end of the initial regrowth has become long-term resistant
to the antibiotic, as consistently wild-type growth is observed, regardless of the
length of break in LB.
A very different outcome is observed with cefotaxime. Surprisingly, at the
low concentration of cefotaxime, growth is observed after all the different LB
break lengths but growth is reduced compared to that observed upon initial
exposure to this concentration of Ctx. The intermediate cefotaxime concentration
demonstrates the outcome expected when no resistance arises, i.e. similar,
sensitive, growth is observed after each re-inoculation. At the high Ctx.
concentration there were no viable cells left after Day 0 (as indicated by the
lack of growth in the first LB break, not shown). Taken together, these results
seem to suggest that regrowth in cefotaxime occurs due to a decrease in antibiotic
concentration.
For mecillinam, we observe that at the lowest concentration used the antibiotic
has negligible impact on the growth of E. coli. At the other Mec. concentrations
the bacterial population grows better upon re-inoculation but growth is still
hampered in comparison to growth without antibiotic. This may indicate
a partially resistant population, perhaps due to a mixture of resistant and
sensitive bacteria. Another explanation could be that the effective mecillinam
concentration is decreasing (mecillinam is degrading) over the course of the
initial 24 hours, and that resistance emerges at a lower effective mecillinam
concentration, and so is only partially resistant when re-exposed to the initial
mecillinam concentration.
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3.4.1.1 Whole genome sequencing
To further understand the re-inoculation experiment we decided to sequence
samples from 24 hour plate reader cultures with observed regrowth. Based on
our interpretation of the re-inoculation experiments we did not expect to observe
resistance in the cefotaxime regrowth, therefore we only used one cefotaxime
sample. For fosfomycin and mecillinam the re-inoculation experiments suggest
that resistance may be emerging and therefore two samples for each antibiotic
were chosen.
The sample cultures sent for genome sequencing were collected from a 96-
well plate after 24 hours of incubation with or without antibiotic in LB. The
samples consisted of one control (from growth without antibiotic), two samples
from growth with fosfomycin (0.5 and 0.25MIC), two samples from growth with
mecillinam (1/16 and 2MIC) and one from growth with cefotaxime (0.25MIC).
The results of the genome sequencing (method described in Chapter 2) are in
the form of mutation frequencies (Table 3.2). As the samples are composed of
mixed populations, it is likely that there are range of mutations present. The
mutation frequency is determined by the number of reads that had the mutation
relative to the total number of reads. If a mutation is causing the observed
regrowth it is expected to occur at high frequency in the population, therefore
the sequencing results were sifted to find the most abundant mutations. These
mutation frequencies can be found in Table 3.2.
The green highlights in Table 3.2 indicate samples where high mutation fre-
quencies were observed in genes which are known to contribute to resistance
if mutated (based on literature reported resistance mutations for the relevant
antibiotic [38, 132]). Blue highlights indicate samples with mutation frequencies
that are high but for which no evidence was found in the literature linking these
mutations to antibiotic resistance.
Resistance mutations detected for fosfomycin
At the higher fosfomycin concentration we detected a mutation in the glpT gene
which encodes for the GlpT transporter. This is one of the transporters used
by fosfomycin to enter the bacterium and reach its target in the cytoplasm [66].
We observed that this mutation is accompanied by a high incidence of mutation
in the paaX gene. The paaX gene encodes for a transcriptional repressor that
participates in transcriptional regulation of genes involved in the catabolism of
Condition Gene Mutation Frequency
sdhA yeaJ rfbC yjgL stfE paaX glpT yciH pykF wbbI ptsI ddlA waaL lysS
0.5MIC Fos. 0.1149 1.0 0.1449 0.4371 0.4320
0.25MIC Fos. 0.3279 0.1111 0.3934 0.1071 1.0000
0.25MIC Ctx. 0.1359 0.1096 1.0 0.1667
2MIC Mec. 1.0 0.1429 0.9527
0.0625MIC Mec 0.1148 0.9828 0.1089 0.1111
Table 3.2: Table of significant gene mutation frequencies, ignoring those that
were present in the antibiotic-free control.
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phenylacetic acid [39]. We hypothesise that this may be linked to a change in
E. coli metabolism to avoid glucose uptake, since fosfomycin enters the cytoplasm
via the same route as glucose [38]. At the lower fosfomycin concentration these
mutations do not appear, and instead we observe mutations in the ptsI and pykF
genes. Mutations in ptsI can reduce the expression of GlpT [66] therefore this
mutation could also corresponds to reduced uptake of fosfomycin. Mutations in
pykF have also been linked to reduced glucose uptake [122]. All in all our genome
sequencing results agree with our interpretation of the re-inoculation experiment,
that regrowth in the presence of fosfomycin is due to the emergence of genetic
mutations. Interestingly, uhpT, a gene commonly associated with fosfomycin
resistance when mutated [38, 66, 76], does not appear in our data.
Resistance mutation detected for mecillinam
The only significant mutation that we detected in our mecillinam samples is in
the gene lysS (for the high concentration of mecillinam). This mutation does
not appear in the work of Thulin et al. [132], who describe over thirty genes
associated with mecillinam resistance [132]. However, the lysS gene is related to
tRNA charging, and mutations in tRNA-related genes have been found to result
in increased levels of ppGpp, which in turn confers resistance to mecillinam, as
PBP2 is no longer required for growth under conditions of high ppGpp [29, 144].
From the literature we might have expected to see more resistance mutations
[132]; however our observation of only a single resistance mutation is consistent
with the partially inhibited growth observed in the re-inoculation experiment
(Figure 3.11). Our conclusion is therefore that regrowth in mecillinam is only
partially due to resistance, and may also be due to a decrease in the effective
mecillinam concentration.
No resistance mutations detected for cefotaxime
We observed no significant gene mutations in our cefotaxime sample. This
is consistent with the re-inoculation experiment which found no evidence for
resistance in the presence of cefotaxime. Therefore regrowth in the presence
of cefotaxime is hypothesised to arise solely due to a decrease in the effective
cefotaxime concentration.
3.4.2 Antibiotic degradation
In several of our population dynamics experiments with mecillinam it was
observed that the antibiotic stock tended to decrease in potency over time. This
strongly suggested that mecillinam degrades easily and we hypothesised that this
degradation could be contributing to the observed regrowth in the presence of
mecillinam. To investigate this, we developed a “delay-time bioassay”.
The delay-time bioassay measures antibiotic degradation rates by sequential
bacterial inoculation of identically-prepared wells in a 96-well microplate, at
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Figure 3.12: Diagram of a 96-well plate used in the delay-time assay. The first
inoculation occurs immediately after the antibiotic is added to the plate, and thus
can be assumed to experience the expected antibiotic concentrations. The second
inoculation occurs 2 hours later, while the third inoculation occurs 4 hours after
the first. If there is any degradation of the antibiotic then this will be reflected
by an increased level of growth in the second and third inoculations.
regular time intervals. If an antibiotic is degrading over time we should observe a
change in the growth dynamics between sequential inoculations. For example, if
an antibiotic had a half-life of two hours, and an inoculate “A” is added two hours
after the plate is filled with antibiotic, at what was initially a concentration of
X µg/ml, inoculate “A” should exhibit the growth dynamics normally associated
with a concentration of X/2 µg/ml.
More specifically, the delay-time bioassay is an adaptation of the protocol for
measuring the MIC (Methods Chapter 2). A microplate was set up as in Fig. 3.12,
with at least 6 columns of 190 µl antibiotic-supplemented growth medium per well.
In these columns, the antibiotic concentration was diluted 2-fold in successive
rows, and the bottom row contained no antibiotic. The starting concentration
was set at four times the MIC as measured by ourselves (Table 2.1 in Chapter 2),
therefore the third row was at the MIC. At least one additional column was
prepared with growth medium only, as a control for contamination.
At the start of the experiment, the first 2 columns were inoculated with 10µl
of a “starter” culture of E. coli RJA002, that had been prepared to be in the
exponential phase of growth at OD∼0.2. Following inoculation, the OD of the
inoculated wells was ∼0.01 and the final volume was 200µl. The plate was
incubated in the plate reader, with OD measurement, as described in Chapter 2
(37°C, 600rpm double orbital shaking). At the same time, the starter culture
was diluted such that it was expected to again reach OD∼0.2 after a period of
2 hours. After the plate and starter culture had been incubated for 2 hours, the
plate was removed from the plate reader, the next 2 columns were inoculated
from the starter culture, the starter culture was again diluted, and incubation
of the microplate was continued. This process was repeated until all wells had
been inoculated. The plate was then incubated in the plate reader, with OD
measurement, for a further 16-18 hours.
Following data acquisition, OD measurements from each pair of replicate wells
were averaged. Furthermore, as the optical density was measured continuously
for each well from the start of the experiment, each set of data was time-shifted
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by its inoculation time, so that the beginning of each growth curve corresponds
to the addition of bacteria. The background optical density of the growth media
was subtracted for each well, using each well’s first data point as that well’s
background. This is feasible as the starting optical density of 0.01 is below the
plate reader’s detection threshold.
This results in a set of growth curves, corresponding to bacterial growth in media
that had been pre-incubated for different lengths of time prior to inoculation.
Figure 3.13 a) shows that we do indeed observe differences in the growth curves in
the presence of mecillinam when there is no delay, compared to a two hour delay,
prior to inoculation. In order to extract a half-life for the antibiotic, under these
experimental conditions, it was necessary to quantify the observed differences in
the growth curves. To achieve this quantification, we set a threshold OD value
(ODt) of 0.75 and recorded, for each growth curve, the time, T , taken to reach
this threshold OD.
Plotting T versus log2(antibiotic concentration) allows us to directly compare
the antibiotic effectiveness at the different inoculation times. If there is no
antibiotic degradation then every growth experiment (from different inoculation
times) should result in the same T versus log2(antibiotic concentration) curve.
However, if there has been antibiotic degradation the T versus log2(antibiotic
concentration) curve will shift in the positive x-direction as inoculation time
increases. The antibiotic half-life is the inoculation delay required to shift the
T versus log2(antibiotic concentration) curve by one unit to the right on the x-
axis. An example of this analysis is shown in Figure 3.13 b), from which an
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Figure 3.13: a) Growth dynamics of E. coli RJA002 in MOPSgluRDM pH 7.4,
37°C, under initial inoculation (solid lines) and two hour delayed inoculation
(dashed lines). Initial antibiotic concentrations are displayed in the legend in
µg/ml. b) The corresponding analysis which approximates a half-life of 2 hours.
Shaded areas represent the standard deviation between replicates.
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estimate of the antibiotic half-life can be obtained (2 hours in this case).
3.4.2.1 Mecillinam degradation
Using the delay-time bioassay with E. coli RJA002 growing in MOPSgluRDM
(pH 7.4 and 37°C) we determined that the half-life of mecillinam was around 2
hours (Figure 3.13b).
The rapid degradation inferred from our delay-time bioassay was confirmed by
direct measurement of mecillinam degradation using Raman spectroscopy in
collaboration with Hugh Vass (University of Edinburgh). Raman spectra were
measured for samples of mecillinam (at 3 mg/ml) in MOPSgluRDM, and for
MOPSgluRDM alone, over a period of 60 hours (see Methods Ch. 2). Figure
3.14 shows part of the resulting subtracted spectra (shifted vertically for clarity).
A peak at 1278 cm−1, which is believed to arise due to the amidine link in
the mecillinam molecule (see Fig. 1.12 and Methods), clearly disappears over
time. This is consistent with evidence that the primary degradation pathway for
mecillinam is via hydrolysis of the amidine bond [5]. Fitting an exponential decay
function to the relative peak height at 1278 cm−1 as a function of time gives a
half life of 1.3± 0.4 hours (Fig. 3.14), in agreement with the delay-time bioassay
value of ∼ 2 hours.
3.4.2.2 Increasing mecillinam stability
To perform bacterial growth experiments in the presence of mecillinam, one would
like to find conditions under which mecillinam is more stable, while the bacterial
growth rate is perturbed as little as possible. Decreasing pH is known to increase
the stability of mecillinam in aqueous solution [5]. E. coli grows well only in
the range pH 6.0 to 7.5 [109], and MOPS acts as a pH buffer in the range pH
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Figure 3.14: Left: Raman spectra from the region of interest between 1000 and
1400 wavenumbers from 0 to 52 hours for 3 mg/ml mecillinam in MOPSgluRDM
at 37°C and pH 7.4. Right: Peak height dynamics at 1278 cm−1 fit with an
exponential decay which gives a half life of 1.3± 0.4 hours.
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Figure 3.15: Left: Raman spectra from the region of interest between 1000 and
1400 wavenumbers from 0 to 52 hours for 3 mg/ml mecillinam in MOPSgluRDM
at 37°C and pH 6.5. Right: Peak height dynamics at 1278 cm−1 fit with an
exponential decay which gives a half life of 7.8± 3.1 hours.
6.2 to 8.0 [95]. Therefore we repeated our delay-time bioassay in MOPSgluRDM
medium at the lower pH of 6.5. As expected, this led to an increase in half-
life of mecillinam, to approximately 4 hours (Figure 3.16), which was confirmed
by Raman spectroscopy (Figure 3.15). Since this is still rather short on the
timescale of a typical bacterial growth experiment, we sought to further optimise
the conditions by decreasing the temperature. Therefore we repeated the delay-
time assay at 34°C, for pH 7.4 and pH 6.5. While a decrease in temperature to
34°C on its own did not significantly increase mecillinam stability (Figure B.8),
combining the temperature decrease with a pH of 6.5 led to a mecillinam half-life
of more than six hours, while still maintaining acceptable bacterial growth rate
(Table 3.3). Decreasing the temperature to 30°C resulted in a significantly lower
bacterial growth rate (Table 3.3) and was therefore not considered any further.
To conclude, regrowth in the presence of mecillinam is caused in part by a
previously little remarked decay of mecillinam in bacterial growth medium (half-
life of approximately two hours) in standard experimental conditions (media at
pH 7.4 and 37°C). Regrowth appears later in growth media at pH 6.5 (Figure B.8,
Appendix) (but still significantly within the timescale of a typical experiment).
Temperature (°C) pH Growth rate (/h) Mecillinam half-life (h)
37 7.4 1.24± 0.20 2
37 6.5 1.18± 0.06 4
30 7.4 0.63± 0.23 N/A
34 7.4 1.43± 0.02 ≥ 2
34 6.5 1.13± 0.22 > 6
Table 3.3: Growth rates in MOPSgluRDM at varying temperature and pH,
measured by applying a linear fit to the log of the optical density measured in
the plate reader (note the data for 34°C and pH 7.4 is from only two replicates).
The corresponding half-life of mecillinam measured using the delay-time bioassay
is also included.
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Figure 3.16: Summary of analysis results to approximate the half-life of
mecillinam under different environment conditions. Top left: MOPSgluRDM
at 37°C and pH 7.4, half-life of mecillinam is approximately 2 hours. Top right:
MOPSgluRDM at 37°C and pH 6.5, half-life of mecillinam is approximately 4
hours. Bottom left: MOPSgluRDM at 34°C and pH 6.5, half-life of mecillinam is
greater than 6 hours. Bottom right: LB at 37°C and pH 7, half-life of mecillinam
is between 4 and 6 hours.
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The best experimental condition for measuring population dynamics in the
presence of mecillinam was determined to be 34 °C and pH 6.5.
3.4.2.3 Cefotaxime degradation
A delay-time bioassay was also performed to determine whether cefotaxime
degradation was contributing to the regrowth observed. Only three cefotaxime
concentrations result in regrowth (Figure 3.17, left panel) and thus the delay-
time bioassay (Figure 3.17, right panel) focuses on this concentration region of
interest. Degradation of cefotaxime appears to be concentration-dependent. We
observe that the cefotaxime concentrations of 0.031 and 0.063µg/ml appear to
have half-lives of around four hours, whereas the concentration of 0.125µg/ml
appears to have a half-life greater than six hours.
From this delay-time bioassay we conclude that cefotaxime can have a short
half-life of four hours in MOPSgluRDM at pH 7.4 and 37°C. Therefore previous
observations of regrowth in LB are also likely to be due to the degradation of
cefotaxime.



































Figure 3.17: Left: Plate reader OD curve for E. coli RJA002 growing in
the presence of cefotaxime in MOPSgluRDM at 37°C and pH 7.4. Only
the intermediate concentrations (0.031µg/ml, 0.063µg/ml and 0.125µg/ml) are
observed to result in regrowth. Right: Delay-time bioassay results for cefotaxime
degradation in MOPSgluRDM at 37°C and pH 7.4, focusing on the intermediate
concentrations (∼ −4, -3 and -2).
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Figure 3.18: Delay-time bioassay results for aztreonam degradation in
MOPSgluRDM at 37°C and pH 7.4. Aztreonam has a half-life of 6 or more
hours in this growth medium.
3.4.2.4 Aztreonam degradation
Aztreonam is another antibiotic of interest that will be studied in this thesis, so
it is important to know how stable aztreonam is in our experimental conditions.
A delay-time bioassay was therefore performed in MOPSgluRDM at 37°C and
pH 7.4. The results of this can be found in Figure 3.18, from which we conclude
that aztreonam has a half-life of 6 or more hours, and can therefore be assumed
to be stable in this growth medium.
3.5 Summary of our initial series of experiments
In this chapter we have discussed a series of experiments using non-steady state
inocula (see methods Ch. 2) and plate reader optical density measurements. Using
these experiments we explored the growth dynamics of E. coli in LB and MOPS
media variants in the presence of fosfomycin, mecillinam and cefotaxime. The
main outcomes from these experiments were as follows:
1. There are two key features of the OD growth curves in the presence of cell
wall-targeting antibiotics: “bump” and “regrowth”.
2. The shape and dynamics of the bump change in different growth media,
indicating growth-medium dependent antibiotic efficacy.
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3. The shape of the bump appears to have some dependence on the mechanism
of action of the antibiotic.
4. The regrowth can result from the emergence of resistant mutations on
fosfomycin and mecillinam.
5. The regrowth observed in the presence of mecillinam and cefotaxime is also
due to degradation of the antibiotic.
Due to observation 5, all of our subsequent experiments with mecillinam will
be carried out at 34°C and pH 6.5 to minimise the impact of degradation on
the observed results. Additionally, in our subsequent work we will continue to
consider cell wall-targeting antibiotics with different mechanisms of action to
further elucidate how the mechanism of action influences the population dynamics
in different growth media. Furthermore, as the regrowth is generally due to either
a genetic mutation or antibiotic degradation it will be ignored in the development
of our mathematical model (Chapters 6 and 7) which will focus on the early time






Chapter 3 presented a broad overview of the population dynamics of E. coli in
the presence of various cell wall-targeting antibiotics, revealing a dependence of
the dynamics on the detailed mode of action of the antibiotic. However for so
many antibiotics it was not feasible to achieve a deep understanding of the cellular
mechanisms behind the population dynamics. To increase the depth of the study
it was necessary to reduce the number of antibiotics investigated.
For this detailed study we focused on two antibiotics: mecillinam and aztreonam.
These were chosen because they both bind specifically to a given molecular
target. Mecillinam targets PBP2, a monofunctional transpeptidase, which is
active during bacterial elongation [16], and aztreonam targets PBP3, also a
monofunctional transpeptidase, which is active during cell septation [16]. This
specificity of binding makes it easier to interpret our results in terms of molecular
mechanisms and to build a mathematical model.
In this chapter the population dynamics of E. coli RJA002 growing in the
presence of mecillinam are examined in detail, in parallel with the morphological
changes observed using microscopy. All the experiments described used E. coli
RJA002 prepared in the steady state growth condition (as described in Methods
Chapter 2 Section 2.1.3) in MOPSglucose variants. E. coli RJA002, which has
a YFP fluorescent tag, was used throughout to ensure consistency between the
population dynamics experiments and the microscopy work.
The morphological changes due to mecillinam were carefully characterised using
steady state E. coli RJA002 in both MOPSgluRDM and MOPSgluMIN. The
main method for imaging the cells was phase contrast microscopy (as described
in Chapter 2 Section 2.4.1); some further imaging of the mecillinam-treated
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cells was performed using the MACS imaging protocol (described in Chapter 2
Section 2.4.2). The results of these two imaging protocols will be compared, to
test the capability of the MACS to produce high-throughput data when the cell
wall is potentially compromised. The results from the phase contrast microscopy
will be used in conjunction with the mathematical model in later chapters, as the
experimental conditions for this imaging protocol were more tightly controlled
and more consistent with those of the population dynamics experiments.
In the literature mecillinam has been reported to result in a bump in the optical
density due to cell lysis [7], and to produce round cell morphologies [126]. It is
thought that these round morphologies arise because cell wall growth continues
primarily via pole synthesis [144]. We will recover these observations in our
own experiments, whilst building our own dataset for use with our mathematical
model.
Experimental results for aztreonam will be presented in the next chapter.
4.2 Population dynamics
The population dynamics of E. coli RJA002 in the presence of mecillinam
were measured in two different types of experiments. Firstly, we measured
growth in small volumes (200µl) via optical density measurements in a plate
reader. Secondly, we tracked growth in larger volumes (10 ml) in a shake flask
with regular measurements of the optical density (using a spectrophotometer)
and colony forming units (CFUs). The plate reader was used to measure
the dynamics for a wide range of mecillinam concentrations over a 22-24 hour
period. This allowed us to select two mecillinam concentrations of particular
interest to use in our shake flask experiments. It was desirable to study fewer
mecillinam concentrations with the shake flask as these experimental techniques
(particularly CFU measurements) are more labour intensive. It was also desirable
to corroborate the plate reader-observed dynamics using shake flask growth, as
there are potential issues with growth in a 96-well plate due to the smaller volumes
and potentially reduced oxygen transfer [32]. For the shake flask experiments,
measurements of CFUs were included because optical density cannot differentiate
easily between changes in cell size/shape versus changes in cell number. As lysis
has been reported in the presence of mecillinam [7] it is necessary to count the
colony forming units to have a quantitative measure of the number of viable cells
in the population.
The various antibiotic-free growth rates and doubling times measured in the
plate reader and shake flask experiments can be found in Table 4.1 for
growth media at pH 6.5 and 34°C (as this condition was found to increase
the stability of mecillinam, Section 3.4.2). For the rich media, the plate
reader and shake flask doubling times agree well (Table 4.1). However, in
the poor media (MOPSgluMIN) the plate reader measured doubling time is
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Experimental method Growth media Growth rate (/h) Doubling time (min)
Plate reader OD MOPSgluRDM 1.52± 0.04 27± 1
Shake flask OD MOPSgluRDM 1.42± 0.03 29± 1
Shake flask CFUs MOPSgluRDM 1.71± 0.08 24± 1
Plate reader OD MOPSgluMIN 0.62± 0.05 67± 5
Shake flask OD MOPSgluMIN 0.75± 0.03 55± 2
Shake flast CFUs MOPSgluMIN 0.71± 0.04 58± 3
Shake flask OD MOPSgluCAA 0.93± 0.08 45± 4
Shake flask CFUs MOPSgluCAA 1.09± 0.04 38± 1
Table 4.1: Growth rates and doubling times measured for E. coli RJA002 growing
without antibiotic in different growth media in different experimental protocols.
These experiments were performed at pH 6.5 and 34°C.
significantly longer than that measured with the shake flask OD (Table 4.1).
From the CFU measurements we find faster doubling times in MOPSgluRDM
and MOPSgluCAA, compared to the doubling time determined from the optical
density. The opposite is observed in MOPSgluMIN (Table 4.1). The shake
flask optical density growth rates will be used as the growth rate values in the
mathematical model. Growth rates were calculated as described in Chapter 2
Section 2.2.1.3.
4.2.1 Population dynamics observed in the plate reader
Figure 4.1 shows the observed population dynamics in the presence of mecillinam
for E. coli RJA002 in two growth media. Both the rich and poor growth
media (MOPSgluRDM and MOPSgluMIN respectively) are at pH 6.5 and
34°C, a condition found to increase the stability of mecillinam to a half-life of
approximately 6 hours (Chapter 3 Section 3.4.2.2).
We first observe that mecillinam is less inhibitive at all concentrations on the
poor growth medium (MOPSgluMIN) compared to the rich growth medium
(MOPSgluRDM) (Fig. 4.1). This agrees with the previously discussed literature
(Chapter 1) suggesting that cell wall-targeting antibiotics are more inhibitive for
faster growing bacteria. This also agrees with the preliminary results discussed
in Chapter 3.
Additionally, Fig. 4.1 shows that for the rich growth condition there is very
little change in the inhibitory dynamics as the mecillinam concentrations is
increased above 0.189µg/ml. Similarly, on the poor growth medium all mecillinam
concentrations tested produce remarkably similar population dynamics. Both
these observations might suggest saturation of binding of mecillinam to PBP2.
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Figure 4.1: Averaged growth curves from two replicates from the plate reader
at different mecillinam concentrations (listed in µg/ml in the legend) and in
different MOPSglucose variants. Top: MOPSgluRDM. Bottom:MOPSgluMIN.
The growth media were at pH 6.5 and 34°C. Errors bars are presented as shaded
areas coloured according to the corresponding mecillinam concentration. These
indicate the standard deviation between multiple wells of the same concentration.
4.2.2 Population dynamics observed via OD
measurements in the shake flask
Growing bacteria in a shake flask, and thus in larger volumes than in the
96-well plate, was necessary to be able to directly compare optical density
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measurements and colony forming units (CFUs). Guided by the plate reader
observations, two mecillinam concentrations were considered. These were the
lowest concentration (0.094µg/ml), which exhibited the most variance in outcome
across the growth media in the plate reader, and the minimum inhibitory
concentration (1.5µg/ml). These will be respectively referred to as the “low”
and “high” mecillinam concentrations. For the shake flask experiments, three
growth media were used: rich (MOPSgluRDM), poor (MOPSgluMIN) and an















Shake flask control Plate reader control
Shake flask 0.094 ug/ml MEC Plate reader 0.094 ug/ml MEC

















Shake flask control Plate reader control
Shake flask 0.094 ug/ml MEC Plate reader 0.094 ug/ml MEC
Shake flask 1.5 ug/ml MEC Plate reader 1.5 ug/ml MEC
Figure 4.2: Direct comparison of the plate reader optical density measurements
from 0 to 300 minutes (with no antibiotic, low and high mecillinam (MEC)) with
the spectrophotometer readings from the shake flask experiment. Error bars
represent the standard deviation of the plate reader OD measurements across
replicate experiments. The spectrophotometer optical density readings are single
measurements, with a reading error of ±0.01: as such the error bars are not










































































































Control Low Mec High Mec
Figure 4.3: Left column: Growth curves from the spectrophotometer at
low (0.094µg/ml) and high (1.5µg/ml) mecillinam concentrations and in
different MOPSglucose variants: MOPSgluRDM (top), MOPSgluCAA (middle)
MOSgluMIN (bottom). Right column: Growth curves from the colony forming
units at low (0.094µg/ml) and high (1.5µg/ml) mecillinam concentrations and in
different MOPSglucose variants: MOPSgluRDM (top), MOPSgluCAA (middle),
MOPSgluMIN (bottom). The growth media were at pH 6.5 and 34°C.
The optical density measurements on the rich (MOPSgluRDM) and poor (MOPS-
gluMIN) media from the shake flask growth experiments were directly compared
with the plate reader OD measurements (Figure 4.2). The MOPSgluRDM
results agree quantitatively between plate reader and shake flask, while the
MOPSgluMIN results differ somewhat. This difference in the MOPSgluMIN
growth dynamics could be due to the ten minute difference in doubling time
between the shake flask and plate reader (Table 4.1). Nevertheless, the same
qualitative trends in the presence of mecillinam are observed, indicating that the
key dynamics are not dependent on the culture volume and experimental set-up.
The complete shake flask OD results for mecillinam can be seen in Figure 4.3, left

































Figure 4.4: Plots directly comparing MOPSgluRDM, MOPSgluCAA and
MOPSgluMIN with high mecillinam (left) and low mecillinam (right). The x-
axis has been re-scaled to the number of antibiotic-free doublings for a better
comparison (time divided by antibiotic-free doubling time). The growth media
were at pH 6.5 and 34°C. Error bars are smaller than the markers.
in the shake flask experiments, the intermediate growth medium MOPSgluCAA
apparently shows increased inhibition relative to both MOPSgluRDM and
MOPSgluMIN. This is apparent when we plot results for all three media together,
as in Figure 4.4. Note however that this conclusion will be modified when we come
to discuss CFUs in Section 4.2.3.
4.2.3 Population dynamics observed via colony forming
units in the shake flask
In an optical density measurement, growth is simply measured as an increase in
light scattering, which is assumed to correlate with total biomass or total cell
volume [146]. The optical density measurement can be affected by changes in
cell morphology, and cannot distinguish between live and dead cells [87]. As
our mathematical model will track the number of living cells it is necessary
to also track the number of living cells experimentally by measuring colony
forming units (see Methods Chapter for experimental details). During the shake
flask experiments, samples were taken and plated following the CFU protocol
(Chapter 2). As a result the optical density and colony forming units can be
directly compared. The results of these CFU measurements can be found in
Figure 4.3, right column.
Comparing the OD and CFU measurements from the shake flask experiments
in MOPSgluMIN demonstrates that in this case the optical density is a good
measure of the population dynamics (Fig. 4.3, bottom row). The OD and CFU
results suggest the same conclusion, that E. coli growing in MOPSgluMIN at
both low and high mecillinam concentrations continue to grow and divide, albeit
at a reduced rate when compared to the antibiotic-free condition. Furthermore,
the high mecillinam concentration is only marginally more inhibitive compared
to the low mecillinam concentration.
In the MOPSgluCAA growth medium, at the low mecillinam concentration
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(orange curve), the OD and CFU measurements both increase, but more slowly
than in the antibiotic-free case (Fig. 4.3, middle row). In contrast, at the high
mecillinam concentration (blue curve), the optical density increases and then
plateaus whereas the CFUs remain pretty much flat. This increase in optical
density, while the CFUs remain unchanged, suggests a morphological change in
the bacteria i.e. that they become larger and therefore scatter more light. The
relatively small change in the number of viable cells (CFUs) suggests that there
is either no successful division occurring, or that cell division is balanced by cell
death. At later times, beyond the scope of the shake flask experiments, we expect
cell death to dominate, as suggested by the decrease in optical density observed
in our plate reader experiments at late times (Figure B.6 - data not at pH6.5).
A similar outcome occurs for MOPSgluRDM. For low mecillinam (orange curve)
the CFUs increase slightly before decreasing (Fig. 4.3, top right), while at high
mecillinam (blue curve) the CFUs clearly decrease from the start. In contrast,
the OD measurements for both high and low mecillinam increase first before
decreasing (Fig. 4.3, top left). This would suggest a similar situation as for
MOPSgluCAA: the cells are undergoing morphological changes (getting bigger at
both low and high mecillinam) causing a larger increase in optical density than
might be expected from the changes in viable cell number. For MOPSgluRDM
it appears that cell death is dominating over cell division, as there is a slight
decrease in CFU after 200 minutes at low mecillinam, and a significant decrease
from the beginning at high mecillinam (Fig. 4.3).
The CFU data provides a different perspective on the growth-medium dependent
action of mecillinam. As discussed previously, from the shake flask OD
measurements it appeared that E. coli growing in MOPSgluCAA were most
inhibited. The CFU measurements, however, suggest that cells growing in
MOPSgluRDM are most inhibited by mecillinam, with a higher rate of cell death.
Taken together we conclude that bacteria growing in the presence of mecillinam
in MOPSgluRDM are getting bigger, and that this increase in size is correlated
with cell death. Our data hints that this phenomenon also occurs for bacteria
growing in the presence of mecillinam in MOPSgluCAA, but to a lesser extent. In
contrast, our data suggests that bacteria exposed to mecillinam in MOPSgluMIN
do not die, since growth measured by OD and CFU is still net positive.
4.2.4 Key data from population dynamics observations
Our conclusions so far regarding E. coli RJA002 population dynamics in the
presence of mecillinam are as follows. Firstly, viable cell numbers, at either low
or high mecillinam, decrease as the richness of the growth medium increases.
Secondly, total biomass (which has been shown to correlate with OD [146])
appears to be minimised in MOPSgluCAA. Thirdly, inhibition saturates with
increasing mecillinam concentration. Lastly, comparing the shake flask optical
density and CFU measurements suggests that cells are undergoing morphological
changes, becoming larger in rich media but not in poor media.
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4.3 Dynamical changes in E. coli morphology
Next, we carefully examine the changes in morphology for E. coli growing in the
presence of mecillinam, as the optical density and CFU measurements described
in previous sections suggested that the bacteria were changing shape and/or size.
E. coli cells were grown under the same low and high mecillinam conditions (in
rich and poor growth media) as for the shake flask experiments and samples
were extracted for phase contrast microscopy (performed by a postdoctoral
researcher in the group, Sharareh Tavaddod). In this way we could be sure
that the morphologies observed would correspond with the population dynamics
previously discussed.
Initially we were concerned that phase contrast microscopy might not provide suf-
ficient cell number statistics to determine the full distribution of cell morphologies.
Therefore, some microscopy was performed with a microfluidic device (‘MACS’)
which enables trapping of a large number of bacteria, to increase the sample
size and improve the statistics (see Chapter 2 Section 2.4.2 for more details).
MACS microscopy was used for E. coli RJA002 growing in MOPSgluRDM
only. Ultimately it was decided that the MACS trapping protocol deformed the
antibiotic-weakened bacteria significantly. This deformation of the morphology
outweighed the benefit of increased sample size, so we focused on phase contrast
microscopy for the majority of our study. Nevertheless the MACS data will be
discussed in Section 4.3.2 as our work represented a novel application for MACS
and the results were of some interest.
4.3.1 Phase contrast microscopy
Phase contrast microscopy was carried out as described in the Methods Chapter
(Ch. 2), for E. coli RJA002 exposed to high (1.5µg/ml) mecillinam in MOPS-
gluRDM and MOPSgluMIN, at pH 6.5 and 34°C (as for the plate reader and shake
flask experiments). These two growth media were chosen in order to cover the
full range of growth dynamics whilst maximising the number of cells that could
be imaged for each growth condition. We also measured some key antibiotic-free
morphology data: the length and width of an average cell in a population growing
Growth media Average length (µm) Average width (µm)
MOPSgluRDM 5.2± 0.6 0.98± 0.06
MOPSgluMIN 2.8± 0.4 1.0± 0.04
Table 4.2: Average cell length and width (with the standard deviation as the
error) measured for E. coli RJA002 growing without antibiotic in MOPSgluRDM
and MOPSgluMIN using phase contrast microscopy. These experiments were




















Figure 4.5: Some representative microscopy images in MOPSgluMIN (top
row) and MOPSgluRDM (bottom row) with no antibiotic (first column), with
mecillinam at 1.5µg/ml after one hour (2nd column) and after three hours (3rd
column).
in MOPSgluRDM or MOPSgluMIN at pH 6.5 and 34°C. This information can be
found in Table 4.2. These dimensions will be used in Chapter 6 to parameterise
our mathematical model.
Figure 4.5 shows some example images of the cell morphology after exposure to
1.5µg/ml mecillinam in rich (bottom row) and poor (top row) growth media.
It is clear that, consistent with the literature [46, 126, 137], E. coli responds
to the inhibition of PBP2 by mecillinam by becoming ovoid, or spherical. It is
important to note that these are unlikely to be “spheroplasts” (a widely reported
consequence of cell wall-inhibiting antibiotics [43]) which have no cell wall and are
osmotically unstable [30]. Spherical cells observed in the presence of mecillinam
are thought to still have at least a partial cell wall, as they are more osmotically
stable [44, 60, 137]. Dividing spherical cells result in butterfly-like morphologies,
as can be seen in the three hour image with mecillinam in MOPSgluMIN (Fig. 4.5,
top right).
Analysing our microscopy data in more detail, at 1.5µg/ml mecillinam in
MOPSgluRDM we find that after sixty minutes the average length has decreased
significantly (Figure 4.6) and the average width has increased significantly
(Figure 4.6). The average length is then stable for the next couple of hours
(Figure 4.6), before increasing at 240 minutes, and the average width continues
to increase (Figure 4.6). This indicates that the cells quickly become fatter
and shorter and thus spherical, before continuing to grow as increasingly larger
spheres. Thus, even though mecillinam selectively inhibits the elongation
machinery, we observe that division also ceases to occur [147]. Later, as cells







































































Figure 4.6: The average length and width dynamics for E. coli RJA002 growing
in both MOPSgluRDM and MOPSgluMIN with a mecillinam concentration of
1.5µg/ml. The error bars are the standard deviations. Each datapoint is averaged
over at least 75 bacteria. The sphere line indicates where length equals width.
In contrast, for cells growing in MOPSgluMIN in the presence of 1.5µg/ml
mecillinam morphological changes appear to be much more gradual. In Figure 4.6
the length can be observed to decrease slowly over a four hour period before
increasing slightly and stabilising after 300 minutes. Figure 4.6 shows that the
cell width increases consistently over the same period. To summarise the data,
Figure 4.7 shows a “morphology track” where length is plotted against width, and
each marker is a different timepoint. Here, the large morphological changes in
MOPSgluRDM can clearly be contrasted with the relatively small morphological
changes in MOPSgluMIN.
4.3.2 High-throughput MACS microscopy
To achieve better cell number statistics, the MACS set-up was used in collabora-
tion with Sebastían Jaramillo-Riveri and Meriem El-Karoui (SynthSys, Unversity
of Edinburgh), to study the cell morphology statistics of the bacterial population
over time at two mecillinam concentrations (low: 0.094µg/ml and high: 1.5µg/ml)
in MOPSgluRDM at pH 7.4 and 37°C. A detailed description of the MACS
protocol can be found in Chapter 2 Section 2.4.2. Briefly, MACS is a microfluidic
device designed for high-resolution microscopy, where the bacteria flow through


































Figure 4.7: ‘Morphology tracks’: The average length and width dynamics
for E. coli RJA002 growing in both MOPSgluRDM and MOPSgluMIN with a
mecillinam concentration of 1.5µg/ml. The error bars are the standard deviations.
Each datapoint corresponds to at least 75 bacteria. The numbers by the
datapoints indicate the time, in minutes, after antibiotic exposure.
Figure 4.8 shows representative images taken after three hours in low and high
mecillinam (MOPSgluRDM) for both MACS and phase contrast microscopy
at pH 7.4 and 37°C. The phase contrast microscopy shows that spherical cells
have developed at both mecillinam concentrations after three hours. We found
that it was difficult to capture these spherical morphologies with MACS due to
the trapping protocol. For the high mecillinam dataset the following trapping
protocol was used: 1) flow on, pressure off 2) flow on, pressure on 3) flow off,
pressure on (for more details see Chapter 2). This results in “strong” trapping and
the mecillinam-treated cells become stretched in the flow direction (Figure 4.8,
high mecillinam). We found that so as not to disrupt the spherical morphology
one should instead use the following trapping protocol: 1) flow on, pressure off 2)
flow on, pressure on i.e. the flow through the channel should be maintained
throughout the imaging process. This results in “weak” trapping which is
sufficient to trap the large spheres which have developed without damaging them
(Figure 4.8, low mecillinam).
To present the data in an easier to compare format, the average lengths and widths
for both mecillinam concentrations are plotted versus time in Figure 4.9, showing
the MACS data alongside the phase contrast results. In these plots the zero
minute datapoint is the average of the measured lengths and widths of bacteria
growing without antibiotic. The width dynamics for the two experimental

















High mecillinam Low mecillinam
Figure 4.8: Example images from the MACS and phase contrast microscopy
in MOPSgluRDM with high mecillinam (left) and low mecillinam (right) after
approximately three hours in the presence of the antibiotic. Scale bar is 10µm.
an increase in cell width (Figure 4.9, top panel). However, the observed
length dynamics are not consistent between the MACS and the phase contrast
microscopy (Figure 4.9, bottom panel). The phase contrast results do not detect
a significant change in length, and low and high mecillinam concentrations lead
to the same average length at 180 minutes. The MACS data in contrast suggests
a slight decrease in length at low mecillinam, but agrees with phase contrast
regarding the length observed at 180 minutes. Meanwhile, as discussed, the cells
appear to have been stretched by the MACS trapping protocol at high mecillinam,
and as such the length appears to increase over time (Figure 4.9, bottom panel).
We conclude that the discrepancy in the cell length dynamics at high mecillinam
between the phase contrast and MACS microscopy was due to the design of the
microfluidic device protocol. Adapting the protocol to maintain flow throughout











































Figure 4.9: Average widths (top) and lengths (bottom) for E. coli RJA002
growing in MOPSgluRDM pH 7.4 at 37°C with low mecillinam (LowMec,
0.094µg/ml) and high mecillinam (HighMec, 1.5µg/ml).
dynamics at low mecillinam (Fig. 4.9) following the same trends as observed
in the phase contrast: namely that the width increases continually and that the
length decreases slightly before stabilising (Fig. 4.6 and Fig. 4.9).
To conclude, the MACS protocol did allow us to image 10-20 times more bacteria
and we succeeded in imaging spherical morphologies using an adapted trapping
protocol. However, the increase in cell size caused by the trapping mechanism
and the uncertainty regarding the repeatability of cell deformation between time
points and replicate experiments (the pressure is shut off when loading each
sample onto the chip, and there is no guarantee that the same pressure will
be applied when turned back on) meant that further MACS microscopy was not
performed for this project. Thus our key conclusions will be drawn from phase
contrast microscopy, combined with CFU and OD measurements.
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4.3.3 Key morphology observations
The key length dynamics for E. coli in the presence of mecillinam can be
summarised as follows. First there is an initial decrease in length in both MOPS-
gluRDM and MOPSgluMIN. Then after about four hours in MOPSgluRDM there
is an increase in length as the bacteria become large spheres. After about four
hours in MOPSgluMIN we instead observe a stabilisation of the average length.
The width dynamics in the presence of mecillinam can be described more simply:
in both MOPSgluRDM and MOPSgluMIN the width is seen to grow continually
at high mecillinam. This increase is more rapid in MOPSgluRDM than in
MOPSgluMIN. Taken together, we get increasingly large spheres then lysis in
MOPSgluRDM, but smaller spheres with division in MOPSgluMIN. We have also
done phase contrast microscopy at pH 7.4 for low mecillinam on MOPSgluRDM






We also performed a detailed investigation into the E. coli dynamics in the
presence of aztreonam. Aztreonam is interesting because it binds selectively to
PBP3, a monotranspeptidase active in the divisome. As PBP3 is active during
cell septation and division, and not during cell elongation (where mecillinam’s
target, PBP2, is active), it was hypothesised that aztreonam inhibition would
lead to different growth dynamics compared to that of mecillinam.
In this chapter the population dynamics of E. coli RJA002 growing in the presence
of aztreonam are examined in detail, in parallel with morphological changes
observed using phase contrast microscopy. All the experiments used E. coli
RJA002 prepared in the steady state growth condition (as described in Methods
Chapter 2 Section 2.1.3) in MOPSglucose media variants at pH 7.4 and 37°C.
In the literature, aztreonam exposure has been reported to result in a slow rate of
bacterial killing at concentrations where PBP3 is saturated (measured using CFU
measurements), even though the corresponding optical density measurements
still show apparent net growth [107, 114]. Aztreonam is also known to produce
filamentous morphologies [3, 54].
5.2 Population dynamics
The population dynamics of E. coli RJA002 in the presence of aztreonam were
measured using the same procedure as described for mecillinam (Chapter 4
Section 4.2), i.e. using both plate reader and shake flask experiments to measure
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optical density and to count colony forming units.
The antibiotic-free growth rates and doubling times measured in the plate reader
and shake flask experiments (at pH 7.4 and 37°C) can be found in Table 5.1. The
shake flask optical density growth rates will be used as the growth rate values in
the mathematical model in Chapter 6.
5.2.1 Population dynamics observed in the plate reader
In Chapter 3, it was found that aztreonam had a relatively long half-life of 6 or
more hours in the MOPS media variants at pH 7.4 and a temperature of 37°C.
We therefore used these conditions so that this work would be comparable with
the majority of the literature. Growth curves for E. coli RJA002 in the presence
of a range of aztreonam concentrations were observed for the three MOPS media
variants: MOPSgluRDM, MOPSgluCAA and MOPSgluMIN, over long times in
the plate reader.
A summary of the results is given in Figure 5.1. In MOPSgluRDM (Fig. 5.1, top
panel) high concentrations of aztreonam (> 0.0313µg/ml) result in a small initial
increase in optical density followed by a plateau. In MOPSgluCAA (Fig. 5.1,
centre panel) a similar picture holds but the bacterial population reaches a higher
optical density followed by a plateau with a slightly negative slope. Finally
in MOPSgluMIN (Fig. 5.1, bottom panel) we again see an initial increase in
optical density but compared to other media the population reaches an even
higher optical density (∼ 0.7) before undergoing a rather rapid decrease in OD,
followed by a plateau with a slight negative slope. Figure 5.2, left panel, brings
together these observations demonstrating that, at concentrations greater than
0.0313µg/ml, aztreonam becomes less inhibitive with decreasing growth rate (see
Figure 5.2, left panel).
Experimental method Growth media Growth rate (/h) Doubling time (min)
Plate reader OD MOPSgluRDM 1.3± 0.04 32± 1
Shake flask OD MOPSgluRDM 1.51± 0.06 28± 1
Shake flask CFUs MOPSgluRDM 1.4± 0.2 30± 4
Plate reader OD MOPSgluMIN 0.68± 0.02 61± 2
Shake flask OD MOPSgluMIN 0.74± 0.03 56± 2
Shake flask CFUs MOPSgluMIN 0.89± 0.05 47± 3
Shake flask OD MOPSgluCAA 0.90± 0.09 46± 5
Shake flask CFUs MOPSgluCAA 1.15± 0.08 36± 2
Table 5.1: Growth rates and doubling times measured for E. coli RJA002 growing
without antibiotic in different growth media in different experimental protocols.
These experiments were performed at pH 7.4 and 37°C.
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Figure 5.1: Averaged growth curves from the plate reader at different aztreonam
concentrations (listed in µg/ml in the legend) and in different MOPSglucose
variants (3-4 replicates). Top: MOPSgluRDM (data from undergraduate student
Elizabeth Tatham (E.T.)). Middle: MOPSgluCAA. Bottom: MOPSgluMIN
(data from E.T.). The experiments were performed at pH 7.4 and 37°C. Error bars
are presented as shaded areas coloured according to the corresponding aztreonam
concentration. This error is calculated as the standard deviation between the
replicate wells of the same concentration.
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Figure 5.2: Contrasting the level of growth achieved between the three growth
media: MOPSgluRDM, MOPSgluCAA and MOPSgluMIN at the aztreonam
concentrations of 0.0625µg/ml (left) and 0.0313µg/ml (right). The x-axis has
units of ‘doublings’ which is the time since antibiotic exposure divided by the
antibiotic-free doubling time. This makes it easier to compare the different levels
of inhibition across the three media.
Curiously, a contrasting growth medium dependence is observed for the lowest
aztreonam concentration of 0.0313µg/ml (Figure 5.2, right panel). At this
concentration significant growth is observed in MOPSgluRDM while less growth
is observed in MOPSgluCAA, and even lower growth in MOPSgluMIN. Thus,
this very low aztreonam concentration is more effective at inhibiting slow-
growing E. coli (see Figure 5.2, right panel). Capturing this concentration-
dependent change in the growth-medium dependence will present a challenge
for the mathematical model to be developed in Chapters 6 and 7.
An interesting observation, from Figure 5.1, is that, for each growth medium, all
aztreonam concentrations higher than 0.0313µg/ml result in apparently identical
early-time growth curves, suggesting saturation of PBP3 by aztreonam.
5.2.2 Population dynamics observed in the shake flask
Growing bacteria in a shake flask, and thus in larger volumes than permitted in a
96-well plate, was necessary to be able to directly compare optical density, colony
forming units and microscopy results. In these experiments only two aztreonam
concentrations were considered: the lowest concentration from the plate reader
experiments, 0.0313µg/ml, and the minimum inhibitory concentration, 0.5µg/ml.
These will be respectively referred to as the “low” and “high” aztreonam
concentrations.
The results of the shake flask experiment agree well with those from the plate
reader, as can be seen in Figure 5.3. The situation is very similar to that discussed
for mecillinam (Ch. 4 Section 4.2.2), where the MOPSgluRDM data across the
two experiments agree very well whilst there is greater discrepancy between the
plate reader and shake flask experiments for MOPSgluMIN. This could be due to















Shake flask control Plate reader control
Shake flask 0.0031 ug/ml AZT Plate reader 0.0031 ug/ml AZT
















Shake flask control Plate reader control
Shake flask 0.0031 ug/ml AZT Plate reader 0.0031 ug/ml AZT
Shake flask 0.5 ug/ml AZT Plate reader 0.5 ug/ml AZT
Figure 5.3: Direct comparison of the plate reader optical density measurements
from 0 to 300 minutes (with no antibiotic and, low and high aztreonam (AZT)),
with the shake flask optical density readings. Error bars represent the standard
deviation of the plate reader optical density measurements across replicate
experiments. The shake flask readings are single measurements, with a reading
error of ±0.01: as such the error bars are not visible on this scale.
flask. For MOPSgluRDM the plate reader doubling time is 32 minutes, while
the shake flask doubling time is 26 minutes. For MOPSgluMIN the plate reader
doubling time is 61 minutes, while the shake flask doubling time is 56 minutes.
Therefore antibiotic-free growth is consistently slightly slower in the plate reader
(as suggested in the literature [87]) but the impact of this is more pronounced
on the minimal media. If the x-axis is scaled by the antibiotic-free doubling time
we observe that the growth medium-dependent growth dynamics are the same in
both the plate reader and the shake flask experiments (Fig. 5.4).
In the shake flask, as in the plate reader, the high aztreonam concentration
becomes less inhibitive as the growth rate decreases from MOPSgluRDM to
MOPSgluMIN (Figure 5.5, left panel). For the low aztreonam concentration
(Figure 5.5, right panel) the shake flask dynamics appear to be growth medium-
independent, at least on the relatively short timescale of these experiments (the
















Shake flask control Plate reader control
Shake flask 0.0031 ug/ml AZT Plate reader 0.0031 ug/ml AZT
















Shake flask control Plate reader control
Shake flask 0.0031 ug/ml AZT Plate reader 0.0031 ug/ml AZT
Shake flask 0.5 ug/ml AZT Plate reader 0.5 ug/ml AZT
Figure 5.4: Direct comparison of the plate reader optical density measurements
from 0 to 300 minutes (with no antibiotic and, low and high aztreonam (AZT)),
with the shake flask optical density readings. Time was scaled by the measured
antibiotic-free doubling times to give the number of antibiotic-free doublings.
Error bars represent the standard deviation of the plate reader optical density
measurements across replicate experiments. The shake flask readings are single
measurements, with a reading error of ±0.01: as such the error bars are not





























Figure 5.5: Growth curves from the spectrophotometer at low (0.0313µg/ml)
and high (0.5µg/ml) aztreonam concentrations and in different MOPSglucose
variants. Plots directly comparing the three media with high aztreonam (left)
and low aztreonam (right). Here the x-axis has been scaled to the number of
antibiotic free doublings (time since antibiotic exposure divided by antibiotic-
free doubling time) for a clearer comparison of the level of inhibition.
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5.2.3 Population dynamics observed via colony forming
units
As for mecillinam in Chapter 4 we took samples from the shake flask experiments
and measured the viable cell count via CFUs (according to the method in
Chapter 2). The CFU dynamics for the three growth media can be seen in
Figure 5.6, right panel. Focusing first on the results for the high aztreonam
concentration, we see that in MOPSgluRDM, E. coli RJA002 undergo significant
cell death. The CFU dynamics for E. coli RJA002 growing in MOPSgluCAA
(Fig. 5.6, middle panel) follow the same pattern as in MOPSgluRDM, although
with a lower rate of cell death at high aztreonam than in MOPSgluRDM.
























































































Control Low Azt High Azt
Figure 5.6: Left column: Growth curves from the spectrophotometer at
low (0.0313µg/ml) and high (0.5µg/ml) aztreonam concentrations and in
different MOPSglucose variants: MOPSgluRDM (top), MOPSgluCAA (middle)
MOPSgluMIN (bottom). Right column: Growth curves from the colony forming
units at low (0.0313µg/ml) and high (0.5µg/ml) aztreonam concentrations and in
different MOPSglucose variants: MOPSgluRDM (top), MOPSgluCAA (middle),
MOPSgluMIN (bottom). The growth media were at pH 7.4 and 37°C.
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relative to that observed in MOPSgluCAA and MOPSgluRDM (Fig. 5.6, right
column). This agrees with the previous observation (from the optical density
measurements) that the high aztreonam concentration is more effective at
inhibiting growth in richer growth media.
For the low aztreonam concentration, in MOPSgluRDM a slight increase in viable
cell number is observed, indicating that there are still successful division events
occurring (Figure 5.6, right panel). Once again MOPSgluCAA results in similar
growth to that observed in MOPSgluRDM. The growth dynamics of E. coli
RJA002 in MOPSgluMIN at low aztreonam display a similar degree of cell death
to the high aztreonam condition (Figure 5.6, right panel). Thus, as observed from
the optical density measurements (Fig. 5.1, Fig. 5.6), the degree of inhibition for
the low aztreonam concentration increases as the growth rate decreases, as seen
by a transition from a positive slope with MOPSgluRDM to a negative slope with
MOPSgluMIN in the CFUs (Fig. 5.6).
Comparing the CFU results with our optical density measurements (Figure 5.6
left vs right columns), the discrepancy between the CFU and OD dynamics is
highlighted. Namely, the decrease in CFU in all media at high aztreonam while
the OD increases before plateauing suggests changes in the cell morphology. For
low aztreonam, the same discrepancy is seen on MOPSgluMIN but on the other
growth media both the optical density and CFUs indicate growth.
5.2.4 Summary of population dynamics observations
The growth dynamics at low and high aztreonam concentrations were found to
be consistent between the plate reader and shake flask experiments. Curiously,
the high aztreonam concentration becomes more inhibitive as the growth medium
becomes richer, while the low aztreonam concentration becomes more inhibitive
as the growth medium becomes poorer. Furthermore the discrepancy between
the optical density and CFU results suggests a significant morphological change
at high aztreonam in all media, and also in low aztreonam in MOPSgluMIN.
5.3 Morphology dynamics: phase contrast
microscopy
Morphology changes for E. coli RJA002 in the presence of aztreonam were studied
using phase contrast microscopy (using the method described in Chapter 2), the
imaging was done by Sharareh Tavaddod and I performed the image analysis. To
ensure enough bacteria were imaged across the rich (MOPSgluRDM) and poor
(MOPSgluMIN) growth media only one aztreonam concentration was studied.
The concentration chosen was that of “high aztreonam” used in the previous
sections: 0.5µg/ml. For comparison, Table 5.2 gives the length and width of
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Growth media Average length (µm) Average width (µm)
MOPSgluRDM 3.9± 0.7 0.95± 0.06
MOPSgluMIN 3.0± 0.6 0.89± 0.06
Table 5.2: Average cell length and width measured for E. coli RJA002 growing
without antibiotic in MOPSgluRDM and MOPSgluMIN using phase contrast
microscopy. These experiments were performed at pH 7.4 and 37°C. N = 203 on
MOPSgluRDM. N = 259 on MOPSgluMIN.
an average cell in a population growing in MOPSgluRDM or MOPSgluMIN at
pH 7.4 and 37°C in the absence of antibiotic.
Some representative images of the cell morphology, in the absence and presence
of high aztreonam in the rich and poor growth media, can be seen in Figure 5.7.
Looking from left to right along the top row of Figure 5.7 it can be clearly seen
that the cells in MOPSgluMIN become much longer after growing in the presence
of the high aztreonam concentration for four hours. In contrast, bacteria in
MOPSgluRDM (Figure 5.7, bottom row) elongate less but appear to undergo a
change in the cytoplasmic content, showing dark spots instead of a homogeneous
texture (Fig. 5.8). Variation in the density of the cytoplasmic content has
previously been linked to the bactericidal activity of beta-lactam antibiotics
[10, 135], therefore this could indicate lack of cell viability in MOPSgluRDM
in the presence of high aztreonam.
At the high aztreonam concentration it was observed that the antibiotic was less


















Figure 5.7: Some representative microscopy images in MOPSgluMIN (top
row) and MOPSgluRDM (bottom row) with no antibiotic (first column), with
aztreonam at 0.5µg/ml after one hour (2nd column) and after four hours (3rd
column). Scale bars are 9µm.
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Figure 5.8: A zoomed-in version of the image in Figure 5.7 of a cell with
changes in the cytoplasmic content after growing in MOPSgluRDMwith 0.5µg/ml
aztreonam, for four hours.
interesting to see from the phase contrast microscopy that it is in MOPSgluMIN
where significant filamentation occurs. Figure 5.9 quantifies the filamentation in
MOPSgluMIN: the average length increases from 3.0 ± 0.6µm in the absence of
aztreonam to 18 ± 8µm after four hours in the presence of high aztreonam. In
contrast a relatively small increase in cell length is observed in MOPSgluRDM,
from 3.8± 0.8µm in the absence of aztreonam to 7± 4µm after four hours in the


























Figure 5.9: The average length dynamics for E. coli RJA002 growing in both
MOPSgluRDM and MOPSgluMIN with an aztreonam concentration of 0.5µg/ml.




























Figure 5.10: The average width dynamics for E. coli RJA002 growing in both
MOPSgluRDM and MOPSgluMIN with an aztreonam concentration of 0.5µg/ml.
The error bars are the standard deviations. Each datapoint is the result of
analysing at least 50 bacteria.
The corresponding measurements of cell width, shown in Figure 5.10, indicate
that there is no significant increase in width in either MOPSgluRDM or
MOPSgluMIN. In fact, in MOPSgluMIN it appears that there is in fact a decrease
in width from three hours onwards. This decrease in average width could be
related to local changes in width along the filaments (Figure 5.11) which may
occur because septal rings form but do not fully constrict when PBP3 is inhibited
[25, 150].
Figure 5.11: An E. coli RJA002 filament after 4 hours growth in MOPSgluMIN




























Figure 5.12: “Morphology tracks”: The average length and width dynamics
for E. coli RJA002 growing in both MOPSgluRDM and MOPSgluMIN with an
aztreonam concentration of 0.5µg/ml. The error bars are the standard deviations.
Each datapoint is the result of measuring at least 50 bacteria and represents a
different timepoint: 0, 60, 120, 180 and 240 minutes (going roughly upwards).
These results suggest that when aztreonam inhibits E. coli ’s division machinery
this has a significant impact on the cell length for slow-growing cells. Interestingly,
this filamentation seems to be associated with survival: there was little change in
the MOPSgluMIN CFUs at high aztreonam, while there was a significant decrease
in CFUS in MOPSgluRDM where we do not see much filamentation (Figure 5.6).
A possible link between filamentation and increased survival under stressful
environments has been suggested in the literature [65]. This is a key hypothesis
that will be explored further with the mathematical model in Chapter 8.
Figure 5.12 summarises our morphology data, showing the average length versus
average width for E. coli cells in both MOPSgluRDM and MOPSgluMIN, in the
presence of aztreonam as a “morphology track”. This plot clearly highlights the
difference in the degree of filamentation between the two media.
5.3.1 Key data from morphology dynamics observations
The cell length dynamics in the presence of high aztreonam can be summarised
as follows. In MOPSgluRDM E. coli RJA002 approximately double in length
within the first hour and then remain around this length for the remainder of
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the four hour experimental period. In MOPSgluMIN filamentation is observed,
in which cell length increases continually, reaching lengths almost ten times the
antibiotic-free average after four hours in high aztreonam.
The bacterial cell width in the presence of high aztreonam does not change
as much as the length. In MOPSgluRDM the width increases slightly within
the first hour and then remains stable for the remaining measurement time. In
MOPSgluMIN the width appears to be fairly constant for the first three hours
before decreasing slightly. Collating the morphology dynamics with the CFU
data leads to the hypothesis (to be discussed in Chapters 7 and 8) that if a cell







The current state of the literature on modelling bacterial cell wall synthesis and
its response to antibiotics was discussed in Chapter 1. To summarise, previous
work can be grouped into three types of mathematical models which either focus
on population dynamics, cell structure or cell physiology. Very few models
link cell physiology to population dynamics [48]. In this chapter, I develop a
mathematical model which aims to link the intracellular dynamics of cell wall-
targeting antibiotics binding to their targets (cell physiology) to changes in cell
morphology (cell structure), and in population dynamics. I will also implement
different models for the triggering of cell division with the aim of testing which
of these are compatible with the results of my experiments.
6.1.1 Linking cell physiology, cell morphology and
population dynamics
To achieve a model that links antibiotic mechanism of action with population
dynamics via cell morphology it is necessary to coarse-grain the biochemistry
- otherwise the number of parameters would be immense. In our model, the
biochemistry is coarse-grained in two ways. Firstly, the intracellular biosynthesis
of peptidoglycan precursors is not modelled explicitly. Rather, it is assumed that
peptidoglycan precursors are simply created at rate S, ignoring the multitude
of individual enzymes involved in peptidoglycan biosynthesis, and the chain
of different precursor molecules. Secondly, the penicillin binding proteins
(PBPs) which are active at the periplasmic/cytoplasmic interface (synthesising
peptidoglycan from precursors and controlling peptidoglycan incorporation) are
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Figure 6.1: Schematic of the mathematical model demonstrating the elongation
and pole synthesis processes. Orange diamonds represent nutrients (not modelled
explicitly). Green fragments represent peptidoglycan precursors. Blue ellipses
represent elongasomes. Red ellipses represent divisomes.
considered simply as two enzyme complexes. One of these enzyme complexes
performs elongation (the elongasome) and the other performs division (the
divisome) [16]. There are assumed to be a number of each of these complexes
per cell. In reality, the nature of the enzyme complexes that are present in the
bacterial cell wall is more complex, and remains up for debate [33, 138].
In the model, this coarse-grained representation of the biochemistry is linked
to the cell morphology via the surface area and volume. Harris and Theriot
[51] have emphasised the importance of the ratio of surface area to volume for
bacterial growth (Chapter 1 Section 1.2.3.5). Here, we make the assumption that
surface area growth is governed only by the incorporation of new peptidoglycan
into the cell wall, ignoring any contributions of phospholipid membrane synthesis
or hydrolysis (removal) of peptidoglycan. Volume growth is assumed to be
independent of the surface area, and to be exponential in time, as in other
models [6, 21, 128]. Furthermore, the density of peptidoglycan is assumed to be
constant [156], although this assumption may not hold for growth in the presence
of antibiotic.
The cell morphology is then linked to the population dynamics via cell division,
which requires the formation of new poles. We will also include lysis in the
presence of antibiotics, which may be morphology-dependent.
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6.2 The Model
The model follows the protocol presented schematically in Figure 6.1 and
described in Figure 6.2. The rate of volume growth, λ, is a model input, based
on the antibiotic-free growth rate in our experiments, and represents the nutrient
conditions. Peptidoglycan precursors are assumed to be continually synthesised.
The model alternates between two phases. In the elongation phase the cylindrical
surface area increases (Fig. 6.3). The model exits the elongation regime if a trigger
for new pole formation (septation) is reached and the bacteria are not “too fat”. If
these conditions are met then the pole formation phase begins. Here, elongation
stops and only the hemispherical pole surface area is increased (Fig. 6.3). Once
enough hemispherical surface area has been made to cover the new poles, the
bacterium is assumed to divide and the model returns to the elongation regime
(note that we track only one daughter cell). Volume growth occurs continually
throughout these cycles of elongation and pole formation (Figure 6.2).
6.2.1 Model set-up
6.2.1.1 Precursor synthesis
As already described, the model coarse-grains the biosynthesis of peptidoglycan
precursors into one synthesis reaction. The synthesis rate S of precursors is
assumed to be proportional to the cell volume V and a baseline synthesis rate
(proportionality constant) s, and to have an additional dependence on the growth
Figure 6.2: Flow chart describing the implementation of the model using the
precursor threshold (Mth) paradigm for triggering pole formation/synthesis.
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Figure 6.3: Schematic showing the different regions of surface area growth (blue
area) during elongation (left) and pole formation (right).
rate λ:







The term in brackets in Eq. 6.1 accounts for the change in relative abundance of
cell wall synthesis enzymes at different growth rates. As discussed in Chapter 1,
Li et al. [82] demonstrate that the synthesis rate of cell wall biosynthesis enzymes
has a positive dependence on the growth rate. In our model we qualitatively
capture this growth rate dependence by considering the most common fold-
change in synthesis rate of cell wall synthesis enzymes, as measured by Li et al.
[82] between MOPSgluRDM and MOPSgluMIN. As our model coarsegrains the
entire biosynthesis process into one equation we hypothesised that it would
be most appropriate if the growth rate dependence captured the fold-change
experienced by the majority of the synthesis enzymes. This was 2-3 fold between
MOPSgluMIN and MOPSgluRDM. Consequently we considered that an equation
with a growth rate dependence that could vary between 1 and 2 would be sufficient
to qualitatively capture the dynamics (it is not unreasonable to have a non-zero
Variable Definition Units
S total precursor synthesis rate ×106 molecules/h
V cell volume µm3
λ growth rate /h
s baseline synthesis rate ×106 molecules/h/µm3
λm maximal growth rate (rmaxκt) /h
M total number of precursors ×106 molecules
M0 number of precursors in the initial cell ×106 molecules
qE/qD incorporation rate for elongation/division ×106 disaccharides/h
Ac/Ap cylindrical/pole surface area µm2
ρ0 peptidoglycan density ×106 disaccharides/µm2
R baseline elongation incorporation rate ×106 disaccharides/h
I baseline septation incorporation rate ×106 disaccharides/h
nE number of elongasomes n/a
nD number of divisomes n/a
Km Michaelis constant for incorporation dynamics ×106 molecules/ µm3
Table 6.1: Summary table of the model variables and their definitions.
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synthesis rate as the growth rate approaches zero [35]). Furthermore as there is a
theoretical limit on how fast E. coli can grow [118], we include the 1/λm (where
λm is the theoretical maximum growth rate) in order to also impose an upper
limit on the synthesis rate. The value of λm was set somewhat arbitrarily and
should perhaps be set as a fit parameter instead. In this way we qualitatively
capture the observed growth rate dependence in Li et al. [82], however this is not
necessarily the most optimum method for capturing the growth rate dependence.
In equation 6.1 the baseline synthesis rate (s) is one of the fitting parameters of
the model, and it is presumed to be constant for a given temperature and pH,
and independent of the growth media composition. As the baseline synthesis rate
is based on the concentration of synthesis enzymes, it is necessary to include a
dependence on the volume, V , so that S becomes the absolute synthesis rate.
The number of precursors M , is set to be M0 in the initial cell (see Table 6.2 for
value range). M increases due to synthesis and decreases due to the incorporation
of precursors into the growing cell wall. Incorporation is assumed to happen at
rate qE during elongation and qD during division, thus in general:
dM(t)
dt
= S(t)− qx(t)/7 (6.2)
In Eq. 6.2 qx has units of 106 disaccharides per hour, whereas dMdt and S
have units of precursors per hour. Based on Vollmer and Bertsche [147],
the average precursor strand is 21 disaccharide units long, and every third
disaccharide is crosslinked, so incorporating one precursor strand corresponds to
crosslinking/incorporating 7 disaccharides on average. The factor of 7 is therefore
used as a conversion factor between number of precursor strands and number of
crosslinked disaccharides.
6.2.1.2 Precursor incorporation
The incorporation of precursors into the cell wall increases the surface area (Ac







where the disaccharide incorporation rate, qx, is scaled by the peptidoglycan
density ρ, in units of ×106 disaccharides/µm2 (see Table 6.2 for literature
estimates), which is assumed to be constant. The incorporation rate is a measure
of the rate at which disaccharides are actively crosslinked into the existing
peptidoglcyan, if no crosslinking occurred the surface area would not be able
to increase in a structurally sound fashion.
The incorporation rate functions qx are assumed to be proportional to a baseline
incorporation rate, R for elongation and I for pole formation, the total volume V
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and the abundance of the relevant enzyme machinery: the number of elongasomes
(nE) for elongation and the number of divisomes (nD) for pole formation. They
also depend non-linearly on the number of precursors M . For elongation, the








Here V̄ is the average volume expected for the fixed growth rate λ, calculated
from Schaechter’s growth law [142], and being employed as a normalisation to
maintain the equation dimensions. In this way the surface area grows at a rate
proportional to volume as discussed in Harris and Theriot [51]. Our reasoning
behind this volume dependence is that the production of elongasomes is limited by
the cytoplasmic volume available for protein synthesis. Relaxing this assumption
would potentially also require relaxing either of the constant volume growth, or









The parameters nE and nD will be fit, taking account of literature estimates [28]
(Table 6.2). For simplicity it is assumed that R = I in the absence of antibiotic
- this is also a fit parameter (taking account of literature estimates, Table 6.2).













As we show in Equation 6.6, the non-linear core of the incorporation rate
equations is an adaptation of the classic reaction rate equation for an enzyme
of concentration [E] with catalytic rate kcat and binding constant Km acting on
a substrate of concentration [S] [36]. Here, the catalytic rate, kcat is substituted
with R, the enzyme concentration [E] is substituted with nE and the substrate
concentration [S] is replaced with M(t)
V (t)
, the concentration of precursors. This has
been rearranged in equations 6.4 and 6.5 in order to simplify the fraction.
6.2.1.3 Volume and surface area growth
As previously mentioned, volume growth is assumed to be independent of surface
area growth, and to be exponential, since the bacteria are in steady state growth
before the antibiotic is added:
dV (t)
dt
= V λ (6.7)
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Parameter Literature Value(s) Reference
rmax 65.8 µM Scott el al 2010 [118]
κt 0.06 µM−1h−1 Scott et al 2010 [118]
R ∼0.018× 106disaccharides/h Lee, Tropini et al 2014 [78]
nE 1 - 150 complexes The range of PBP2 molecules at
different growth rates [28]
nD 1 - 150 complexes The range of PBP3 molecules at
different growth rates [28]
ρ 50 disaccharides/µm2 Lower bound: 1 disaccharide ≈
0.02µm2 [78]
0.2× 106 disaccharides/µm2 Upper bound: 1 disaccharide ≈ 6×
10−6µm2 [147]
M0 0.5− 30× 106 mol. Wientjes et al [151]
Table 6.2: Literature values for some of the key model parameters. These were
used to constrain the phase space.
where λ is the experimentally measured population growth rate in the absence of
antibiotic.





(Equations 6.7 and 6.3 with Eq. 6.4). Once the condition to start
pole formation is met, volume growth continues, but elongation stops and pole
growth commences with dAp
dt
(Equation 6.3 with Eq. 6.5). When sufficient pole
surface area has been made for the new poles, division occurs; the number of
cells is doubled while volume, cylindrical surface area, pole surface area, and the
number of precursors are halved. This process is visualised in Figure 6.2. In this
way a population of identical cells grows exponentially and deterministically in
the absence of antibiotic, with a growth rate equal to λ if the volume and surface
area growth are balanced correctly by fitting the s, R, Km and M0 parameters.
6.2.1.4 Lysis rates
The model at this stage can describe the population dynamics in the absence
of antibiotics, as well as the cell morphology in the presence and absence of
antibiotics (representing the effect of antibiotic by a change in R, I, nE or nD).
However the model cannot predict the effect of antibiotic on the number of viable
bacteria as no lysis (cell death) rates have been introduced. The aim of the model
is to successfully replicate the population dynamics experimentally measured for
E. coli growing in the presence of mecillinam and aztreonam (Chapters 4 and 5),
therefore it is necessary to include cell lysis in the model.
Mecillinam and aztreonam exposure result in very different population dynamics
(Figures 4.3 and 5.6). Therefore we hypothesised that the different modes of
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inhibition (i.e. inhibiting elongation versus division) induce different types of
lysis. When elongation is inhibited (mecillinam, simulated by decreasing R),
the corresponding lysis rate (LE) is assumed to be proportional to the number of
elongasomes (nE), the change in the incorporation rate (R0−R) and the ratio of
initial surface area to volume (SA/V )0 to current SA/V (which acts a measure of
how stretched the cell wall has become).




The dependence on nE and R0 − R is based on the concept of out-of-control
elongasomes. Within the elongasome there is a balance between transpeptidase,
glycotransferase and hydrolase reactions [16]. By decreasing the incorporation
rate this balance is upset and a toxic cycle can occur, which leads to lysis [16].
The surface area to volume ratio term is based on the hypothesis that as the
bacteria become larger and larger spheres the cell wall becomes unstable, and the
rate of lysis therefore increases. The lysis rate constant of proportionality φE is
another parameter that will need to be set.
Meanwhile, when division is inhibited (aztreonam, simulated by decreasing nD),
the corresponding lysis rate is assumed to have two options: a filament-associated
component or a non-filament associated component. This assumption arises from
the observed population dynamics (Figure 5.6), where filaments lyse more slowly
than non-filamenting bacteria exposed to the same aztreonam concentration.
We assume that LD = LfilamentD or LD = L
non−filament
D i.e. that there are two
distinct lysis regimes with no combination of the lysis rate options. The filament-
associated option is assumed to be proportional to the fractional increase in length
((l − l0) /l0), and to be active throughout elongation:
LfilamentD = ψD (l − l0) /l0 (6.9)
This is controlled by the parameter ψD. We suppose that filaments are
unsustainable as they get longer based on observations in the literature that
filaments eventually lyse [18, 45].
The non-filamenting option is assumed to result due to out-of-control divisomes
as fast lysis has been observed with division inhibitors when the cell is unable to
prevent hydrolase activity, despite the lack of incorporation [18]. This faster non-
filament lysis is controlled by the constant of proportionality φD. Lnon−filamentD is
assumed to be proportional to the incorporation rate (I) and the change in the
number of divisomes (nD0 − nD) (in the same manner as for mecillinam-related
lysis), and only active during pole formation:
Lnon−filamentD = φDI (nD0 − nD) (6.10)
The development of the lysis rate equations generates additional parameters that
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require fitting: φE, φD, ψD. This will be described in Chapter 7.
6.2.2 Division criteria
The trigger for E. coli cell division is a topic of intense debate in the literature
[6, 51, 128, 148]. In this model I have implemented three division models to test
which are capable of capturing the observed experimental dynamics. We use the
term “division model” to describe the criterion that the mathematical model uses
to transition from the elongation regime to the pole formation regime.
Our first division model is the “Precursor Threshold” model, which is based
on a suggestion by Harris and Theriot [51]. In this model pole formation is
initiated once a threshold number of precursors (Mth) is reached. In our model
this threshold number was assumed to be twice the initial precursor number, M0,
plus the number of precursors theoretically required to form new poles i.e. Ap×ρ.
In other words, the cell triggers division once it has built up enough precursors
to carry out division.
Our second division model is the well-discussed “Adder Model” [128], which was
proposed based on single-cell measurements of bacterial growth [128]. In the
adder model a constant volume (or length) is added between birth and division.
The molecular mechanism underlying this is not known. To simulate the adder
model in our mathematical model framework, it was hypothesised that if there
is a constant volume added between birth and division, then there must also be
a constant volume (∆) added between birth and new pole initiation. Thus the
model tracks the volume added during each elongation cycle and initiates pole
formation once a threshold volume added value ∆ is reached. In fact, as discussed
in Chapter 8, we find that the precursor threshold and adder models behave very
similarly, although with some key differences.
Thirdly, a “Timer Model” based on the Cooper-Helmstetter division model [20]
(discussed in Chapter 1) was implemented. This model tracks the time elapsed
from birth and at a set time (in proportion to the expected length of the cell
cycle, tp) new pole initiation is triggered.
6.2.3 Fatness threshold
Regardless of the division model implemented, our model imposes the condition
that if cells are too fat then division cannot be initialised. This assumption is
based on the observation that division is inhibited if the cellular levels of FtsZ are
decreased below a critical level, preventing formation of the septal ring [85, 149].
This suggests that a critical density of FtsZ around the cell circumference is
needed for division. Therefore we suggest that if the cell width becomes too
large, then the FtsZ ring will be unable to form.
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In our model the threshold radius (rth) at which division is no longer possible is
a fit parameter, guided by assuming a minimum density of divisomes (x) around
the septal ring. This can be described with the following equation:
rth = xnD (6.11)
An initial estimate for rth was determined based on antibiotic-free literature values
for the number of divisomes at different growth rates [28], and our microscopy
measurements for the cell width at comparable growth rates. We approximate
the number of divisomes using the number of PBP3 molecules and so compared
the number of PBP3 molecules in minimal and rich media (63± 12 and 132± 17,
respectively [28]), with average E. coli radii at comparable growth rates measured
in our microscopy experiments (0.45± 0.03µm and 0.47± 0.03µm, respectively).
Comparing nD
r
across the two growth rates gives rise to the observation that
the average cell radius < 0.008× the average number of PBP3 molecules, under
antibiotic-free conditions. Therefore,
rth = 0.008nD (6.12)
was used as an initial estimate for what we term the “fatness threshold” in the
absence of antibiotic. This will be fit more carefully in Chapter 7. 0.008 can be
viewed as the hypothetical maximum distance, in microns, covered per divisome
required for successful division. As we shall see, this fatness threshold is important
for the cell morphology dynamics in the presence of antibiotics. In fact, this turns
out to be much more important than the choice of division model.
6.2.4 Determining the cell length and width
It is necessary to know the length and width (or radius) of the simulated cells
for two reasons: to implement the fatness threshold on division, and secondly to
directly compare model output with our microscopy data. The model does not
track these dimensions explicitly, but they can be determined from the surface
area and volume if a spherocylinder geometry is assumed (e.g. Fig. 6.3).
Taking the cylindrical portion of the cell to have length l and radius r, the
hemispherical ends have the same radius r. Therefore the total volume can be
written as the sum of the cylindrical and spherical volumes:










Combining equations 6.13 and 6.14, a polynomial in terms of the radius can be
derived with the (known) volume and cylindrical surface area as coefficients:
8
3
πr3 + Acr − 2V = 0 (6.15)
In the simulations, this is solved using the Python numpy.roots function to
determine the radius, which can then be used to find the length according to
Eq. 6.14.
From our experimental results (Chapter 4) (and the literature) it is clear that
bacteria exposed to the action of mecillinam will end up having a spherical
geometry. For cells growing as spheres, rather than spherocylinders, we need
a different geometrical description. The model copes with the transition from
spherocylinder to sphere by assuming that there is some minimal cylindrical
length (lth) at which the bacterium re-models its peptidoglycan network to a
spherical geometry: the “sphere threshold”. This minimal cylindrical length is
assumed to depend on the radius according to:
lth = xr (6.16)
where x is a fraction. A dependence on the radius is included as it is assumed
that if the bacterial cells are becoming fatter, then they will become more likely
to transition to a spherical morphology. The value of x will be discussed in
detail in Chapter 7. Once the cylindrical length hits this threshold and the
cylindrical length is set to zero, the bacterium is considered a sphere and its







Once the bacteria have become spherical it is assumed that they cannot return
to the spherocylinder geometry.
6.3 Parameterising the model in the absence of
antibiotics
Now that the foundations of our mathematical model have been laid out, it is
necessary to parameterise the model. First, suitable parameters have to be found
for antibiotic-free growth. These parameters are the baseline synthesis rate s,
the baseline incorporation rate R = I, the Michaelis constant Km, the number of
elongasomes nE, the number of divisomes nD and the initial number of precursor
molecules M0. We will use our experimental data for the antibiotic-free bacterial
morphology to determine the best parameter values at different growth rates.
It should be noted that most of the parameter fitting was performed using the
precursor threshold division model.
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6.3.1 Constraining the parameter space
As previously noted, the model in the absence of antibiotic has a relatively large
number of parameters (6-8 depending on the division model): the peptidoglycan
density (ρ), the baseline synthesis rate (s) of PG precursors, the Michaelis
constant for precursor-enzyme dynamics (Km), the incorporation rate of PG
precursors into the cell wall during elongation and pole formation (R = I), the
initial number of precursor molecules (M0), the number of elongasomes (nE),
the number of divisomes (nD), the constant volume added (∆) for the adder
division model and the time to initiate pole formation (tp) for the timer division
model. Nevertheless, it is possible to determine these using only the antibiotic-
free experimental data. If we consider the peptidoglycan density to be fixed,
the precursor threshold division model has six fit parameters and there are nine
constraints. These constraints will now be discussed in more detail.
For the four experimental growth conditions (MOPSgluRDM pH 7.4, MOPS-
gluRDM pH 6.5, MOPSgluMIN pH7.4 and MOPSgluMIN pH 6.5) we have
measured average cell morphology (length and width) in the absence of antibiotic.
The MOPSgluRDM and MOPSgluMIN pH 6.5 growth conditions were used
to study the population dynamics and morphology of E. coli growing in the
presence of mecillinam, while the MOPSgluRDM and MOPSgluMIN pH 7.4
growth conditions were used to study the impact of aztreonam. Having four
experimental conditions provided us with four antibiotic-free growth rates and
the corresponding average lengths and widths of E. coli growing at these growth
rates. For each growth rate the model has to return an average length and width,
within the experimental error, and maintain stable steady-state growth. Thus
there are three constraints per growth rate.
Further constraints on the parameter values arise from their expected growth
rate dependence. Chemical reaction rates are known to be affected by pH and
temperature [110], hence s, R = I andKm are expected to change between the pH
6.5 and pH 7.4 conditions; however if the pH and temperature are constant, these
fundamental enzymatic properties should not be affected by the growth medium.
Therefore the baseline synthesis rate s, baseline incorporation rate R = I and
the Michaelis constant Km are assumed to be growth medium independent, but
pH dependence is allowed. This means that the two growth media at pH 6.5 are
assumed to have the same s, R = I and Km values, and the two growth media
at pH 7.4 will have the same s, R = I and Km values, but these may be different
from those at pH 6.5.
Meanwhile the number of elongasomes nE and the number of divisomes nD are
assumed to have a positive growth rate dependence. The growth rate dependence
of the number of elongasomes and divisomes is based on the observation that there
are more of every PBP in fast growing E. coli than in slow growing E. coli [28].
Furthermore, the number of initial precursors M0 is hypothesised to have little,
or a slight negative, dependence on growth rate based on measurements of the
precursor pools for E. coli in different growth media [88]. This means that the nE
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and nD values for the MOPSgluRDM condition are required to be greater than (or
equal to) those for the corresponding MOPSgluMIN condition and the M0 values
should be approximately equal , while sharing the same s, R and Km. Thus there
are six additional constraints based on the expected growth rate dependence.
The parameter space searched is defined in Table 6.3. The ranges for ρ, nE,
nD, R and M0 were constrained using the literature [28, 78, 88, 151]. The
ranges for s and Km were determined by preliminary simulations, as such s
and Km were the only truly free parameters in the fitting routine. For each
condition the parameter set which satisfied the constraints and produced a
cell morphology closest to the measured average values was chosen. Only a
small proportion of the theoretically possible parameter space was searched. In
particular only one possible peptidoglycan density has been considered: ρ =
0.1× 106 disaccharides/µm2 [151].
6.3.2 Finding the best fit parameters
The parameter search was performed in a “brute-force” way by systematically
scanning, in a grid-like fashion, all possible parameter combinations within the
range defined by Table 6.3 and following the protocol described in Figure 6.4.
For each growth condition, the growth rate, a sensible birth volume and birth
surface area are set from the experimental data. The model is then run with
each possible parameter set for 20 simulation hours. This simulation length was
chosen because we expect that a sensible parameter set should reach steady state
growth by 10-12 divisions.
Each parameter set was scored based on its predicted steady-state cell dimensions.
The steady state cell length (l̄) and radius (r̄) were calculated by averaging
over fifty measurements taken over the final 250 simulation minutes. For a
parameter set to be deemed acceptable, the steady state radii had to be within the
Parameter Range searched
ρ 0.1× 106 disaccharides/µm2 [151]
nE & nD MOPSgluRDM 75 - 160 enzyme complexes [28]
nE & nD MOPSgluMIN 10 -100 enzyme complexes [28]
s (0.1 - 2.0) ×106 molecules/h/µm3
Km (0.01 - 1.0) ×106 molecules/ µm3
R = I (0.009 - 0.018) ×106disaccharides/h [78]
M0 (0.5 - 6.0) ×106 molecules [88]
Table 6.3: Final parameter ranges used in the parameter space search. These
ranges were guided by literature values (if possible) and then refined via wider,
exploratory, space searches which determined that these ranges were more likely
to contain the ideal solutions.
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all parameter sets tested for fast and slow conditions
generate a fast/slow parameter set
run model for 20 simulation hours
output l̄ and r̄
check if l̄ and r̄ are within bounds
calculate l̄score, r̄score and totscore
check for steady state growth
save fast/slow parameter set with totscore
discard fast/slow parameter set
sort saved fast and slow parameter sets according to totscore
match fast and slow parameter sets with the same s, Km and R







Figure 6.4: Flow diagram demonstrating the process of finding the best fit
parameter sets according to the cell morphology. Fast and slow parameter sets
are searched in parallel, and only brought together to check the growth-rate
dependent constraints once all possible fast and slow parameter sets have been
tested.
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experimental cell radii and their standard deviations. Cell lengths were allowed to
vary significantly over a cell cycle therefore the steady state lengths were allowed
to be within 30% of the experimental cell length and its standard deviation. If
a parameter set produced an average radius and length within the acceptable
limits, a “goodness of fit” score was assigned to that parameter set. This score
has two components, lscore and rscore, corresponding to the lengths and widths:
lscore = |l̄exp − l̄|





The “goodness of fit” score (totscore) is the sum of the deviation between the
average model radius and the average experimental radius, and one tenth of
the deviation between the average model length and the average experimental
length (Eq. 6.18). The length component of the score is scaled by ten because
the cell length is generally about a factor of ten larger than the radius. This
ensures that variations in length and radius contribute approximately equally
to the total score. A low score therefore signifies a model parameter set that
produces dimensions close to the average experimental cell. A chi-squared test
would be a good, and perhaps more standard, method for measuring the goodness
of fit. The main advantage of chi-squared would be that it takes the experimetnal
distribution into account (not just the averages as was used in totscore). As such
it would measure whether the distribution of lengths and widths over a simulated
cell cycle is consistent with the experimentally measured distribution.
Having done this, the next stage was to group together parameter sets for the
fast and slow growth conditions, which were under the same pH and temperature
conditions. As discussed previously, it is assumed that cells growing at the same
temperature and pH will have the same baseline synthesis rate of precursors (s),
the same baseline incorporation rate (R = I) and the sameKm, thus fast and slow
parameter sets were paired according to s, R and Km and the fast and slow scores
added together to give the total “goodness of fit” score for that pair. The best
Growth condition ρ0 s Km R = I nE nD M0 ∆ (µm3) tp (hr)
pH 6.5 34°C fast 0.1 1.9 0.1 0.009 120 160 3.3 1.28 0.288
pH 6.5 34°C slow 0.1 1.9 0.1 0.009 20 100 2.8 0.7 0.8040
pH 7.4 37°C fast 0.1 1.4 0.3 0.0113 120 180 1.5 0.655 n/a
pH 7.4 37°C slow 0.1 1.4 0.3 0.0113 20 75 1.8 0.4 n/a





Figure 6.5: An ellipse representation of the good parameter set for MOPSgluRDM
and MOPSgluMIN pH 6.5 and 34°C. The average lengths and widths are used
to plot ellipses over time. This kind of figure can be used to visualise the
morphology predictions of the model. Representative experimental images are
shown alongside, the scale bar is 9µm.
parameter set pair for that pH and temperature is then the combination with the
lowest total score. Having the fast and slow growing cells in two pH/temperature
conditions provided enough experimental data to enable the model to be fit purely
to antibiotic free morphology data, thus freeing up the antibiotic data to act as
a test of the model’s capacity for prediction and for fitting the lysis rates. This
pairing process is described in the blue zone of Figure 6.4.
The resulting “best” parameters are listed in Table 6.4, and a representation of the
morphology output for the best fit to the pH 6.5 and 34°C data can be found in
Figure 6.5. From these best-fit parameter values it is possible to determine that
under normal growth conditions M/V is on the order of 20-30 times greater than
Km, and therefore M is saturating the need for cell wall insertion. Furthermore,
examining the range of parameter sets with good scores it is possible to conclude
that there is no dependence on M0 (within an appropriate range).
An illustration of how changing s andKm can result in good or very bad “goodness
of fit” scores can be found in Figure 6.6. The s and Km values used for illustration
in Figure 6.6 were chosen based on the phase space slice visualised in Figure 6.7.
In Figure 6.7 the output of combined rich and poor parameter sets at different s
and Km (and for fixed nE, nD, M0 and R = I) is represented. Filled circles
indicate parameter sets which satisfied all the constraints, and are coloured
according to the total score. Black diamonds represent parameter sets which
broke all constraints. Other markers indicate which constraint was broken for
that parameter set. Orange stars indicate that fast growing cells were too fat,
while blue crosses indicate that poor growing cells were too fat. Open circles
indicate that steady state growth was not achieved, with the colour indicating
the corresponding growth rate: black for slow growing cells, green for fast growing
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Figure 6.6: Trajectories of the total score (“goodness of fit”) with time in
simulations with good, poor and very bad s and Km pairs for both fast and
slow growth conditions. Here nE, nD, M0 and R were kept constant using the
values found in Table 6.4 for the pH 6.5 34°C condition.
cells, and red if neither growth rate achieved steady state growth. Cells being
too long, but not too fat, were not observed and are therefore not indicated.
There are some limitations to this method of parameter space search. In
particular, the space was discretised somewhat arbitrarily and searches stopped
when reasonable parameter sets were found. It is probable that there are other
valid parameter sets with equally good, or better, fits which were not found
here. This method is also computationally inefficient. However, as explored in
Chapter 8 the fits turn out to be good enough to reproduce other experimental
observations relating to the population dynamics and morphology of bacteria in
the presence of various cell wall-targeting antibiotics.
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Figure 6.7: A slice of the parameter phase space with nE, nD, M0 and R fixed at
the values found in Table 6.4 for the pH 6.5 34°C condition demonstrating how
the size and steady state constraints reduce the space of viable parameter sets.
Figure 6.8: Phase space diagrams for the s andKm space when using the precursor
threshold division model in the parameter search. Top left: pH 6.5 34°C fast, top
right: pH 7.4 37°C fast, bottom left: pH 6.5 34°C slow, top right: pH 7.4 37°C
slow. The colour represents the “goodness of fit” score.
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6.4 Observations about the model
Following the development and antibiotic-free parameterisation of the model,
several observations can already be made.
• Cell morphology on slow media is less sensitive to the choice of parameters.
This is shown in Figure 6.8. From our parameter space search we can
generate a visual representation of the s and Km space, where the colour
of each (s, Km) point indicates the lowest “goodness of fit” score that was
found at that s and Km by varying all the other parameters (s and Km are
used to visualise the parameter space as the same ranges were searched for
all growth conditions). Figure 6.8 shows a higher prevalence of low-scoring
parameter sets for the slow growth conditions. This might suggest that slow-
growing E. coli are generally more robust to biochemical perturbations.
• The timer division model does not work with this model construction as a
steady state is never reached. This is demonstrated in Figure 6.9, where we
observe a decreasing birth volume contrasted with the relative stable birth
volumes found in the precursor threshold and adder division models. Due































































Figure 6.9: Birth volume dynamics in the model using the parameters listed in
Table 6.4 for the pH 6.5 condition and the three division models. Top: Adder.
Middle: Precursor threshold. Bottom: Timer. 112
Chapter 7
Mathematical model: fitting the
antibiotic parameters
Here we complete the development of our mathematical model introduced in
Chapter 6, by determining the parameters related to antibiotic action. We will
start by fitting the model to mecillinam data and then move on to aztreonam.
These two antibiotics have been shown experimentally (Chapters 4 and 5) to
exhibit very different behaviour.
The parameters that we need to fit include the “inhibition levels” (values of R or
nD/nD0, for mecillinam and aztreonam respectively) which correspond to the high
and low antibiotic concentrations used in the experiments. We also need to fit the
lysis rates: φE for mecillinam, and φD and ψD for aztreonam (to reproduce the cell
number dynamics). The “fatness threshold” (the radius at which pole formation
is no longer attempted) and the “sphere threshold” (the length at which a cell is
considered to turn into a sphere) also need to be fit.
These fits will be performed with the precursor division model, for fast growing
bacteria for both mecillinam and aztreonam. These fits will be tested by applying
them to the remaining experimental datasets in Chapter 8, where the adder
division model will also be compared.
In all cases, the remaining parameters nE, s, Km, R0, nD0 and M0 are fixed
at the values that were established in Chapter 6 using the antibiotic-free data
(Table 6.4), where it was determined that M is saturating the need for cell wall
insertion under normal growth conditions. R0 and nD0 are the antibiotic-free
incorporation rate and divisome number.
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7.1 Simulation protocol
The typical simulation protocol for modelling the addition of antibiotic to bacteria
growing in the steady state was as follows. The simulation was started with
no antibiotic and allowed to stabilise to steady state growth. Since the model
generally took 10 or 11 divisions in both fast and slow growth conditions to
reach the steady state (defined by stable length and width dynamics), “antibiotic
challenge” was only applied after at least 12 divisions. Once 12 divisions had
been completed the relevant parameter was decreased to mimic antibiotic action
e.g. the precursor incorporation rate during elongation, R, for mecillinam.
The protocol as currently described would always add the “antibiotic” at the
beginning of a cell cycle i.e. to the newborn cell after the twelfth division.
However, in the experiments the bacterial population is composed of cells at
different stages of the cell cycle when the antibiotic is added. We decided that to
best mimic the experiments we should also add the antibiotic at different points
in the cell cycle. This was achieved by running multiple simulations, applying
the “antibiotic” at different points in the cell cycle (10%, 20%, 30% , 40%, 50%,
60%, 70%, 80%, 90% and 95% of the way through a theoretical cell cycle were
used). The length of a cell cycle was assumed to be the doubling time (ln 2/λ)
determined by the fixed model growth rate (λ).
The outputs (e.g. cell length, cell width, cell number) from the multiple
simulations, where “antibiotic” was applied at different points in the cell cycle,
were then averaged, taking account of the age distribution in a steady-state
population. The theoretical distribution of cell ages during exponential growth
is [20]:
f (α) = ln(2)21−α (7.1)
This captures the phenomenon that in a population of exponentially growing
bacteria, we expect to see twice as many newborn bacteria as dividing bacteria:
f(0) = 1.386 while f(0.9) = 0.743. Averages were computed according to:∑
j
f (αj)Aj (7.2)
where Aj is the simulation output for simulation j in which antibiotic was added
after fraction αj of the cell cycle.
7.2 Parameter fits for mecillinam
As mecillinam inhibits the transpeptidase PBP2 (which incorporates new precur-
sors during elongation), the action of mecillinam is modelled by decreasing the
elongation incorporation rate, R. We therefore need to establish which values
of R correspond to the high and low mecillinam concentrations used in our
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experiments. This was done by fitting our simulation results for cell morphology
(without lysis), to the experimental morphology dynamics in the presence of high
mecillinam.
Once an inhibition level (R < R0) was found which fits the experimental
morphology dynamics for the high mecillinam concentration at the fast growth
rate, this inhibition level was used to fit the lysis rate (φE) in order to reproduce
the corresponding cell number dynamics.
7.2.1 Fitting process for mecillinam morphology dynamics
The parameter R (elongation incorporation rate) was varied over a series of
simulations, and the resulting length and width dynamics extracted using the
previously described simulation protocol (Section 7.1). These length and width
dynamics are presented as “morphology tracks”, alongside the experimental
morphology track (Chapter 4 Section 4.3.1), for high mecillinam in MOPS-




















Figure 7.1: Simulated morphology tracks for fast growing bacteria at various
values of R, compared to the experimental morphology track for E. coli RJA002
growing in MOPSgluRDM, exposed to high mecillinam. Each marker corresponds
to a single timepoint: 0, 60, 120, 180, and 240 minutes from the addition of
mecillinam, going roughly from left to right.
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Figure 7.2: Experimental data with high mecillinam in MOPSgluRDM after 3
hours (RDM Mec3h) and in MOPSgluMIN after 4 hours (MIN Mec4h). Looking
at the distribution of the width subtracted from the cell length indicates a highly
conserved limit of around 0.5µm. This strongly suggests that there are no true
spheres observed experimentally, with cells instead exhibiting a prolate spheroid
geometry.
gluRDM, in Figure 7.1. It should be noted that experimentally no cells become
perfect spheres, instead reaching a prolate spheroid morphology (Figure 7.2). I
hypothesise that this arises due to the immutable nature of the old poles which
results in a non-removable length component, and thus the length is always
greater than the width. However, extracting the length and width of a prolate
spheroid from the surface area and volume is non-trivial and as such for our
qualitative model we instead consider the cells as perfect spheres. This results
in the model containing a mixed population of spherical, and non-spherical cells
depending on when in the cell cycle the antibiotic is applied (Figure D.1)
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Figure 7.3: The residual sum of squares between simulated and experimental
data, at different simulated incorporation rates (R) relative to the baseline
incorporation rate (R0) for fast growing cells. The minimum at R = 0.5R0
indicates that this value of R best approximates the morphology dynamics at
high mecillinam in MOPSgluRDM.
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The experimental and simulated morphology tracks are compared by calculating
the sum of the square distance between equivalent time points (Figure 7.3). The
inhibition level that gives the least square distance is assumed to best correspond
to the high mecillinam concentration. A chi-squared test would be a potential
improvement upon this fitting method as discussed in Section 6.3.2. Thus, based
on Figure 7.3, R = 0.5R0 (where R0 is the elongation incorporation rate in the
absence of antibiotic) is the inhibition level that makes the best prediction for
the morphology dynamics of fast growing E. coli at high mecillinam.
7.2.2 Sphere and fatness thresholds
It was additionally realised that two components of the mathematical model
played a key role in controlling the geometry under mecillinam-like inhibition,
for fast growing cells. Adjusting these components generally lead to incorrect
morphology but in an illuminating way.
The first component to consider is the “spherical threshold” i.e. the point at
which the bacterial cell is defined in the model to have changed its geometry
from a spherocylinder to a sphere. Once this threshold is passed Eq. 6.17 is used
rather than Eq. 6.15 to calculate the geometry. This is described in terms of the
cylindrical length at the point of transition (lth) and the radius (r): lth ≤ xr,
where x is a positive real number.
The impact of the spherical threshold on fast growing cells is as follows. If
the value of x is very low, e.g. 0.01, the model assumes that the cylindrical
length has to be negligible before the bacterium is considered as a sphere.
Such a low value of x results in non-biological morphology under mecillinam-
like inhibition: after 200 minutes the cell width decreases during elongation, and
the cell length increases considerably (see Figure 7.4 top panel for example width
and length dynamics). As such dynamics are not observed experimentally this
suggests a flaw in the model, and in the model’s assumptions. It is possible
that the assumptions of constant volume increase and constant peptidoglycan
denisty are no longer valid when mecillinam is present. However, the model
also assumes a spherocylindrical geometry, and as our microscopy data clearly
shows a deviation from spherocylinders in the presence of mecillinam, I chose to
relax this assumption as a starting point. Ideally, the model would transition
from a spherocylinder to a prolate spheroid. However, as previously described,
determining the semi-major axes of a prolate spheroid from the surface area
and volume is non-trival, therefore I decided to approximate this behaviour with
spherical geometries. This leads to the requirement that a cell transitions to a
sphere before the non-biological dynamics manifest, therefore it was hypothesised
that the value of x should be larger. In reality, a larger value of xmight correspond
to the bacterium actively adjusting its morphology towards that of a sphere, as
a spherocylinder shape starts to become unsustainable. It is also very likely
that the peptidoglycan denisty is changing under this condition, and a potential
improvement of the model would be to allow the peptidoglycan density to change.
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lth = 0.01r : too small spherical threshold gives filamentation.



















lth = r : becomes spherical too quickly



















Figure 7.4: The length and width dynamics in the model for R = 0.5R0 with a
spherical threshold of lth = 0.01r (top) or lth = r (bottom). The markers represent
the experimental results for the average width and average length for E. coli in the
presence of 1.5µg/ml mecillinam. For a small value of lth (top) the key observation
is that from around 300 minutes the width decreases during elongation, and
the cell length becomes exceedingly long, which does not correspond with the
experimental observations. For a large value of lth (bottom), the key observation
is that cells grow too quickly as spheres leading to a poor fit to the experimental
data at 180 and 240 minutes.
If the sphere threshold x is too high (e.g. x = 1), this also leads to qualitatively
incorrect results. In particular this leads to the production of spheres at earlier
times, which grow very quickly (“runaway spheres”), leading to a poor fit to the
experimental data at three and four hours (Figure 7.4, bottom panel). The sphere
threshold was set to 0.6 in the end.
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lth = 0.6r and rth = 0.007nD: spheres emerge too quickly





















lth = 0.6r and rth = 0.008nD: biologically sound dynamics at all R




















lth = 0.6r and rth = 0.009nD: biologically sound dynamics at all R




















Figure 7.5: Results from the precursor division model with different fatness
thresholds for fast (rich media) growing cells.
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Morphology with mecillinam: precursor model
Figure 7.6: Length and width dynamics. A comparison between experimental and
simulated results using the precursor division model in the rich growth conditions
under mecillinam-like inhibition (R = 0.5R0). The values in the legend indicate
the inhibition level. Each marker corresponds to a single timepoint: 0, 60, 120,
180, and 240 minutes from the addition of mecillinam, going roughly from left to
right.
The other component of the model to consider is the “fatness threshold” i.e. the
radius at which the bacterial cell becomes too fat to divide. The fatness threshold
(rth) depends on the number of divisomes (nD) and the hypothetical distance a
divisome has to cover for successful division (x).
rth = xnD (7.3)
If the fatness threshold is too small (e.g. rth = 0.007nD), the model produces
runaway spheres (Figure 7.5, top panel) in a similar manner as when the spherical
threshold is too high. These aberrant morphologies can be avoided by increasing
the fatness threshold to rth = 0.008nD, which gives a reasonably good fit to the
experimental data (Figure 7.5, middle panel); an even better fit can be achieved
with a fatness threshold of rth = 0.009nD (Figure 7.5, bottom panel).
To summarise, we found that to best fit the experimental data our mathematical
model should have a sphere threshold of lth = 0.6r and a fatness threshold of rth =
0.009nD. Further work could be done exploring the impact of these thresholds.
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7.2.3 Best fit morphology dynamics in detail
Table 7.1 (at the end of this chapter) combined with Table 6.4, summarise the
best fit parameters for mecillinam. Figure 7.6 shows the resulting morphology
dynamics, comparing model output to experiments, for 1.5µg/ml mecillinam and
R = 0.5R0. With our mathematical model we can successfully capture:
• the decrease in length, and increase in width after 60 minutes exposure to
high mecillinam.
• the stabilisation of the length while the width continues to increase at 120
and 180 minutes.
• the significant increase in width and the increase in length at 240 minutes.
7.2.4 Lysis rates: fitting population dynamics in the
presence of mecillinam
Our next task is to set the constant in the lysis rate equation (φE, Eq. 6.8 in
Section 6.2.1.4). As R has units of ×106 disaccharides/h and the lysis rate
(LE) has units of /h, φE has units of ×10−6 disaccharides. Setting φE was
done by fitting to the CFU results at high mecillinam using the parameters that
had already been determined and R = 0.5R0. The cell number dynamics were
modelled using the same simulation protocol as described in Section 7.1. The
simulation was initialised with a number of cells close to the initial number of
colony forming units in the experiments (Chapter 4), to allow direct comparison.
Only a small range of values were tested for φE (1.0 to 1.5 ×10−6 disaccharides)
Figure 7.7: A demonstration of how changing the lysis rate constant, φE impacts
the fit of the simulation output (solid lines) to the experimental data (filled circles)
for growth in MOPSgluRDM with high mecillinam (1.5µg/ml)
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Population dynamics with mecillinam: precursor model















Figure 7.8: Solid lines: The log cell number dynamics in the model at high
(R = 0.5R0) and low (R = 0.8R0) mecillinam like inhibition for fast growing
bacteria using the precursor division model, for φE = 1.2 × 10−6 disaccharides.
Filled circles: The experimental data for colony forming units in the presence of
high (1.5µg/ml Mec.) and low (0.094µg/ml Mec.) for both fast and slow growing
cells.
as the aim was to recover the general dynamics rather than to obtain an exact
fit (see Figure 7.7 to see the impact of small changes to φE).
From this search φE = 1.2× 10−6 disaccharides was chosen as the best fit value.
Figure 7.8, blue line, shows the model output for the cell number dynamics
in the presence of a high concentration of mecillinam in rich media, using this
value of φE. The model captures the population dynamics well at early times,
however there is some significant deviation from the experimental results after
240 mintutes.
7.2.4.1 Value of R corresponding to low mecillinam
Assuming that the lysis rate (φE) is independent of mecillinam concentration we
can now determine the level of inhibition (value of R) that corresponds to the
low mecillinam concentration (0.094µg/ml). To this end the incorporation rate
R was changed by increments of 0.1 and the value of R that best fit the CFU
dynamics, for low mecillinam, in the rich media chosen (Figure 7.9). This value
was R = 0.8R0 (Figure 7.8, orange line and Figure 7.9).
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Figure 7.9: A demonstration of how changing the value of the incorporation rate,
R, using the precursor division model, impacts the fit of the simulation output
(solid lines) to the experimental data (filled circles) for growth in MOPSgluRDM
with low mecillinam (0.094µg/ml). The other simulation parameters are as in
Tables 6.4 and 7.1.
7.3 Parameter fits for aztreonam
Our model also needs to simulate the action of the antibiotic aztreonam, which
inhibits division. To do this we need to fit four more parameters, corresponding to
the inhibition levels for high and low aztreonam, and the two rates of aztreonam-
induced lysis (Section 6.2.1.4). Using the same protocol as for mecillinam, we
performed fits to the morphology using the rich media data.
Because experiments involving aztreonam were performed at pH 7.4 and 37°C
(not pH 6.5 and 34 °C as for mecillinam), we use the parameters for pH 7.4 in
Table 6.4 (Chapter 6).
Aztreonam is known to inhibit cell division by binding to the divisome protein
PBP3. This could be implemented in the model, in principle, by either decreasing
the pole formation incorporation rate (I) or by decreasing the number of
divisomes (nD). However, within this model, decreasing the pole formation
incorporation rate does not result in filamentation whereas decreasing the number
of divisomes does (Figure 7.14).
As filamentation is a key morphological change we want to capture when
modelling the inhibitory action of aztreonam we define the level of inhibition
as the fraction of uninhibited divisomes relative to the antibiotic-free number of
divisomes: nD/nD0. Using the precursor threshold division model we determined
the value of nD/nD0 which produced the correct length dynamics for bacteria
growing in the rich medium in the presence of high aztreonam. This inhibition
level, determined for high aztreonam, was then used to fit the lysis rate constants
(φD and ψD) to reproduce the cell number dynamics in both rich and poor media
(both growth media are required to constrain the two constants).
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We then determined the value of nD/nD0 corresponding to the low aztreonam
concentration by fitting to the CFU dynamics at low aztreonam on the rich
media.
7.3.1 Best fit morphology dynamics for fast growing
bacteria in high aztreonam
Figure 7.10 shows model morphology tracks, for decreasing values of nD for fast
growing bacteria. While the model clearly does not capture the correct width
dynamics in the presence of high aztreonam (Figure 7.10, top panel) we can still
find a best fit inhibition level which reproduces the length dynamics (Figure 7.10,
bottom panel). From the length-only dynamics in Figure 7.10, bottom panel,
nD/nD0 = 0.5 was chosen as the best fit value.
7.3.2 Fitting the lysis rates for aztreonam-like inhibition
Using the same protocol as for mecillinam, the constants in the lysis rate equation
(φD and ψD) were set by comparing the cell number dynamics at high aztreonam
(nD = 0.5nD0), with the experimental CFU data for 0.5µg/ml. To recap, ψD is
the rate constant for lysis due to excessive cell length and has units of /h as it
scales the fractional change in length (which is dimensionless) and the lysis rate
has units of /h. Meanwhile φD is the rate constant for divisome-mediated lysis
(due to out of control hydrolase action) and has units of ×10−6 disaccharides, in
the same manner as φE. On rich media, bacteria inhibited by high aztreonam
(nD = 0.5nD0) do not develop as filaments, therefore the population dynamics
are hypothesised to depend only on φD. Therefore φD is fit by comparing the
predicted cell number dynamics at nD = 0.5nD0 for fast-growing cells, with the
experimental CFU data for E. coli growing in MOPSgluRDM at high aztreonam
(Figure 7.11). A value of φD = 2.1 × 10−6 disaccharides was found to give the
best fit.
On poor media, aztreonam does cause filamentation. Therefore, setting φD to
2.1×10−6 disaccharides and nD = 0.5nD0, we fit ψD by examining the population
dynamics of slow-growing bacteria (Figure 7.12). This lead to a best fit value of
ψD = 0.007 h−1. To summarise, φD = 2.1 × 10−6 disaccharides, and ψD =
0.007 h−1 were found to give reasonable fits for high aztreonam in the rich and
poor media.
7.3.2.1 Value of nD corresponding to low aztreonam
Finally, we also need to find the level of inhibition in the model which corresponds
to the low aztreonam concentration used in the experiments. This was obtained
by fitting the CFU data for fast-growing bacteria at low aztreonam, assuming that
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Morphology with aztreonam: precursor model
Rich media























Cell length dynamics with aztreonam
Rich media
Figure 7.10: Length and width dynamics. A comparison between experimental
(Exp, red triangles) and simulated values (no markers) in rich growth conditions
under 0.5µg/ml aztreonam or aztreonam-like inhibition. The values in the legend
indicate the fraction of active divisomes (nD/nD0). Each marker corresponds to a
single timepoint: 0, 60, 120, 180 and 240 minutes going roughly from bottom to
top. Other simulation parameters are as in Tables 6.4 and 7.1.
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Figure 7.11: The impact of varying φD on the fit to the high aztreonam (0.5µg/ml)
using the inhibition level nD = 0.5nD0 for fast growing E. coli. φD = 2.1× 10−6
disaccharides was chosen as the best fit. Other simulation parameters are as in
Tables 6.4 and 7.1.
Figure 7.12: The impact of varying ψD on the fit to the high aztreonam (0.5µg/ml)
data using the inhibition level nD = 0.5nD0 for slow growing E. coli on poor
media. ψD = 0.007/h was chosen as the best fit. Other simulation parameters
are as in Tables 6.4 and 7.1.
the lysis rate constants φD and ψD were independent of aztreonam concentration.
This fit is illustrated in Figure 7.13. nD = 0.8nD0 was found to be a good fit to the
low aztreonam experimental CFU data for the fast growing cells (Figure 7.13).
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Figure 7.13: Fitting nD to the experimental CFU results for fast growing E. coli
in the presence of low aztreonam (0.0313µg/ml) on rich media. nD = 0.8nD0 was
chosen as the best fit to low aztreonam. Other simulation parameters are as in
Tables 6.4 and 7.1.
7.4 Discussion
A summary of the antibiotic related parameter fits for mecillinam and aztreonam
can be found in Table 7.1, along with the experimental data that was used for
the fitting. The remaining experimental datasets will be used to test the model
in the next chapter.
From the parameter fitting process, and by visualising the length and width
dynamics with an ellipse plot (Figure 7.14), various observations can be made:
• Whether we model mecillinam by changing the incorporation rate during
elongation (R), or the number of elongasomes (nE) makes no discernible
difference (Figure 7.14). This suggests that the downstream impact of
inhibiting elongation is key rather than whether we decrease the number
of elongasomes or their activity, similar to the “lethal malfunctioning”
described in Cho et al. [16].
• Sphere formation during elongation inhibition arises due to a combination
of the inhibited elongation machinery and the non-inhibited division
machinery. As cells become fatter to decrease the surface area to volume
ratio, and hence cope with the reduced elongation rate, they then spend
more time in pole formation to produce sufficient peptidoglycan to cover
the increased pole area (∼ r3). The possibilty of concurrent elongation and
division will be discussed in Section 8.2.1.1.
• Inhibition of division results in filamentation (as we see experimentally for
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aztreonam) only if the number of divisomes (nD) is inhibited. Reducing
the divisome incorporation rate (I) alone does not result in filamentation
(Figure 7.14), as in the model filamentation arises from the assumption/hy-
pothesis that a bacterial cell requires a minimum number of divisomes per
micron to begin pole formation: the “fatness threshold”.
Strikingly, an estimate of the fatness threshold using literature data agrees with
the best fit value found using the mecillinam morphology tracks. Using the
observation from Pisabarro et al. [107] that filamentation arises at inhibition
of 60% of the PBP3, combined with the data from Dougherty et al. [28] for
the number of PBP3 molecules (approximately 60) at the same doubling time
(approximately 54 minutes, estimated from Figure 2 [107]), we can approximate
that filamentation arises when there remain around 25 active PBP3 molecules.
Combining this with the typical radius of E. coli at this doubling time (∼ 0.3µm
[113]) gives a fatness threshold of rth ' 0.01nD, remarkably close to our best fit





Figure 7.14: The impact of inhibiting either R, nE, I or nD visualised by plotting
ellipses based on the cell length and width. Both axes have arbitrary units. The
time between ellipses is approximately five minutes.
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MECILLINAM Parameters Experiments used
High inhibition R = 0.5R0 RDM high Mec. morphology
Low inhibition R = 0.8R0 RDM low Mec. CFUs
Lysis rate φE = 1.2 × 10−6 disaccha-
ridess
RDM high Mec. CFUs
Sphere threshold lth = 0.6r RDM high Mec. morphology
Fatness threshold rth = 0.009nD RDM high Mec. morphology
AZTREONAM Parameters Experiments used
High inhibition nD = 0.5nD0 RDM high Azt. morphology
Low inhibition nD = 0.8nD0 RDM low Azt. CFUs
Lysis rates φD = 2.1 × 10−6 disaccha-
rides, ψD = 0.007 h−1
RDM and MIN high Azt.
CFUs
Sphere threshold lth = 0.6r RDM high Mec. morphology
Fatness threshold rth = 0.009nD RDM high Mec. morphology




Mathematical model: results and
predictions
In Chapters 6 and 7 we have found the values of all the parameters of our
model, by fitting to a subset of our experimental data (Tables 6.4 and 7.1). In
this chapter, we recap the model’s performance for the data it has been fitted
to, and thoroughly test its capabilities by comparing its predictions with the
remaining experimental data, to which it has not been fitted. We will start with
the precursor threshold division model, and later discuss the differences (or lack
thereof) with the adder division model at the end of the chapter.
8.1 Mecillinam
Using the parameters that were fitted for fast growing bacteria in the previous
chapter (Table 7.1), the model predictions for bacteria in poor media (MOPS-
gluMIN) and intermediate media (MOPSgluCAA) exposed to low and high
mecillinam can now be tested. For completeness, we also include the model
fits for the fast growth media (MOPSgluRDM).
8.1.1 Morphology predictions
Starting with cell morphology, Figure 8.1 shows the model fit for MOPSgluRDM
and the model predictions for MOPSgluMIN, for 1.5µg/ml mecillinam. For the
minimal medium, the model successfully captures the transition to shorter, and
fatter (but not spherical) bacteria in the presence of high mecillinam, although it
does not capture the exact morphology dynamics, with the cell width predicted
to become larger than observed experimentally and the cell length not decreasing
as significantly as in the experiments. The relatively poor prediction for the
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Morphology dynamics with Mecillinam














































Figure 8.1: Length and width dynamics. A comparison between experimental
and simulated results using the precursor division mode under mecillinam-like
inhibition (R = 0.5R0 in simulations; 1.5µg/ml in experiments). Each marker
corresponds to a single timepoint: 0, 60, 120, 180, and 240 minutes from the
addition of mecillinam, going roughly from left to right. Model parameters as in
Tables 6.4 and 7.1.
minimal media morphology dynamics could be due to the inhibition level chosen.
For example, in Figure 7.3, Section 7.2.1, R = 0.6R0 was also a relatively good
fit for the morphology dynamics in rich media. Using this lower inhibition level
improves the prediction for the morphology dynamics on minimal media (see
Appendix Figure D.2).
As an alternative way to visualise the model output, we use “ellipse” trajectories,
as in Figure 8.2. In these plots the average length and width predicted by the
model at thirty minute intervals are depicted by an ellipse of that length and
width. Figure 8.2 makes it very clear that in the presence of high mecillinam,
slow growing bacteria are predicted to turn into small, dividing “lemons”, while
fast growing bacteria get fatter, and shorter, eventually turning into large
spheres/lemons. The transition to the more spherical morphology on the rich
media occurs around 180 minutes.1
8.1.1.1 Low mecillinam morphology predictions for fast and slow
growing bacteria
The model also allows us to predict the cell morphology dynamics at low
mecillinam, 0.094µg/ml (R = 0.8R0) (Figure 8.3), where we do not yet have
1The ellipse trajectories for the alternative fit, R = 0.6R0 are also interesting to consider as
they more clearly demonstrate a spherical morphology on the rich media at 300 minutes, rather
than large lemons (Appendix Figure D.3). To truly distinguish which value of R is a better fit
on rich media, more microscopy data at later times (≥ 300 minutes ) would be necessary.
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Precursor model: slow growing bacteria in high mecillinam











Precursor model: fast growing bacteria in high mecillinam











Figure 8.2: Ellipse trajectories generated by the model, based on the average
length and width every thirty simulation minutes for R = 0.5R0. Parameters as
in Tables 6.4 and 7.1. The ellipse dimensions have arbitrary units.
Precursor model: slow growing bacteria in low mecillinam











Precursor model: fast growing bacteria in low mecillinam











Figure 8.3: The predicted ellipse trajectories generated by the model for low
mecillinam based on the average length and width every thirty simulation minutes
(R = 0.8R0). Parameters as in Tables 6.4 and 7.1. The ellipse dimensions have
arbitrary units.
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experimental data. The ellipse trajectories in Figure 8.3 show that the prediction
for slow growing cells exposed to low levels of mecillinam is that they will become
slightly fatter but not significantly shorter, and will continue to divide. Meanwhile
fast growing bacteria are predicted to become significantly shorter and fatter,
again reaching a large lemon morphology. Further work would be needed to test
this prediction experimentally.
8.1.2 Predicted population dynamics for slow growing
cells in the presence of mecillinam
Figure 8.4 (left) recaps the model fit for the CFU data on rich media. The model
can also be used to predict the CFU dynamics of slow growing bacteria in the
presence of mecillinam. In these simulations the model was initialised with a
number of cells close to the initial experimental number of colony forming units
(Chapter 4) for direct comparison. The predicted population dynamics can be
found in Figure 8.4 (right).
Our mathematical model successfully predicts that slow growing bacterial
populations will continue to grow in the presence of both low and high mecillinam,
although at a reduced rate (Figure 8.4). The model is also correct in predicting
that high mecillinam is only slightly more inhibitive than low mecillinam for slow
growing bacteria at early time. These successful predictions suggest that our
hypothesis that the inhibition level and lysis rate are independent of growth rate
is correct, at least for the MOPS-based growth media used here. However, as for
high mecillinam in the rich media, there is a significant deviation between the
model prediction and experimental results in poor media at later times.
Population dynamics with mecillinam: precursor model














Fit on rich media
















Prediction on poor media
Figure 8.4: Solid lines: The log cell number dynamics from the model at high
(R = 0.5R0) and low (R = 0.8R0) mecillinam like inhibition for cells growing on
rich and poor media. Filled circles: The experimental data for colony forming
units in the presence of high (1.5µg/ml Mec.) and low (0.094µg/ml Mec.) for slow
growing cells in MOPSgluMIN and fast growing cells in MOPSgluRDM. Model
parameters as in Tables 6.4 and 7.1.
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8.1.3 Predicting the population dynamics in
MOPSgluCAA
Up to this point we have only discussed model results for bacteria growing in rich
and poor growth media, but we also have experimental data for an intermediate
growth medium (MOPSgluCAA). The model was tested to see if it could recover
the intermediate growth medium dynamics, without a full parameter search being
performed at the intermediate growth rate.
To test the model for the MOPSgluCAA condition, values for those parameters
which vary between fast and slow growing cells had to be approximated. These
parameters are the numbers of elongasomes and divisomes (nE and nD), the
starting number of precursors (M0) and the starting cell dimensions (and the
volume added (∆) for the adder model, see Section 6.2.2). All these parameters
(for cell dimensions, length and radius) were assumed to have a linear dependence
on growth rate, and hence interpolated using the values for rich and poor media
(see Table 8.1). The other parameters were as in Tables 6.4 and 7.1.
Figure 8.5 shows that the model produces results in remarkably good agreement
with the experimental CFU results for MOPSgluCAA. The model correctly
predicts a decreasing observed growth rate with increasing inhibition, to a similar
extent as observed experimentally. The only aspect of the dynamics that the
model does not capture is the slight population decrease at high mecillinam after
250 minutes (this only happens after 350 minutes in the model, Figure 8.6). This
could be due to an incorrect estimate from the linear interpolation e.g. for the
number of elongasomes. Further work could include microscopy for this growth
medium to find the antibiotic-free cell morphology and check the “goodness-of-fit”
of the estimated parameters.
Putting together the model results for the three growth media (Figure 8.6)
demonstrates that the model successfully captures the growth-medium dependent
dynamics of E. coli exposed to mecillinam. To briefly recap, the key features
of the experimentally-observed growth-medium dependent dynamics were that:
(i) inhibition increases as the richness of the growth medium increases, and (ii)
decreasing cell numbers (lysis) were predominantly observed in MOPSgluRDM.
Both of these features are captured by the model.
Growth condition nE nD M0 ∆ (µm3) V0 Ac0 Ap0
pH 6.5 34°C rich 120 160 3.3 1.28 2.6085 8.043 3.2685
pH 6.5 34°C inter. 42 113 2.9 0.82 1.603 4.108 3.2685
pH 6.5 34°C poor 20 100 2.8 0.71 1.314 2.974 3.2685
Table 8.1: Simulation parameters for the rich, intermediate and poor growth
conditions at pH 6.5 34°C which are assumed to vary with growth rate. The
intermediate parameter values are interpolated from the rich and poor values.
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Population dynamics with mecillinam: intermediate media

















Figure 8.5: Solid lines: The log cell number dynamics from the model for high
(R = 0.5R0) and low (R = 0.8R0) mecillinam-like inhibition for intermediate
growth medium (MOPSgluCAA). Filled circles: The experimental data for colony
forming units in the presence of high (1.5µg/ml Mec.) and low (0.094µg/ml Mec.)
for cells growing in MOPSgluCAA. Model parameters as in Tables 6.4, 7.1 and 8.1.
To summarise, the model performs well in reproducing the morphology and
population dynamics of bacteria growing in three growth media and at low and
high concentrations of mecillinam. This suggests that a model which focuses on
the surface area and volume growth dynamics of an individual cell can be sufficient
to capture non-trivial individual cell and population level phenomena related to
the inhibition of E. coli by cell wall-targeting antibiotics, such as mecillinam.
Nevertheless, the systematic deviation between the experimental results and the
model dynamics at later times suggests that there could be something lacking in
the model.
8.2 Aztreonam
For aztreonam, the model parameters were fitted using the morphology track in
MOPSgluRDM, the CFU dynamics at low and high aztreonam in MOPSgluRDM
and the CFU dynamics at high aztreonam in MOPSgluMIN. The remaining
experimental data (which was not used in the fitting process) can be used to
test the model. This consists of: the morphology track for slow growing bacteria
(MOPSgluMIN) in the presence of high aztreonam; the CFU dynamics for slow
growing bacteria in the presence of low aztreonam; and the CFU dynamics at













































































Figure 8.6: Comparison between model and experimental data for cell number
dynamics in three different growth conditions: rich, intermediate and poor, for
high (left) and low (right) mecillinam concentrations.
8.2.1 Morphology tracks
Figure 8.7 (left) shows the model fit for the morphology data for fast-growing
E. coli in the presence of high aztreonam (0.5µg/ml) (see Section 7.3). Figure 8.7
(right) shows the corresponding model prediction for slow-growing bacteria in the
presence of high aztreonam. The prediction of the model is that slow-growing
bacteria will get slightly thinner, and significant longer, in the presence of high
aztreonam. This agrees very well with the experimental observation, although
the simulated bacteria do reach much longer cell lengths after three hours than
observed experimentally.
To summarise, the model successfully captures filamentation on poor media, but
not rich media, in the presence of high aztreonam.
8.2.1.1 Improving the aztreonam morphology tracks
In our model cells generally become fatter if there is an imbalance between
the surface area and volume growth (since fat cells have a smaller surface area
to volume ratio). I hypothesised that the model predicted fatter, fast-growing
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NO ELONGATION DURING POLE FORMATION
Morphology with high aztreonam: precursor model















































































Figure 8.7: Length and width dynamics. A comparison between experimental
and simulated results (using the parameters in Tables 6.4 and 7.1), under
high aztreonam-like inhibition. Top: Morphology tracks where each marker
corresponds to a single timepoint: 0, 60, 120, 180 and 240 minutes, going roughly
from bottom to top. Bottom: The dynamics of the average length with time at
high aztreonam.
bacteria than observed experimentally, under aztreonam challenge, because pole
formation was slowed down due to the reduced number of divisomes. Under
conditions where pole formation can still be attempted (as the fatness threshold
has not been reached), the model then spends more time in pole formation, due
to the reduced rate of peptidoglycan incorporation, in order to make sufficient
surface area to cover the new poles. During this time volume growth continues
uninhibited, while surface area growth is hampered. Therefore an imbalance
occurs between surface area and volume growth during pole formation. This can
lead the model to incorrectly predict sphere formation at high aztreonam for
fast-growing bacteria (Figure 8.9).
Sphere formation is not observed experimentally at high aztreonam for fast-
growing E. coli ; instead we observe no change in width, and a doubling of the
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Growth condition ρ S KM R = I nE nD M0 ∆ (µm3)
pH 7.4 37°C rich 0.1 1.6 0.3 0.009 120 160 1.5 0.76
pH 7.4 37°C inter. 0.1 1.6 0.3 0.009 41 81 1.66 0.47
pH 7.4 37°C poor 0.1 1.6 0.3 0.009 20 60 1.7 0.4
Table 8.2: New simulation parameter values for the case where elongation is
included during pole formation: for the rich, intermediate and poor growth
conditions at pH 7.4 37°C. The intermediate parameter values are interpolated
from the rich and poor values.
average cell length. In the model, one can correct the aberrant sphere formation
by allowing some elongation to continue during pole formation. This restores
the balance between surface area and volume growth. There is some evidence
that elongation does continue (at a reduced rate) during pole formation in the
literature [21, 25]. To examine this possibility a trial model was implemented
where elongation continues during pole formation, but at a 40% slower rate
(chosen arbitrarily).
A test run including elongation during pole formation, and using the parameters
in Table 6.4 resulted in a very poor fit to the antibiotic-free experimental
morphology for both fast and slow growing bacteria (Figure D.8, Appendix).
Therefore to correct this, a parameter phase space search was performed, as
WITH ELONGATION DURING POLE FORMATION
Morphology with aztreonam: precursor model






















































Figure 8.8: Length and width dynamics with elongation during pole formation.
A comparison between experimental and simulated values in rich (left) and poor
(right) growth conditions under aztreonam-like inhibition. The previous best fit
inhibition level nD = 0.5nD0 is displayed alongside the new best fit inhibition
level of nD = 0.6nD0. Each marker corresponds to a single timepoint: 0, 60, 120,
180 (and 240 for minimal media) minutes going roughly from bottom to top.
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previously described (Ch. 6) using the antibiotic-free data only, to determine
new best fit parameter values. The resulting parameter values for this model
implementation can be found in Table 8.2, and the resulting morphology tracks
are shown in Figure 8.8. The main difference between this parameter set, and
the one found with no elongation during pole formation (Table 6.4) is that the
synthesis rate has increased, while the incorporation rate and number of divisomes
have decreased.
Figure 8.8 (left) shows that including elongation during pole formation, and re-
parameterising, leads to a great improvement in the morphology fit for cells in
rich media. The cells no longer become exceedingly fat but instead undergo a
doubling of the cell length, as we see in the experiments.
On poor media (Figure 8.8, right), including elongation during pole formation
results in a slight increase in the width of the filamenting cells, while the
length dynamics now become more consistent with the experimental observations.
Filamentation is now observed at all inhibition levels for slow-growing bacteria
(Figure 8.20 contains a plot at a wide range of inhibition levels).
Without elongation during pole formation nD = 0.5nD0 was chosen as the best
fit inhibition level for high aztreonam. Figure 8.8 shows that, with elongation
during pole formation nD = 0.6nD0, could be a better choice.
As previously described, we can also visualise the morphology data with ellipse
plots. These help to highlight the impact of including elongation during pole
formation on the predicted morphologies in the presence of high aztreonam for
slow and fast growing bacteria (Figure 8.9). For slow growing cells it can be seen
that the filaments develop more gradually with elongation during pole formation.
For fast growing cells, filamentation is observed with the inclusion of elongation
during pole formation, whereas spheres are incorrectly predicted if elongation
during pole formation is omitted.
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Precursor division model
Slow growing bacteria in high aztreonam: no elongation during PF











Slow growing bacteria in high aztreonam with elongation during PF











Fast growing bacteria in high aztreonam: no elongation during PF











Fast growing bacteria in high aztreonam with elongation during PF











Figure 8.9: Ellipse trajectories generated from the model, based on the average
length and width every thirty simulation minutes for nD = 0.5nD0. Parameters
as in Tables 7.1, 6.4 and 8.2. Here we compare the impact of having elongation
during pole formation (PF) or not. The ellipse dimensions have arbitrary units.
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Population dynamics with aztreonam: precursor model














Fit on rich media
















Prediction for low Azt. on MIN
Figure 8.10: Population dynamics in the presence of aztreonam. Solid lines:
The log cell number dynamics from the model, with no elongation during pole
formation, at high (nD = 0.5nD0) and low (nD = 0.8nD0) aztreonam-like
inhibition for both fast growing (left) and slow growing (right) cells. Filled circles:
The experimental data for colony forming units in the presence of high (0.5µg/ml
Azt.) and low (0.0313µg/ml Azt.) for both fast and slow growing cells. Model
parameters as in Tables 7.1 and 6.4.
8.2.2 Population dynamics in the presence of aztreonam
8.2.2.1 Without elongation during pole formation
Figure 8.10 shows the model results for the population dynamics, in the absence
of elongation during pole formation. For fast-growing bacteria the model fits well
for both high and low aztreonam. However, for slow-growing bacteria, the model
fit is good at high aztreonam but the model predicts growth at low aztreonam
whereas in fact the population should decrease.
8.2.2.2 With elongation during pole formation
As better morphology dynamics were found when elongation was included during
pole formation, the population dynamics predictions were also tested for this
implementation of the model. However as the best fit morphology for fast growing
bacteria is now at the inhibition level of nD = 0.6nD0, we have to fit new values
for the lysis rate constants and the inhibition level for low aztreonam. As before,
the lysis rate constant φD was fit using the CFU data for fast-growing cells in high
aztreonam (φD = 2.3×10−6 disaccharides) and ψD was fit using the CFU data for
slow-growing cells in low aztreonam (ψD = 0.011h−1) (see Appendix Figure D.9).
The new inhibition level for low aztreonam was found to be nD = 0.75nD0 (see
Appendix Figure D.9). The model prediction for low aztreonam for slow-growing
bacteria is compared with the experimental CFU data in Figure 8.11 (right), while
the fit on rich media is shown in Fig. 8.11 (left). The model is now successful in
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AZTREONAM Parameters Experiments used in fitting
High inhibition nD = 0.6nD0 RDM high Azt. morphology
Low inhibition nD = 0.75nD0 RDM low Azt. CFUs
Lysis rates φD = 2.3 × 10−6 disaccha-
rides, ψD = 0.011h−1
RDM and MIN high Azt.
CFUs
Table 8.3: New simulation parameter values for the case where elongation is
included during pole formation. The experimental data used in the fitting process
is also detailed.
capturing the decreasing population of slow-growing bacteria with low aztreonam
(compare to Figure 8.10, right (orange line), in the absence of elongation during
pole formation.
To summarise, aztreonam shows growth-medium dependent inhibition in the
following way. At high aztreonam, fast-growing bacteria are more inhibited than
slow-growing bacteria. In contrast, at low aztreonam, fast-growing bacteria are
less inhibited than slow-growing bacteria. Our model captures this behaviour, and
suggests that this growth-medium dependent inhibition stems from the different
numbers of divisomes that are required to grow at different growth rates in the
absence of the antibiotic. Specifically, in our model, more divisomes are needed for
antibiotic-free growth on rich media to ensure that surface area growth continues
to match volume growth, and therefore maintain a rod-shaped bacterium. In the
Prediction for population dynamics with aztreonam if elongation is
included in pole formation














Fit on rich media
















Prediction for low Azt. on MIN
Figure 8.11: Population dynamics in the presence of aztreonam. Solid lines: The
log cell number dynamics from the model, with elongation during pole formation,
at high (nD = 0.6nD0) and low (nD = 0.75nD0) aztreonam-like inhibition for both
fast growing (left) and slow growing (right) cells. Filled circles: The experimental
data for colony forming units in the presence of high (0.5µg/ml Azt.) and low
(0.0313µg/ml Azt.) for both fast and slow growing cells. Model parameters as in
Tables 8.2 and 8.3
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presence of aztreonam, the interplay between the number of active divisomes,
filamentation and lysis leads to three possible population dynamics outcomes. In
the first scenario few divisomes are inhibited, and cells can continue to divide at
a rate higher than the lysis rate (e.g. rich media, low aztreonam). In the second
scenario, a significant proportion of divisomes are inhibited but pole formation is
still attempted. Here, cells continue to divide but at a rate lower than the lysis
rate leading to a net loss of CFUs (e.g. rich media, high aztreonam). In the
third scenario, enough divisomes are inhibited that pole formation can no longer
be attempted (due to the fatness threshold) resulting in non-dividing filamentous
cells which have a low lysis rate at early times (e.g. poor media, high and low
aztreonam). This leads to the observed growth-medium dependence because cells
growing on the poor medium have fewer divisomes in the absence of antibiotic and
therefore reach the third, filamenting, scenario even at low aztreonam, whereas
the fast growing cells still have sufficient, uninhibited divisomes to continue
dividing (scenario 1).
8.2.3 Further predictions for population dynamics with
aztreonam
8.2.3.1 MOPSgluCAA
We also have experimental data for bacteria exposed to aztreonam in an
intermediate medium (MOPSgluCAA). The model predictions for aztreonam-
like inhibition can therefore be tested for these intermediate growth dynamics.
As in section 8.1.3, we use interpolation to estimate the parameter values for the
MOPSgluCAA growth medium, both with and without elongation during pole
formation (Table 8.4).
Figure 8.12 shows that the mathematical model performs similarly with and
No elongation nE nD M0 ∆ (µm3) V0 Ac0 Ap0
pH 7.4 37°C rich 120 180 1.5 0.95 1.474 4.351 2.799
pH 7.4 37°C inter. 41 97 1.7 0.67 1.067 3.029 2.556
pH 7.4 37°C poor 20 75 1.8 0.73 0.969 2.698 2.4885
With elongation nE nD M0 ∆ (µm3) V0 Ac0 Ap0
pH 7.4 37°C rich 120 160 1.5 0.76 1.474 4.351 2.799
pH 7.4 37°C inter. 41 81 1.66 0.47 1.067 3.029 2.556
pH 7.4 37°C poor 20 60 1.7 0.4 0.969 2.698 2.4885
Table 8.4: Growth-medium dependent simulation parameters for the rich,
intermediate and poor growth conditions at pH 7.4 37°C. The intermediate
parameter values are interpolated from the rich and poor values.
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Population dynamics with aztreonam with the precusor model:
intermediate media
















No elongation during PF
















With elongation during PF
Figure 8.12: Solid lines: The log cell number dynamics from the model at
high and low aztreonam-like inhibition for the intermediate growth medium.
Parameters with no elongation during pole formation as in Tables 6.4, 7.1 and 8.4.
Parameters with elongation during pole formation as in Tables 8.2, 8.3 and 8.4.
Filled circles: The experimental data for colony forming units in the presence
of high (0.5µg/ml Azt.) and low (0.0313µg/ml Azt.) for cells growing in
MOPSgluCAA.
without elongation during pole formation for aztreonam in MOPSgluCAA.
The model successfully predicts positive population growth observed with
low aztreonam, performing better with elongation during pole formation, but
Population dynamics with aztreonam with the precursor model:
intermediate media



































Figure 8.13: Solid lines: The log cell number dynamics in the model at high
(nD = 0.6nD0) and low (nD = 0.75nD0) aztreonam-like inhibition for intermediate
growth-rate cells with different nD0 values. Other parameters as in Tables 8.2
and 8.3. Filled circles: The experimental data for colony forming units in the
presence of high (0.5µg/ml Azt.) and low (0.0313µg/ml Azt.) for cells growing
in MOPSgluCAA.
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gives an incorrect prediction for the high aztreonam dynamics; specifically the
model predicts slight positive population growth whereas population decline was
observed experimentally. This may be due to the linear interpolation of the
parameter values. For example, if the number of divisomes (with elongation) is
reduced from 81 to 68 or 65 a better prediction results for the MOPSgluCAA
data (Figure 8.13).
8.2.3.2 Growth-medium dependent inhibition
We can now assess overall whether the model gives the correct predictions
for growth-medium dependent inhibition by aztreonam. Figure 8.14 compares
the model results (with elongation during pole formation, and nD0 = 65 at
intermediate growth rate) for aztreonam on three media, with the experimental
results. The growth-medium dependent inhibition predictions are very good.
The model captures the low aztreonam behaviour well (Figure 8.14, right), in
particular the similar dynamics observed for MOPSgluRDM and MOPSgluCAA.
The high aztreonam predictions (Figure 8.14, left) are also good, apart from
the result for MOPSgluCAA that was discussed above. Strikingly, the model
successfully captures the reversal of the growth-medium dependence for low
Model prediction











































































Figure 8.14: Comparison between cell number dynamics in three different growth
conditions: rich, intermediate and poor, in a high (0.5µg/ml) aztreonam-like
inhibition (left) and a low (0.0313µg/ml) aztreonam like-inhibition (right).
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Figure 8.15: Left: The predicted morphology tracks from the model for fast-
growing bacteria at a range of aztreonam-like inhibition levels. Filaments are
predicted at inhibition levels greater than nD = 0.6nD0. Right: The predicted
population dynamics from the model for fast growing cells at inhibition levels of
nD = 0.2nD0 and nD = 0.5nD0, both of which are predicted to give filaments.
aztreonam - i.e. for low aztreonam, in contrast to other conditions, inhibition
is strongest for slow-growing cells.
8.2.3.3 Long filaments on rich media
In our microscopy experiments with high aztreonam, long filaments were observed
in the poor media (lengths of around 20µm) while in rich media filaments were not
observed, although the cell length was observed to approximately double (lengths
of around 8µm) (Chapter 5). The model makes an interesting prediction that
longer filaments are expected to emerge on rich media, at higher concentrations
of aztreonam. For example, Figure 8.15 (left) shows that filaments are predicted
on rich media for inhibition levels greater than nD = 0.6nD0.
The model further predicts that the filaments that form at nD = 0.5nD0 become
fatter as well as longer, while those at a higher inhibition level nD = 0.2nD0,
simply become longer (Figure 8.15, left). We hypothesised that these different
filament dynamics would also result in different predictions for the population
dynamics, and so examined this with the model (Figure 8.15, right). Indeed,
for high inhibition, nD = 0.2nD0, on rich media, the model predicts population
dynamics similar to that previously observed on poor media (Figures 8.11, right
and 8.15, right), i.e. there is no cell division. A somewhat lower level of inhibition
(nD = 0.5nD0) appears to produce cells which can still divide while also becoming
filamentous. This means that the population alternates between the two lysis
regimes, that due to out-of-control divisomes and that due to the unstable increase
in length (Figure 8.15, right, visible in the alternating gradients). This leads to
the interesting prediction that the intermediate inhibition level of nD = 0.5nD0
gives a higher lysis rate compared to the higher inhibition level of nD = 0.2nD0
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(Figure 8.15, right), at early times.
If these predictions are true, they could have clinical implications for the use
of aztreonam against infections. Firstly, filamentous E. coli can subvert the
innate immune response [65], so it could be hypothesised that using a very
high aztreonam concentration that results in long filaments might make it more
difficult to clear an infection. Secondly, the model predicts that there is a range
of intermediate aztreonam concentrations where the lysis rate is greater than that
predicted at very high aztreonam concentrations. As an antibiotic may not be
at the site of interest for more than a couple of hours [94], the model predicts
that it could be quicker to clear an infection using an intermediate aztreonam
concentration than using a high concentration.
8.3 The adder division model
As previously discussed (see Chapter 6), we have also implemented the adder
division model in our simulations. We were interested to see if the adder
model would give significantly different predictions to the precursor model. It
turns out that the adder and the precursor division models generally give very
similar predictions, with only subtle differences that would be very difficult to
differentiate between experimentally.
We will now discuss some of these subtle differences between the division models.
The complete set of results for the adder division model can be found in the
Appendix.
8.3.1 Mecillinam
The adder division model predicts slightly different morphology dynamics at
high mecillinam for fast growing bacteria, compared to the precursor threshold
division model (Figure 8.16, bottom). For the adder division model, the
transition to a spherical morphology happens slightly earlier than it does in the
precursor division model. This can be explained by looking at the length and
width dynamics in more detail (Figure 8.17). Figure 8.17 highlights that when
mecillinam inhibition is applied (midway through the cell cycle in this example)
the division models give different predictions.
Specifically, the precursor threshold division model predicts that cells become
elongating lemons after the third division event, before a spherical morphology
is reached, when high mecillinam is applied (Figure 8.17). In contrast, the adder
model predicts a transition directly to a spherical morphology after four division
events. This happens because the fatness threshold has not yet been reached
when the precursor model first transitions to the lemon morphology. This could
potentially be due to cells reaching the criteria for pole formation earlier in the
147
Precursor model: slow growing bacteria











Adder model: slow growing bacteria











Precursor model: fast growing bacteria











Adder model: fast growing bacteria











Figure 8.16: Ellipse trajectories generated by the model, based on the average
length and width every thirty simulation minutes for R = 0.5R0. Parameters as
in Tables 7.1 and 6.4. The adder model predicts more spherical morphologies
while the precursor model predicts lemon morphologies.
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precursor threshold model (before getting too fat), perhaps due to a build-up of
precursors. These different predictions are consistent regardless of when in the
cell cycle the mecillinam inhibition is applied. The length and width dynamics
when mecillinam inhibition is applied at either the beginning or the end of the
cell cycle can be found in the Appendix Figure D.10.
The adder model also gives slightly different morphology tracks under mecillinam-
like inhibition for slow-growing bacteria (Figure 8.18). The main difference
between the precursor and adder division models is that the adder model tends to
predict an increase in length after 180 minutes, at low and high inhibition levels,
whereas the precursor model predicts a continuous decrease in length. These
predictions could be tested experimentally by performing microscopy with E. coli
Precursor model

































Figure 8.17: The length and width dynamics generated by the precursor and
adder models for fast growing bacteria, when high mecillinam inhibition is applied
halfway through the cell cycle. Parameters as in Tables 7.1 and 6.4. The bacteria
become spherical when the length and width become equal i.e. when length
width
= 1.
Markers represent the experimental data at high mecillinam in MOPSgluRDM.
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Morphology with mecillinam in poor media











































Figure 8.18: Length and width dynamics. A comparison between simulated
results using the precursor and adder division models in poor growth conditions
under mecillinam-like inhibition. The values in the legend indicate the inhibition
level. Each marker corresponds to a single timepoint: 0, 60, 120, 180, and
240 minutes from the addition of mecillinam, going roughly from left to right.
Parameters as in Tables 7.1 and 6.4. The adder model predicts an increase in
length after 180 minutes
growing in poor media at a wider range of mecillinam concentrations.
We observe very little difference between the adder and precursor division models
in terms of their population dynamics predictions. The only difference of note
occurs on rich media forR = 0.5R0 i.e. high mecillinam. In this case, as discussed,
division stops at about 200 minutes in the precursor division model, but not until
about 250 minutes in the adder model (see Appendix Figure D.4). However this
does not make a significant difference to the log of the cell number.
8.3.2 Aztreonam
For aztreonam, the only significant difference between the predictions of the
adder and precursor division models occurs at inhibition levels nD = 0.4nD0 and
below (i.e. at higher aztreonam concentrations than used experimentally) for
cells growing in rich media (Figure 8.19, right). Figure 8.19 shows that for the
adder division model, cells become less fat at these inhibition levels with filaments
observed at nD = 0.4nD0, whereas the precursor model predicts much fatter cells
and no filaments at nD = 0.4nD0. This difference between the division models
can be explained as follows. If cells do not filament on rich media (nD > 0.3nD0),
they spend more time in pole formation, gradually getting fatter. As the exact
timing of pole formation and the length of time spent in pole formation can vary
slightly between the adder and precursor division models, the models predict
slightly different cell widths.
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Morphology with high aztreonam in rich media
















































Figure 8.19: Length and width dynamics. A comparison between the simulated
results using the precursor and adder division models, in rich growth conditions
under high aztreonam-like inhibition. The values in the legend indicate the
fraction of divisomes still active despite the inhibition. Each marker corresponds
to a single timepoint: 0, 60, 120, 180 and 240 minutes, going roughly from bottom
to top. Parameters as in Tables 6.4 and 7.1.
When elongation is included during pole formation we again see increased
filamentation with the adder model in rich media (Figure 8.20, top) compared to
the precursor model. No difference is observed between the adder and precursor
division models on the poor media (Figure 8.20, bottom).
Despite the increased filamentation predicted by the adder model, there is no
significant difference in the population dynamics of bacteria in the presence
of aztreonam using either the adder or precursor division model for the
concentrations of aztreonam used in our experiments (see Figure D.7). To
conclude, from these predictions it not possible to differentiate between the adder
and precursor division models when exposing the bacteria to aztreonam.
8.4 Summary
In summary, the model makes qualitatively, and largely quantitatively, correct
predictions for the morphology at high mecillinam in MOPSgluMIN, and for
the CFU dynamics in MOPSgluMIN and MOPSgluCAA, at both low and
high mecillinam. The model is able to capture the non-trivial growth-medium
dependence of inhibition that we observe experimentally, although long term
dynamics are not always captured correctly. For aztreonam, the model is able to
correctly predict long filaments on MOPSgluMIN, and short (fatter) filaments on
MOPSgluRDM, at high aztreonam concentration, however it predicted positive
population growth on MOPSgluMIN with low aztreonam, whereas we observe
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slight negative growth experimentally. We found that improved morphology
predictions could be achieved if elongation was allowed to continue at a reduced
rate during the pole formation phase of the cell cycle. This then led to correct
predictions for the CFU dynamics at low and high aztreonam in all three growth
media i.e. low aztreonam is most inhibitive on the poor medium and high
aztreonam is most inhibitive on the rich medium.
WITH ELONGATION DURING POLE FORMATION
Morphology with aztreonam in rich media


















































Morphology with aztreonam in poor media
















































Figure 8.20: Length and width dynamics with elongation during pole formation.
A comparison between simulated results in rich (top) and poor (bottom) growth
conditions under aztreonam-like inhibition, and with the precursor (left) or adder
(right) division models. The values in the legend indicate the fraction of divisomes
still active despite the inhibition. Each marker corresponds to a single timepoint:
0, 60, 120, 180 and 240 minutes going roughly from bottom to top. Parameters
as in Tables 8.2 and 8.3
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Chapter 9
Expanding the project to more
antibiotics
This thesis has so far discussed the population and morphology dynamics of
E. coli in the presence of mecillinam and aztreonam in detail (Chapters 4 and 5),
as well as giving an overview of the population dynamics of E. coli in the presence
of cefotaxime and fosfomycin (Chapter 3). In this chapter we will compare
experimental population dynamics results for two more antimicrobials, along with
those for the four antibiotics already discussed. Additionally, we will present some
microscopy results for cefotaxime and fosfomycin, along with some preliminary
model results for fosfomycin-like inhibition.
9.1 Population dynamics with other cell
wall-targeting antimicrobials
Plate reader experiments in poor media (MOPSgluMIN) and rich media (MOPS-
gluRDM) were used to observe the population dynamics of E. coli RJA002 in
the presence of two more antimicrobial compounds: the antibiotic ampicillin and
the antimicrobial compound A22. These results will be compared directly with
the results observed in the presence of mecillinam, aztreonam, fosfomycin and
cefotaxime.
Ampicillin primarily targets the endopeptidases PBP4, PBP7 and PBP8 (as
discussed in Chapter 1, endopeptidases cleave the covalent bonds in the PG
network to open space for new material [98]), although at higher concentrations
it can target all major PBPs [72, 75, 115]. Thus ampicillin can be considered to
inhibit both elongation and division. In contrast, A22 has a very specific target:
MreB. As discussed in Chapter 1, MreB is a bacterial actin-like cytoskeletal
filament that associates with the elongasome to produce E. coli ’s characteristic
rod-shape [117]. During elongation MreB forms dynamic filaments that rotate
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Antimicrobial Target
mecillinam PBP2 (elongasome) [33]
aztreonam PBP3 (divisome) [107]
fosfomycin MurA (precursor synthesis) [38]
cefotaxime PBP3 (PBP1a/PBP1b at high concentrations) [72]
ampicillin PBP4, PBP7, PBP8 [72]
A22 MreB (elongation) [141]
Table 9.1: Summary table of the antimicrobials used and their key targets.
around the long axis of the cell [131]. MreB can be considered to be a key
component of the elongasome [112] and therefore A22 can be considered to target
elongation. The primary targets for all six antimicrobials that will be discussed
here are listed in Table 9.1.
Based on the targets of the antimicrobials we can make some hypotheses regarding
their expected effect on E. coli ’s population dynamics. As A22 solely inhibits
elongation, it might be expected to have similar effects as mecillinam. As
ampicillin can inhibit both elongation and division it may have similar effects as
fosfomycin, which effectively inhibits both elongation and division by preventing
the production of precursors. Lastly as cefotaxime primarily inhibits PBP3 it is
expected to result in similar effects as aztreonam.
9.1.1 The six antimicrobials on rich media
Plate reader results for the six antimicrobials acting on E. coli RJA002 growing
in MOPSgluRDM can be found in Figure 9.1, in this figure all media are at pH
7.4 and 37°C apart from the mecillinam case where the more stable environmental
conditions of pH 6.5 and 34°C were used. As hypothesised, cefotaxime (Fig. 9.1a)
and aztreonam (Fig. 9.1b) display very similar looking growth curves, with a small
increase in optical density followed by a plateau at all antibiotic concentrations.
Furthermore mecillinam (Fig. 9.1c) and A22 (Fig. 9.1d) also give similar results,
with a significant bump in optical density at most concentrations. From these
plate reader observations we hypothesise that antimicrobials that primarily
inhibit division (cefotaxime and aztreonam) result in a plateau phenotype for
cells in MOPSgluRDM, while antimicrobials that primarily inhibit elongation
(mecillinam and A22) result in a bump phenotype.
As mentioned, fosfomycin and ampicillin effectively inhibit both elongation and
division, although in different ways. However, their effects on the plate reader-
observed growth curves are very different. Ampicillin (Fig. 9.1f) results in a
plateau phenotype (perhaps suggesting from previous observations that it may
be inhibiting division more than elongation). Fosfomycin (Fig. 9.1e) results in
a mixed phenotype. For concentrations below 4µg/ml a bump phenotype is
observed, with a curious double peak at the lowest concentrations. However
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(a) Cefotaxime in MOPSgluRDM.























(b) Aztreonam in MOPSgluRDM.
(c) Mecillinam in MOPSgluRDM.




















(d) A22 in MOPSgluRDM.
(e) Fosfomycin in MOPSgluRDM.






















(f) Ampicillin in MOPSgluRDM.
Figure 9.1: Plate reader optical density curves for E. coli growing in
MOPSgluRDM at pH 7.4 and 37°C with six different antimicrobials, apart from
the mecillinam data which was at pH 6.5 and 34°C.
at higher concentrations, above 8µg/ml, a plateau phenotype is observed.
This might perhaps suggest that elongation is more inhibited at the lower
concentrations (potentially resulting in spherical morphologies), and division is
more inhibited at the higher fosfomycin concentrations (potentially resulting in
filament morphologies).
9.1.2 The six antimicrobials on poor media
The plate reader results for the six antimicrobials in MOPSgluMIN are displayed
in Figure 9.2. Unlike on MOPSgluRDM, cefotaxime (Fig. 9.2a) and aztreonam
(Fig 9.2b), which both target division, display different growth curves on
MOPSgluMIN. Cefotaxime results in a plateau phenotype at all concentrations.
Conversely, aztreonam results in a bump followed by a plateau at all concentra-
tions except the lowest (0.03125µg/ml), which simply plateaus.
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(a) Cefotaxime in MOPSgluMIN. (b) Aztreonam in MOPSgluMIN.
(c) Mecillinam in MOPSgluMIN.






















(d) A22 in MOPSgluMIN.
(e) Fosfomycin in MOPSgluMIN.




















(f) Ampicillin in MOPSgluMIN.
Figure 9.2: Plate reader optical density curves for E. coli growing in
MOPSgluMIN at pH 7.4 and 37°C with six different antimicrobials, apart from
the mecillinam data which was at pH 6.5 and 34°C.
For mecillinam (Fig. 9.2c) and A22 (Fig. 9.2d) the growth curves on poor media
are similar, with both of the antimicrobials displaying weak growth inhibition on
this medium. Furthermore our results for fosfomycin (Fig. 9.2e) and ampicillin
(Fig. 9.2f) are similar in MOPSgluMIN, with both these antibiotics now resulting
in a plateau phenotype.
9.1.3 Comparing population dynamics on rich and poor
media
In Chapter 3 we discussed the growth medium dependence of the population
dynamics of cefotaxime, fosfomycin and mecillinam as measured via optical
density in a plate reader. There we concluded that cefotaxime and fosfomycin
were more inhibitive on poor media, while mecillinam was apparently more
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inhibitive on intermediate media (but still more inhibitive on rich media than
poor media). As A22 apparently displays similar results to mecillinam in both
rich and poor growth media this could suggest that antimicrobials that primarily
target elongation are generally less inhibitive for slower growing bacteria.
For the antimicrobials targeting division, or both division and elongation, the
growth medium dependence is less obvious. While fosfomycin is clearly more
inhibitive on MOPSgluMIN, inhibition by ampicillin on MOPSgluMIN is not
much different to that in MOPSgluRDM. Furthermore, while cefotaxime is more
inhibitive on MOPSgluMIN, most aztreonam concentrations appear to be less
inhibitive on MOPSgluMIN with only the lowest concentration becoming more
inhibited on the poor media.
9.1.4 Conclusions regarding the six antimicrobials
Comparing the six antimicrobials across rich and poor media, for experiments
using the plate reader, our results can be summarised as follows. For an-
timicrobials that primarily inhibit division a plateau phenotype is observed
in the optical density measurements. Based on our results for aztreonam
(Chapter 5), we hypothesise that this plateau phenotype may be related to the
emergence of a filamentous morphology. As such, future microscopy experiments
with cefotaxime, ampicillin and high concentrations of fosfomycin may reveal
filamenting bacteria. This hypothesis agrees with literature observations that
cefotaxime results in filamentation of bacteria [45, 69], as does ampicillin [47].
Furthermore, for E. coli in the presence of cefotaxime above the MIC, Kjeldsen
et al. [69] observed elongated cells at 2 hours after inoculation and then no
further growth. This is similar to what we observed for high aztreonam in rich
media (Ch. 5 Sec. 5.3), further suggesting that the similar population dynamics
for cefotaxime and aztreonam in rich media correlate to similar morphology
dynamics.
Meanwhile for antimicrobials that primarily inhibit elongation a bump phenotype
is observed in our optical density measurements. Based on our results for
mecillinam (Chapter 4) we hypothesise that a bump phenotype corresponds to
the development of spherical cells followed by lysis. Therefore future microscopy
with A22 and low fosfomycin concentrations may reveal spherical morphologies.
This hypothesis is also consistent with the literature observations that A22 results
in lemon morphologies [42, 58] and that fosfomycin results in fatter (and longer)
E. coli cells (Figure 9.7) [51].
157
9.2 Microscopy with cefotaxime and fosfomycin
To test the hypotheses that cefotaxime should produce filaments and fosfomycin
should produce spherical morphologies some preliminary phase contrast mi-
croscopy was carried out. These experiments were done in rich LB media using
E. coli MG1655.
9.2.1 Cefotaxime
Following the protocol in Chapter 2 for our plate reader experiments, samples
were removed every hour, from a 96-well plate, to be studied using microscopy.
To achieve this the plate reader was stopped every 60 minutes and 3−5 µl samples
taken from a selection of wells. This allowed us to directly correlate the observed
morphologies with the plate reader optical density measurements. Samples from
a range of cefotaxime concentrations were chosen and imaging was done with a
60x objective.
Interestingly, after one hour of exposure to a high concentration (1µg/ml) of
cefotaxime, primarily spherical cells are observed while after two hours filaments
were seen to have arisen (Figure 9.4). The spherical cells that we see in the first
hour after exposure to cefotaxime are unexpected, and to our knowledge have not
been described in the literature.
We also observe some spherical cells at all concentrations after three hours. These
may be spheroplasts [45, 154] which form due to turgor pressure pushing the
inner and outer membranes out through defects in the cell wall. We believe these
are spheroplasts as spheroplasts have previously been reported to emerge after
exposure to cefotaxime [45, 154].
Figure 9.3: An example of a several bulges forming on a filament after 3 hours in
1 µg/ml cefotaxime at 60x magnification.
Some of our images for cefotaxime also show bulge formation (e.g. at 1 µg/ml


























1µg/ml Ctx. 0.0625µg/ml Ctx. 0.125µg/ml Ctx.
Figure 9.4: Microscopy images corresponding to 1 hour timepoints in the first
6 hours of E. coli MG1655 growth at cefotaxime concentrations of 1, 0.125 and
0.0625µg/ml in LB. Scale bars are 10µm.
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1 hour 3 hours 4 hours
Figure 9.5: E. coli MG1655 imaged in LB with 0.5µg/ml fosfomycin at 1, 3 and
4 hours using a 60x objective.
9.2.2 Fosfomycin
Microscopy of E. coli exposed to various fosfomycin concentrations was carried
out in parallel with growth in the plate reader, using the same protocol as
described in Section 9.2.1. The resulting images can be seen in Fig. 9.8, and
some higher resolution examples in Figure 9.5.
At the high fosfomycin concentrations (8 and 32µg/ml) E. coli MG1655 are
observed to turn into small, spherical cells which do not appear to grow much
over time. In the presence of the low fosfomycin concentration (0.5µg/ml), small
filaments are seen to appear, and these increase in both length and width after 3
hours of exposure to the antibiotic (Figure 9.6).
Figure 9.6: The experimental average widths (left), lengths (centre) and SA/V
(right) after three hours growth at 0µg/ml and 0.5µg/ml fosfomycin. N = 39 at
0µg/ml. N = 54 at 0.5µg/ml. Error bars show standard error of the mean.
Figure 9.7: Panel D from Figure 2 of Harris and Theriot [51] demonstrating the



























32µg/ml Fos. 8µg/ml Fos. 0.5µg/ml Fos.
Figure 9.8: Microscopy images corresponding to 1 hour timepoints in the first
6 hours of E. coli MG1655 growth in LB for select fosfomycin concentrations:
32µg/ml, 8µg/ml and 0.5µg/ml. Scale bars are 10µm.
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As previously mentioned, Harris and Theriot [51] also observed that E. coli cells
become slightly larger in the presence of fosfomycin in LB, while maintaining
a rod shape (an excerpt from Figure 2 of [51] is shown in Figure 9.7). Our
antibiotic-free bacteria are slightly smaller than those in Harris and Theriot [51],
however correcting for this and applying a linear projection on the data in Harris
and Theriot [51] to a fosfomycin concentration of 0.5µg/ml yields good agreement.
Our measured average width after 3 hours at 0.5µg/ml Fos. is 1.14±0.18µm while
the projection from the Harris and Theriot data gives a width of 1.06± 0.17µm.
Similarly the average length we measured after 3 hours at 0.5µg/ml Fos. is
3.5± 1.4µm, and the projection gives a length of 4.1± 0.7µm.
Interestingly, these morphology dynamics are the opposite of what we hypoth-
esised in Section 9.1.3 based on the optical density curves. The OD curves
showed a bump at low fosfomycin and a plateau at high fosfomycin, thus we
hypothesised that elongation was inhibited at low fosfomycin (suggesting likely
spherical morphologies) while division was more inhibited at high fosfomycin
(suggesting likely filaments). However our microscopy data demonstrates that in
fact filaments form at low fosfomycin, and small spherical morphologies form at
high fosfomycin.
9.3 Modelling fosfomycin morphology dynamics
Figure 9.6 shows that, after three hours of exposure to 0.5µg/ml fosfomycin, cell
length and width increase relative to growth in the absence of antibiotic. These
“fat filaments” were observed at the low fosfomycin concentration, while small
spherical cells were observed at fosfomycin concentration at the MIC and above.
The model was tested to see if it could recover this behaviour.
Fosfomycin can be mimicked by decreasing the synthesis rate of precursors in our
0.20.40.60.81.0



























Figure 9.9: Simulation output for average width (left) and length (right) after
three hours at various synthesis rates S = xS0, where S0 is the antibiotic-free
synthesis rate. Parameters taken from Tables 7.1 and 8.2.
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Figure 9.10: Predicted SA/V after 3 hours at decreasing synthesis rates,
reproducing fosfomycin-like dynamics. Results of model simulations using
parameters from Table 6.4.
mathematical model. Simulations were carried out as discussed previously (Ch 7
Section 7.1) at a range of synthesis rates, and the morphology assessed. The
parameter values for pH 7.4, 37°C were used (see Table 6.4).
Figure 9.9 shows that the morphology dynamics were successfully captured
in the model. The cell width and length after three hours of fosfomycin
exposure increase with decreasing synthesis rate (mimicking increasing fosfomycin
concentration) (Figure 9.9), and the surface area to volume ratio decreases with
increasing inhibition (Figure 9.10) as we see in our experimental data (Figure 9.6)
at the low (filament-forming) 0.5µg/ml fosfomycin, and as reported by Harris and
Theriot [51]. The model successfully predicts small fat filaments at low levels of
fosfomycin-like inhibition but, as can be seen in Figure 9.9, at high inhibition
levels the model predicts longer and fatter filaments, not the small spheres we
observed experimentally (Figure 9.8). This could be due to the lack of lysis in the
simulations. This preliminary result is nevertheless encouraging, since it suggests




Ideas for further work
10.1 Short term future work
To verify some of the model’s predictions it would be useful to carry out more
microscopy on the intermediate growth medium MOPSgluCAA, for mecillinam
and aztreonam. This would allow us to verify if the quality of predictions
for the CFU dynamics (using linear interpolation for the parameter values),
correspond to the quality of the morphology predictions, by also comparing the
morphology tracks. In particular, as the linear interpolation for the number of
divisomes did not capture the correct CFU dynamics in the presence of high
aztreonam, having more microscopy data would allow us to perform a fit to
the antibiotic-free morphology and compare the predicted parameter values with
those hypothesised from the linear interpolation. It would also be interesting
to see if this antibiotic-free fit is able to recover the observed CFU dynamics at
high aztreonam in MOPSgluCAA. Furthermore, having fits to the antibiotic-free
morphology in MOPSgluCAA (and potentially other media variants) would allow
us to determine the growth medium dependence of these parameters.
It would also be useful to have more experimental data with fosfomycin e.g.
microscopy and CFUs in MOPS media variants rather than LB. Higher resolution
microscopy in MOPS media would allow us to better quantify the morphology
dynamics of E. coli in the presence of fosfomycin, and better compare to the
model results. Furthermore, having CFU data would allow us to determine the
lysis rates when precursor synthesis is blocked. This would allow us to test
whether the experimental observation at high fosfomycin concentration is better
predicted by the model when lysis is included.
164
10.2 Long term future work
10.2.1 Extending our work with the current antibiotics
In order to be able to make more predictions from the model it would be necessary
to determine in more detail the relationship between the experimental antibiotic
concentration and the inhibition level in the model. In order to determine this
relationship it would be necessary to perform experiments, and fit the morphology
dynamics, for a wider range of antibiotic concentrations.
Furthermore, the model currently assumes instantaneous diffusion of the antibi-
otics to their cellular target. This is not necessarily the case: e.g. cefotaxime is
thought to take up to 2 hours to reach a sufficient concentration in the periplasm
to be fully active [69]. Thus the model may make better predictions if the diffusion
rates of the antibiotics are taken into account.
The model could also be extended to include the evolution of antibiotic resistance
and thus recover the expected regrowth dynamics at later times, where the
regrowth is caused by evolution. It would additionally be interesting to explore
how well the model performs in scenarios when the antibiotic concentration is not
constant. For example, one might wonder whether the model can recover normal
growth once the antibiotic pressure has been removed, despite lacking the explicit
inclusion of hydrolases/remodelling enzymes. It could also be interesting to know
if the model can be adapted for resistant mutants, e.g. with modified PBPs.
10.2.2 Antibiotic combinations
Another interesting area that our model could be applied to is that of antibiotic
combinations. Combination therapies are currently being used to improve
antibiotic efficacy in the clinic, and can reduce the emergence of resistance [14].
It is necessary to study antibiotic combinations carefully as the combined impact
is not always more effective at clearing the bacterial population. Furthermore, it
is experimentally expensive to study antibiotic combinations in detail and only
possible due to advances in automation [8].
Antibiotic combinations can result in synergy or antagonism. Synergy occurs
with antibiotic combinations when less of each antibiotic is required to have the
same level of inhibition, whilst antagonism occurs when the antibiotics are less
effective when used in combination [14]. The class of antibiotic can often be
used to guess if synergy or antagonism is expected, e.g. aminoglycosides and cell
wall-targeting drugs are known to be synergistic [155].
It would be useful to have a mathematical model that can predict which
combinations of cell wall-targeting antibiotics are likely to be synergistic or
antagonistic. We believe that our model can help with this, and we have
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Figure 10.1: Heat map for cell growth (represented as optical density) at five
antibiotic-free doublings in the presence of both fosfomycin and mecillinam.
performed a small amount of preliminary work in this direction.
10.2.2.1 Population dynamics with fosfomycin in conjunction with
mecillinam
In order to test the model’s capabilities for antibiotic combinations we carried
out a pilot “checkerboard assay” experiment for combinations of fosfomycin and
mecillinam in MOPSgluRDM (this was performed in collaboration with E.T.).
The protocol is as described in [77, 97] and involves carefully pipetting antibiotic
solutions into the wells such that one antibiotic has a concentration gradient
vertically and the other horizontally (Figure 10.1). The results for fosfomycin
with mecillinam can be found in Figure 10.1, represented as a heatmap where the
colour is indicative of the optical density reached after five antibiotic-free doubling
times. From analysis of the growth rates in this experiment we conclude that the
combination of fosfomycin and mecillinam is generally more inhibitive than either
antibiotic on its own i.e. synergistic (see Figure E.1 in Appendix). Based on this
statement one might expect the heat map in Figure 10.1 to have a gradient
from green in the bottom right corner, to red in the top left corner. However,
while the top left corner is indeed red, the bottom corner is in fact more orange
and there is a green band across the diagonal. This means that higher optical
densities are being reached at higher concentrations of the antibiotics, despite the
synergism between them. We were interested to see if the model could explain
this phenomenon.
10.2.2.2 Testing the model for fosfomycin and mecillinam synergy
The model can also be used to predict the population dynamics in combinations of
mecillinam and fosfomycin in rich media. The model was set up using parameters
in Tables 7.1 and 8.2 and the synthesis rate and elongation incorporation rate
varied simultaneously. In order to be able to directly compare between the
experiments and the simulation the number of cells after five antibiotic-free
doubling times was extracted from the model. It has previously been shown
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Figure 10.2: Predicted heat maps for cell growth at five doublings in the presence
of both fosfomycin-like (S1) and mecillinam-like (R1) inhibition. The top grid
on the left is the number of cells output from the model and the top grid on the
right is the number of cells multipled by the volume to approximate biomass.
The bottom grid is the number of cells divided by the surface area to give some
approximation to the optical density
that the turbidity of a bacterial population that experiences shape changes,
scales with 1/r2 [73]. Therefore to approximate optical density the number
of cells at five antibiotic-free doubling times was divided by the surface area.
These two interpretations of the model output can be seen in Figure 10.2 (Note
that there is no lysis in this version of the model). By scaling the number
of cells with the surface area, some of the non-monotonic behaviour observed
experimentally can also be observed when R (the incorporation rate) is decreased
at a range of synthesis rates. This suggests that the model indeed has potential
for application to antibiotic combinations. Scaling the number of cells by the
volume to approximate total biomass results in a similar heat-map as for the
number of cells only, with no non-monotonic behaviour. This could be due to the
lack of lysis in this model implementation, or perhaps the observation that optical
density scales with total biomass no longer holds when bacteria experience large
changes in cell width, as suggested in [73].
10.3 Conclusions
In this thesis we have presented a comprehensive experimental data set covering
the morphology and population dynamics of E. coli in a range of growth media
and with a range of cell wall-targeting antibiotics. Using our experimental results
for mecillinam and aztreonam, and literature estimates, we have successfully
constructed a mathematical model that can predict the morphology and CFU
dynamics of E. coli in different growth media, by considering the mechanism of
action of the antibiotic. This mathematical model makes a range of assumptions,
and coarse-grains many of the cellular processes, while still successfully capturing
the growth medium dependent inhibition of both mecillinam and aztreonam.
One of the core assumptions of our model was that cell wall expansion was
carried out by elongasome and divisome enzyme complexes. During the
course of this thesis, continuing work in the field has determined that the
elongation machinery is more complex than a simple elongasome complex,
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with evidence for multiple autonomous systems. It appears that aPBPs (bi-
functional transpeptidase/glycotransferase enzymes) carry out elongation activity
independently of the rod complex (i.e. PBP2, RodA MreC etc.) [26].
Furthermore it has been shown that in B. subtilis the rod-complex and aPBPs
have inverse effects on cell width [26]. This could be relevant for future refinement
of our model.
Some of the other key assumptions of the model were that peptidoglycan
density remained constant, that lysis rates had a linear dependency on the
fractional change imposed by the antibiotic on enzyme activity or enzyme number
(e.g. in R for mecillinam), that there is some relation between lysis and the
changes in morphology (e.g. becoming large spheres or long filaments), that the
peptidoglycan precursor incorporation rate scaled with the volumem, that there
exists some kind of fatness threshold, as well as a sphere threshold. Most of these
assumptions arose in order to make the model fit the data. Possible refinements
of the model could lie in removing, or relaxing, these assumptions. Potentially
most importantly, relaxing the assumption of constant peptidoglycan density may
remove the need for a sphere threshold. This could also allow the development of
a more abstract model. For example, we believe similar results would be found in
a model which only explicitly modelled the volume and surface area growth, but
which had a fatness threshold. This in theory would still result in the key model
predictions for lysing, spherical cells under the action of mecillinam, short lysing
filaments in rich media under the action of aztreonam and long, relatively stable
filaments in poor media under the action of aztreonam. Such a simplification of
the model would allow us to more fully explore the phase space.
Another limitation of the model is that it deals with average behaviour i.e. does
not account for cell to cell variation. As the aim of the model was to reproduce
population level dynamics, this is a reasonable approximation. Nevertheless, cell
to cell variation and heterogeneity, as well as potential stochastic effects (e.g.
efficacy of antibiotics against individuals may depend on stochastic variation in
gene expression e.g. in the formation of persister cells [70]), are likely to impact on
the population dynamics observed experimentally. The model could be adapted
to draw parameter values from various distributions e.g. number of elongasomes,
lysis rates. In this way, by running many versions of the model it may be possible
to recover any dynamics which arise due to variation in the population.
Our key result for mecillinam is that the antibiotic is less inhibitive on poor media
as the bacteria can continue to divide as small spheres, whilst on rich media the
spheres become too large and lyse (due to the fatness threshold). For aztreonam,
our key result is that at low concentrations the poor medium is more inhibitive
due the formation of filaments, whilst the rich medium is more inhibitive at higher
concentrations due to malfunctioning divisomes. The aztreonam results are also
dependent on the presence of the fatness threshold which has proven to be the
most significant feature of the model. How, and if, such a fatness threshold is
present in E. coli requires more careful experimental work.
168
In the model we also tested three models for the triggering of division: timer,
adder and precursor threshold. We found that the timer model did not result
in steady state growth in this simulation set-up. Little difference was observed
between the adder and precursor threshold models. More work could be done to
examine differences between the division models; for example, all the parameter
fitting was performed with the precursor threshold model, and it would be
interesting to see if the same parameter values emerge as best fits if the adder
division model were to be used instead.
Overall the model has been very successful and has a lot of potential for extension
in the current area, as well as application to new antibiotics, combination of
antibiotics, and antibiotic resistant mutants.
10.3.1 Novelty with respect to other models in the
literature
While other models exist that look at the relationship between bacterial cell
morphology and population dynamics in the presence of cell wall-targeting
antibiotics [124], we believe that our model is the first to successfully link cell
wall biosynthesis, the antibiotic mechanism of action, changes in morphology and
population dynamics. Furthermore the model is capable of making predictions
for various cell wall-targeting antibiotics, with different mechanisms of action.
The complexity of cell wall synthesis (even in this coarse-grained form) results in
a model which does not nicely collapse onto a universal result like that in Greulich
et al. [48] for ribosome-targeting antibiotics. However, there is potential to take
elements of the model and abstract them a little to get interesting analytical
results. Nevertheless our model makes some broad conclusions. Firstly, we found
that the fatness threshold was a crucial component for achieving the expected
morphology dynamics in the presence of both mecillinam and aztreonam. Our
fit for the fatness threshold (rth = 0.009nD) was also found to agree with an
estimate derived from literature data (rth ' 0.01nD, Chapter 7). Additionally,
it was observed that the mode of inhibition of elongation is not significant, but
rather the downstream impact of the morphological changes which results in the
lytic activities of the antibiotics. Overall this model, while it could be refined
further, has made a decisive step towards increasing our understanding of the





• Cell wall model paper - I am currently drafting a manuscript which will
include both experimental and modelling results.
• Morphology paper - I am also expecting to have a shorter paper focusing
on the cell morphology results.
• Mecillinam degradation paper - I am also drafting a short note detailing




B.1 Population dynamics in 50ml tubes with
mecillinam in LB and M9 variants
We see qualitatively similar growth curves for mecillinam when using test tubes
instead of the plate reader Figure B.1, compared to Figure 3.5. This is re-assuring
as it suggests that the increased growth at low Mec. concentrations are not
dependent on the method used for measuring optical density. For this trial of
growth in the shaker using tubes rather than using the microplate and plate
reader, cultures were grown to exponential phase for 3 hours before inoculation
into the final tubes. In the first trial the media for the final tubes was not pre-
warmed to 37°C - this explains the slight lag seen in all three growth conditions.
Despite this lag, we still recover very similar growth dynamics to those observed
in the plate reader (Figure 3.5).
B.2 E. coli population dynamics in M9 media
variants
B.2.1 Fosfomycin Summary
These observations are based on Figure B.2.
• In M9 minimal + glucose there are no bumps, no lysis is seen to occur.
There appears to be normal growth up to some critical antibiotic threshold,
which corresponds to the MIC.
• In M9 + casamino acids bumps start to appear, but they do not always
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Figure B.1: Growth curves for MG1655 in 50 ml tubes in the shaker at
37C/200rpm in 3 different media (LB, M9 glucose and M9 glucose with casamino
acids) and at 2 different mecillinam concentrations: high - 0.3µg/ml and low -
0.0096µg/ml, alongside growth in the absence of antibiotic.
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Growth of MG1655 in LB at varying concentrations of Fosfomycin - No=107















































Figure B.2: Growth curves for MG1655 at varying concentrations of fosfomycin
(indicated in the legend with units of µg/ml) in three different growth media: LB
(top), M9 glucose + CAA (middle) and M9 glucose (bottom)
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collapse to near background OD. The shifts of the bumps with fosfomycin
concentration are less pronounced.
• In LB bumps decrease to background levels of OD and the bumps shift with
fosfomycin concentration.
FOS IS MORE INHIBITING IN RICHER MEDIA
B.2.2 Cefotaxime Summary
These observations are based on Figure B.3.
• In M9 minimal + glucose there are no bumps, but all antibiotic concentra-
tions inhibit growth.
• In M9 + casamino acids there are bumps but with slower lysis than in LB,
generally the antibiotic is more inhibitive compared to growth in LB but
there are similar levels of regrowth.
• In LB bumps appear at the same time and height for all concentrations and
characteristic regrowth is observed.
CTX IS LESS INHIBITING IN RICHER MEDIA
B.2.3 Mecillinam Summary
These observations are based on Figure B.4
• inhibition seems to increase during growth in M9 + casamino acids
compared to LB.
• no enhanced growth at low Mec. concentrations on M9 + casamino acids
compared to growth on LB and M9 + glucose.
• on M9 + glucose see relatively less inhibition compared to growth in LB.
MEC IS MOST INHIBITING IN INTERMEDIATE MEDIA
B.3 MOPS variants - supplementary curves
B.4 Supplementary curves from the delay-time
bioassay
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Growth of MG1655 in LB at varying concentrations of Cefotaxime - No=107















































Figure B.3: Growth curves for MG1655 at varying concentrations of cefotaxime
(indicated in the legend with units of µg/ml) in three different growth media: LB
(top), M9 glucose + CAA (middle) and M9 glucose (bottom)
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Growth of MG1655 in LB at varying concentrations of Mecillinam - No=107















































Figure B.4: Growth curves for MG1655 at varying concentrations of mecillinam
(indicated in the legend with units of µg/ml) in three different growth media: LB
(top), M9 glucose + CAA (middle) and M9 glucose (bottom)
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(a) Cefotaxime in MOPSglycRDM.




















(b) Cefotaxime in MOPSgluCAA.





















(c) Cefotaxime in MOPSglycCAA.




















(d) Cefotaxime in MOPSglycMIN.
Figure B.5: Supplementary figure: Comparing the efficacy of cefotaxime across
MOPS media variants at pH 7.4, 37°C.























(a) Mecillinam in MOPSglycRDM.





















(b) Mecillinam in MOPSgluCAA.





















(c) Mecillinam in MOPSglycCAA.



















(d) Mecillinam in MOPSglycMIN.
Figure B.6: Supplementary figure: Comparing the efficacy of mecillinam across
MOPS media variants at pH 7.4, 37°C.
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(a) Fosfomycin in MOPSglycRDM.





















(b) Fosfomycin in MOPSgluCAA.





















(c) Fosfomycin in MOPSglycCAA.




















(d) Fosfomycin in MOPSglycMIN.
Figure B.7: Supplementary figure: Comparing the efficacy of fosfomycin across
MOPS media variants at pH 7.4, 37°C.
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LB media at 37°C and pH 7: no delay versus 2 hours delay




















MOPSgluRDM at 37°C and pH 7.4: no delay versus 2 hours delay





















MOPSgluRDM at 37°C and pH 6.5: no delay versus 2 hours delay























MOPSgluRDM at 34°C and pH 6.5: no delay versus 3 hours delay


















Figure B.8: Supplementary delay-time bioassay growth curves for E. coli RJA002
growing in LB and MOPSgluRDM with mecillinam (concentrations in legend in
µg/ml). The dashed curves are from the delayed inoculate where time has been


































































































































































































































































































Extra MACS data analysis
Figure C.1: Box plots with and without mecillinam derived from the MACS
data in order to better visualise the length and width distributions (Top) MACS
data for the low mecillinam condition at fast growth rate. Cell length (left) and
width(right) are presented over time with and without mecillinam. (Bottom)





















Figure C.2: Comparing the antibiotic-free morphologies measured using phase
contrast and MACS microscopy in MOPSgluRDM 37°C, pH7.4. The MACS
dataset was analysed with both MicrobeJ [31] and with a custom Matlab GUI




Figure D.1: Comparing the model (circles) and experimental (squares) length
and width distributions after 240 minutes under the action of high mecillinam
in MOPSgluRDM. Diamond markers indicate the experimental average and the
weighted averages for the model results. The sphere line indicates where the cell
length is equal to the width.
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Figure D.2: Length and width dynamics. A comparison between experimental
and simulated results using the precursor division model in poor growth
conditions under mecillinam-like inhibition (R = 0.6R0). The values in the legend
indicate the inhibition level. Each marker corresponds to a single timepoint: 0,
60, 120, 180, and 240 minutes from the addition of mecillinam, going roughly
from left to right.
Using the inhibition level of R = 0.6R0 to represent high mecillinam
Precursor model: slow growing bacteria in high mecillinam











Precursor model: fast growing bacteria in high mecillinam











Figure D.3: Ellipse trajectories based on the average length and width every
thirty simulation minutes for R = 0.6R0. Tables 7.1 and 6.4 for parameter
values.
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Population dynamics with mecillinam: adder model
































Figure D.4: Solid lines: The log cell number dynamics in the model at high
(R = 0.5R0) and low (R = 0.8R0) mecillinam-like inhibition for slow growing
cells using the adder division model. Filled circles: The experimental data for
colony forming units in the presence of high (1.5µg/ml Mec.) and low (0.094µg/ml
Mec.) for slow growing cells in MOPSgluMIN.
Population dynamics with mecillinam: intermediate media


































Figure D.5: Solid lines: The log cell number dynamics in the model at high
(R = 0.5R0) and low (R = 0.8R0) mecillinam-like inhibition for intermediate
growing cells. Filled circles: The experimental data for colony forming units














































































Figure D.6: Comparison between cell number dynamics in three different
growth conditions: rich, medium and poor, in a high (1.5µg/ml) mecillinam-like
inhibition (left) and a low (0.094µg/ml) mecillinam-like inhibition (right).
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Population dynamics with aztreonam: precursor model
































Population dynamics with aztreonam: adder model
































Figure D.7: Population dynamics with no elongation during pole formation.
Solid lines: The log cell number dynamics in the model at high (nD = 0.4nD0)
and low (nD = 0.5nD0) aztreonam-like inhibition for both fast growing (left)
and slow growing (right) cells. Filled circles: The experimental data for colony
forming units in the presence of high (0.5µg/ml Azt.) and low (0.0313µg/ml Azt.)
for both fast and slow growing cells. In this example φD = 1.7 and ψD = 0.01.
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Figure D.8: A comparison between the antibiotic-free morphology from the
experiments and the model when using the parameters fit without elongation
during pole formation (Tables 6.4 and 7.1), applied when elongation is included
during pole formation. This poor fit highlights the need to perform a parameter
search with elongation included during pole formation.
188
With elongation during pole formation
Fitting φD: high Azt., rich media Fitting ψD: high Azt., poor media
Fitting nD: low Azt., rich media
Figure D.9: Plots demonstrating the fitting for the lysis rate constants (φD and
ψD) under high aztreonam-like inhibition, and for the inhibition level (nD) under
low aztreonam inhibition, using the parameters found when elongation is included
during pole formation (Table 8.2). φD = 2.3× 10−6 disaccharides, ψD = 0.011/h
and nD = 0.75nD0 were chosen as the best fits.































































































Figure D.10: Comparing the transition to spherical morphology between the
precursor threshold division model (top row) and the adder division mode
(bottom row), when mecillinam like inhibition is applied at the beginning (1st




Additional data analysis for the
combination of fosfomycin and
mecillinam
Figure E.1: Analysis of the growth rate in the presence of both fosfomycin and
mecillinam to determine the interaction type using the formula in [97]. Red
signifies synergy, purple additive behaviour and blue antagonism.
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